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Summary 
 
Autism spectrum disorder (ASD) is a highly impairing neurodevelopmental condition, 
manifesting in childhood and continuing into adult life. Comorbid psychiatric and 
physical illness lends considerable increased mortality to the condition. An increased 
awareness of comorbid conditions in adults with normal IQ ASD could improve 
diagnostic formulation, facilitate targeted treatments and improve psychosocial 
outcomes.  
 
This study examines the prevalence of comorbid psychiatric and physical illness in 413 
adults with normal IQ ASD, attending a tertiary referral neurodevelopmental clinic in 
South London, to determine if rates of comorbid illness would be greater than rates 
reported in the general population. 
 
This study noted autism spectrum disorder in 70% of participants, with a male-to-
female ratio of 2.8:1. Milder forms of ASD were recorded for 88%. Participants with 
autism spectrum disorder were more likely to be single, unemployed and living in the 
company of others. Seventy-six percent suffered from a comorbid Axis I illness and 
2% suffered from a comorbid Axis II condition. Anxiety spectrum disorders were the 
most common comorbid psychiatric illness, followed by attention deficit hyperactivity 
disorder, mood disorders and deliberate self-harm. Psychosis, substance-use 
disorder, eating disorder and tic disorder were rarely diagnosed. Participants with 
Asperger’s syndrome were statistically more likely to be diagnosed with a comorbid 
psychiatric illness, most commonly obsessive compulsive disorder. Eighty-four percent 
of participants had a history of physical illness, most frequently asthma followed by 
head injury. Sleep difficulties and eating disturbance were notably high at 42% and 
25% respectively. 
Adults with normal IQ autism spectrum disorder suffer higher rates of physical and 
psychiatric morbidity, display a poorer ability to engage with treatment and have a 
lower chance of recovery compared to the general population. Increased awareness 
and a high degree of diagnostic skill to identify those with the disorder should be 
promoted among physicians and psychiatrists. 
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Chapter 1: Introduction Chapter 
 
1.1 Overview 
Autism spectrum disorder (ASD) is a pervasive disorder characterised by a triad of 
impaired social skills, rigid communication style and characteristic repetitive and 
ritualised behaviours, first evident in infancy and persisting into adulthood. This 
introductory chapter aims to introduce autism spectrum disorder, describe the history 
of the disorder, discuss epidemiology, aetiology, clinical presentation, methods of 
diagnosis and outline psychiatric and physical illnesses which can co-occur with the 
disorder.  
This literature review consisted of a database serach to identify articles examining the 
psychiatric and physical comorbidities of adults with normal intellectual ability suffering 
from autism spectrum disorder. Search topics included the history of autism spectrum 
disorder, epidemiology, clinical presentation, aetiology, assessment and diagnosis, 
comorbid psychiatric illness and comorbid physical illness based on the population 
under study. This population referred to adult males and females with an intelligence 
quotient greater than 70 suffering from autism spectrum disorder. The author selected 
suitable articles based on the title or occasionally by study author when an author was 
widely published in the area of autism spectrum disorder; examples include Kanner, 
Asperger, Wing and Lord. All abstracts were read and when referring to the population 
under study, the full article was retrieved. All full text articles were read in detail by the 
author. 
 
1.2 The History of Autism Spectrum Disorder 
Although the origins of autism spectrum disorder as a medical condition only date from 
1943, the concept of individuals different to those around them, has existed since the 
Middle Ages. Medieval folklore speaks of ‘changeling children’; strange, beautiful, elf-
like creatures left in the place of human babies by fairies and trolls who wished for their 
offspring to be reared by human parents. Folklore used this theory of changeling 
creatures to explain the existence of infants with unexplained illness such as 
intellectual or physical disability. Early accounts of changeling children list many 
18 
 
features consistent with autism spectrum disorder and may reflect early attempts to 
explain the unexplainable (Wing, 2002a).  
Multiple terms continued to evolve over the following centuries and more recently over 
the past decades. Henry Maudsley expressed concern over odd patterns of childhood 
behaviour which he termed childhood insanity in 1867 (Wing, 2002a). Likewise other 
authors described and named a litany of childhood disorders which were most likely 
autism spectrum disorder or the rarer condition of childhood-onset schizophrenia. Such 
terms included ‘dementia precocissima’, ‘dementia precocissima catatonica’, ‘primitive 
catatonic psychosis of idiocy’, ‘symbiotic psychosis’ and ‘childhood psychosis’ (Wing, 
1979).  
‘Autism’ was introduced to medical nomenclature by Swiss psychiatrist Eugen Bleuler 
to describe a tendency towards social withdrawal and progressive loss of 
communication seen in patients with schizophrenia praecox (Bleuler 1911, Vannucchi 
2014a). It was not until 1943 that Leo Kanner first introduced ‘autism’ in the way 
physicians and psychiatrists use the term today. Kanner used the term in a broader 
context than Bleuler and was the first to publish a series of case studies of individuals 
with social, communication and behavioural dysfunction. Erroneously, this duplication 
of a previously coined term led to autism being considered an early onset variant of 
schizophrenia for many decades until, after much research and debate, it was 
recognised as a condition in its own right (Kolvin 1971, Volkmar 1991, Konstantareas 
2001, Stahlberg 2004). 
Leo Kanner (1943) described a distinctive pattern of deficits he called ‘inborn autistic 
disturbances of affective contact’ in eleven children under the age of twelve years 
(Kanner 1943, Henninger 2012). Kanner painstakingly outlined the presenting 
complaint, family histories, clinical observations and treatment outcomes of eight boys 
and three girls, concluding their diagnosis to be ‘early infantile autism’. Kanner noted 
ten common criteria among the eleven children which he suggested could be used by 
other clinicians and psychiatrists to assess for early infantile autism in their patients. 
These included an inability to develop relationships with others, delay in speech 
acquisition, non-communicative use of speech after it developed, delayed echolalia, 
pronoun reversal, repetitive and stereotyped activities, obsessive insistence on the 
maintenance of sameness, lack of imagination, good rote memory and a normal 
physical appearance (Rutter, 1978). Kanner subsequently went on to publish further 
19 
 
on this condition (Kanner 1946, Kanner 1956, Kanner 1957, Kanner 1971, Kanner 
1972). His instinct to continue publishing on the subject of early infantile autism allowed 
the condition to gain recognition throughout the academic and scientific communities.  
Hans Asperger (1944) described ‘autistic psychopathy’ in four boys under his care in 
the University Children’s Hospital in Vienna in the 1940s. His criteria were very similar 
but slightly different to Kanner’s description. Asperger described normal timing of 
speech development but abnormally pedantic and often stereotyped content with 
difficulty using pronouns, impaired non-verbal communication including little use of 
facial expression, limited or clumsy gestures, perplexed affect, impaired two-way social 
interaction, lack of understanding, an inability to use the rules governing social 
behaviour, repetitive activities and resistance to change. A distinct difference was that 
Kanner’s initial descriptions focused mainly on children while Asperger’s account 
included some adults (Howlin, 2012). In addition, Kanner was unsure as to the IQ range 
associated with ‘early infantile autism’ while Asperger’s subjects all fell within the range 
of normal intelligence. 
Historical literature is unclear as to the timing of Asperger’s first observations 
compared to those of Kanner and he was one year later in publishing. This however, 
is not the sole reason Asperger’s description remained relatively unknown. Other 
factors include a comparable lack of published articles, publication in the German 
language only (Asperger 1944, Asperger 1968), publication in non-medical literature 
(The National Autistic Society monthly magazine, 1979) and use of the term 
‘psychopathy’ which limited his prospective readership. It was not until 1981, when his 
work was revisited and revised by Lorna Wing that his findings became accessible to 
the general scientific community. Asperger’s 1944 article, originally published only in 
German, was translated by Uta Firth in her book Autism and Asperger Syndrome in 
1991, further increasing awareness of the condition among psychiatrists and 
physicians.  
Steve Silberman, a science journalist with Wired Magazine has suggested the close 
timing of the Kanner (1943) and Asperger (1944) descriptions were not entirely 
coincidental. Silberman explains that Hans Asperger worked closely with a Jewish 
physician George Frankl in the Children’s Clinic at the University Children’s Hospital in 
Vienna in the 1930’s, until Austria was annexed by German troops. A physician of the 
same name is quoted as a staff member in the Child’s Study Home in Maryland in 
20 
 
Kanner’s seminal 1943 article, when describing two weeks of observational study of 
Donal T (case 1). Silberman hypothesised that Frankl fled Nazi-occupied Austria to live 
in the United States of America bringing with him knowledge of the clinical presentation 
of Asperger’s autistic psychopathy. Other authors suggest this as the reason for 
Kanner’s use of the passive tense in the opening statement of his seminal article ‘since 
1938, there have come to our attention…’ implying he does not take credit for the 
description and rather hints to the condition as alerted to him (Coplan, 2015).  
Although, this literature review was unable to find reference by Kanner to Asperger’s 
work, there is reference by Asperger to Kanner’s findings. Personal communication 
between Hans Asperger and Lorna Wing (1981) states ‘Asperger acknowledges that 
there were many similarities between his syndrome and Kanner’s early infantile autism, 
nevertheless, he considered these were different because he regarded autism as a 
psychotic process and his own syndrome as a stable personality trait’. This is unusual, 
given the abundance of literature in the intervening years differentiating early infantile 
autism from childhood schizophrenia, especially Israel Kolvin’s (1971) seminal work 
using age of onset to differentiate the two conditions. Since that time, including the 
year of Asperger’s comment, the two diagnoses have been considered different and 
distinct entities. 
Lorna Wing is credited for outlining the ‘triad of impairments’ in her work with Judith 
Gould, broadening the concept of Kanner’s autism to include a range of deficits, each 
existing along a continuum of severity rather than as a discrete entity (Wing, 1979). 
These included lifelong deficits in reciprocal social interaction, communication skills 
and restricted interests and behaviours. Michael Rutter (1978) had published very 
similar findings the previous year, when he suggested autistic symptoms required 
grouping into the universal and specific to allow accurate diagnosis. He identified three 
broad symptom categories; a profound and general failure to develop social 
relationships, language retardation with impaired comprehension, echolalia and 
pronominal reversal and ritualistic or compulsive phenomena.  
In 1981, Wing went on to strongly suggest Asperger’s ‘autistic psychopathy’ be 
renamed ‘Asperger’s syndrome’ due to the use of ‘psychopathy’ at the time to reflect 
sociopathic tendencies. Her proposed switch in diagnostic terminology was accepted 
by the medical profession and adopted into the medical nomenclature. Currently, the 
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term autism spectrum disorder is widely used to refer to this cohort of psychiatric 
patients (American Psychiatric Association, 2013) 
 
1.3 Epidemiology of Autism Spectrum Disorder 
Though difficult to measure (Hill, 2008), the importance of knowing the accurate 
prevalence and incidence rates of autism spectrum disorder cannot be understated. 
Epidemiological studies would provide data which could be used to direct future 
research, permit examination of clinical hypotheses, ensure funding to train 
diagnosticians, increase understanding of causal mechanisms (Lotter 1966, Hill 2008) 
and allow accurate service planning and provision.  
Incidence is a measure of the number of new cases that develop in a population over 
a particular time period (Hill, 2008). Prevalence describes the number of people in a 
specific population who have an illness at a particular time point (Hill, 2008). 
Prevalence is considered important in understanding service needs and allowing 
service planning while incidence is required to allow for research into causality 
(Fombonne, 2005).  
Timing onset in autism spectrum disorder is very difficult and this compromises the 
researcher’s ability to accurately record its incidence rate. Many parents note their child 
to be ‘different’ to siblings or other children between six and eighteen months of age. 
However, this does not indicate onset of illness at age six months rather that symptoms 
were first noted or the illness diagnosed at this age. 
As with much research into autism spectrum disorder, prevalence figures have shown 
a steady rise from the 1960s to the mid-1990s (Howlin 2012, Miles 2012). These 
studies have focused primarily on ‘autism’ to the exclusion of the autism spectrum 
(Newschaffer, 2003) and been largely based on child or mixed IQ cohorts. A selection 
of mixed age and mixed IQ studies is outlined in Table 1.1. 
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Table 1.1 
 
Selection of Papers Showing Variable Prevalence Rates 
for Autism Spectrum Disorder across Six Decades 
Author, 
Year of 
Publication 
Means of 
Diagnosis 
 
ASD 
Subtype 
Rate per 
10,000 
Male: 
Female 
Ratio 
Study Cohort 
Lotter,    
1966 
Creak Criteria Autistic 
Behaviour 
4.1  2.6:1 Child cohort 
Mixed IQ 
Wing,    
1979 
Triad of 
Impairments 
Typical 
Autism 
4.9  15:1 Child cohort 
Mixed IQ 
Shah,    
1982 
Triad of 
Impairments 
Kanner’s 
syndrome 
400  Unreported Adult cohort 
All with ID 
Ehlers,   
1993 
Gillberg & 
Gillberg 
Criteria 
Asperger’s 
syndrome 
36 4.1:1 Child cohort 
Mixed IQ 
CDC,     
2000 
National 
Environmental 
Public Health 
Tracking 
Network 
Autism 
Spectrum 
Disorder 
67  Unreported Children born in 
1992 
Mixed IQ 
Nylander, 
2001 
ASD - ASQ Autism 
Spectrum 
Disorder 
140 2.8:1 Adult cohort 
Mixed IQ  
CDC,       
2002 
National 
Environmental 
Public Health 
Tracking 
Network 
Autism 
Spectrum 
Disorder 
66 Unreported Children born in 
1994 
Mixed IQ 
Wing,     
2002a 
Summary 
Paper of 39 
studies from 
1966 - 2002 
Autism 
 
0.7 - 60  Unreported Mixed age 
Mixed IQ 
Wing,    
2002a 
Summary 
Paper of 39 
studies from 
1966 – 2002 
 
Asperger’s 
syndrome 
 
26 - 57  Unreported Mixed age 
Mixed IQ 
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Author, 
Year of 
Publication 
Means of 
Diagnosis 
 
ASD 
Subtype 
Rate per 
10,000 
Male: 
Female 
Ratio 
Study Cohort 
Wing,    
2002a 
Summary 
Paper of 39 
studies from 
1966 - 2002 
Autism 
Spectrum 
Disorder 
20 - 36  Unreported Mixed age 
Mixed IQ 
CDC,       
2004 
National 
Environmental 
Public Health 
Tracking 
Network 
Autism 
Spectrum 
Disorder 
80  Unreported Child cohort 
Mixed IQ 
Fombonne, 
2005 
Summary 
Paper of 37 
studies from 
1966 - 2005 
Autism 0.7 - 72.6  1.4 - 16:1 Mixed age 
Mixed IQ 
Baird,      
2006 
SCQ, ADI-R 
and ADOS-G 
Autism 
Spectrum 
Disorder 
116.1 3.3:1 Child cohort 
Mixed IQ 
CDC,       
2006 
National 
Environmental 
Public Health 
Tracking 
Network 
Autism 
Spectrum 
Disorder 
90 Unreported Child cohort 
Mixed IQ 
Ellefsen, 
2007 
DISCO Autism 
Spectrum 
Disorder 
56 6:1 Child cohort 
Mixed IQ 
CDC,     
2008 
National 
Environmental 
Public Health 
Tracking 
Network 
Autism 
Spectrum 
Disorder 
113 Unreported Child cohort 
Mixed IQ 
Williams K, 
2008 
State and 
National data 
on government 
record 
Childhood 
Autism and 
Asperger’s 
syndrome 
3.6 - 40.8 4:1 Child cohort 
Mixed IQ 
Williams E, 
2008 
NHS records Autism 
Spectrum 
Disorder 
 
 
51.1 6.8:1 Child cohort 
Mixed IQ 
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Author, 
Year of 
Publication 
Means of 
Diagnosis 
 
ASD 
Subtype 
Rate per 
10,000 
Male: 
Female 
Ratio 
Study Cohort 
Williams E, 
2008 
NHS records Childhood 
Autism 
21.6  Unreported Child cohort 
Mixed IQ 
Williams E, 
2008 
NHS records Atypical 
Autism 
10.8  Unreported Child cohort 
Mixed IQ 
Williams E, 
2008 
NHS records Asperger’s 
syndrome 
16.6  Unreported Child cohort 
Mixed IQ 
Williams E, 
2008 
NHS records PDD-nos 13 Unreported Child cohort 
Mixed IQ 
CDC,        
2010 
National 
Environmental 
Public Health 
Tracking 
Network 
Autism 
Spectrum 
Disorder 
147 Unreported Child cohort 
Mixed IQ 
Brugha,  
2011 
 
AQ-20 and 
ADOS-G 
Autism 
Spectrum 
Disorder 
98 9:1 Adult cohort 
Mixed IQ 
White,     
2011 
 
AQ-50 High- 
Functioning 
Autism 
Spectrum 
Disorder 
190 1.5:1 Adult cohort 
Presumed 
normal IQ 
Kim,        
2011 
ASSQ, ADOS 
and ADI-R 
Autism 
Spectrum 
Disorder 
264 2.5:1 Child cohort 
Mixed IQ 
Kočovska, 
2012 
DISCO-11 Autism 
Spectrum 
Disorder 
94 2.7:1 Mixed age 
Mixed IQ 
 
Victor Lotter (1966) was the first author to look at the epidemiology of autism spectrum 
disorder. He identified a prevalence rate of 4.5 per 10,000 in a cohort of young children 
aged eight to ten years in the county of Middlesex, United Kingdom. As data were 
incomplete for three children, a conservative prevalence rate of 4.1 per 10,000 with a 
male-to-female ratio of 2.6:1 was reported. Over the years, this rate has steadily 
increased until Baird et al (2006) reported a significantly higher prevalence rate of 
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116.1 per 10,000 for autism spectrum disorder with a male-to-female ratio of 3.3:1, in 
the Special Needs and Autism Project (SNAP) in South London. This reflects an almost 
ten-fold increase in the prevalence of the disorder over 40 years. 
From 1966 through to 2012, rates as low as 0.7 per 10,000 (Wing 2002a, Fombonne 
2005) and as high as 400 per 10,000 (Shah, 1982) have been reported. Unfortunately, 
the highly diverse populations under study make these rates almost impossible to 
interpret. Study populations range from those with severe-profound intellectual 
disability (Shah, 1982) to high functioning autism spectrum disorder (White, 2011) and 
from birth (Fombonne, 2005) to 75+ years (Brugha, 2011). 
Relatively little is known about the prevalence rate of autism spectrum disorder in 
adults (Spencer, 2011). Brugha et al (2011) were the first to report data on prevalence 
rates in an adult only cohort. This survey was conducted in 2007 and originally 
published by the National Health Service Information Centre for Health and Social Care 
as ‘Autism Spectrum Disorders in adults living in households throughout England: 
Report from the Adult Psychiatric Morbidity Survey, 2007’. Four years later, on May 2nd 
2011, Brugha et al published the ‘Third National Adult Psychiatric Morbidity Survey in 
England’ quoting findings from their 2007 report. This paper described the prevalence 
rate of autism spectrum disorder as 98 per 10,000 adults within the United Kingdom. 
This cohort, though adult only and the first publication of its kind, did include individuals 
with intellectual disability. 
The only publication identified by this literature review looking at the prevalence rate 
of autism spectrum disorder among adults with normal range IQ was a study by White 
et al (2011). White et al (2011) recruited 667 college students, with presumed normal 
range IQ, in a public university in the south-eastern United States of America. A 
prevalence rate of 1.9% (190 per 10,000) for high-functioning autism spectrum disorder 
was reported. White et al (2011) do not refer to their study as the first to examine 
prevalence of autism spectrum disorder in normal IQ adults, yet it was the earliest and 
only paper identified in current scientific literature by this review. 
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Figure 1.1 - 1.3, demonstrate the variability of prevalence rates across the past six 
decades. 
 
Figure 1.1 
 
 
 
Figure 1.2 
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Figure 1.3 
 
 
It is now agreed that autism spectrum disorder constitutes 0.6% - 1% of the child 
population (Baird 2006, Hill 2008). In relation to estimates for adult rates, the dearth of 
published literature makes this figure impossible to report as part of this literature 
review. However, reported prevalence rates over the past six decades suggest autism 
spectrum disorder is a pervasive disorder which persists throughout life and is 
impervious to the effects of environment or education (Asperger 1943, Wing 1981, 
World Health Organisation 1992, Newschaffer 2003, Wentz 2005, Baird 2006, Sizoo 
2010, Oldershaw 2011, White 2011, Vannucchi 2014b). 
 
1.4 What Causes Autism Spectrum Disorder? 
The aetiology of autism spectrum disorder is not yet completely clear and although 
several explanatory models exist, no all-embracing concept provides a full explanation 
for the multiplicity of the clinical presentation or all the disorder’s core features (Roy, 
2013). Likewise, there is no evidence for a clear-cut genetic disorder or syndromal 
cause to autism spectrum disorder (Van Elst, 2013). It is proposed that a combination 
of the current existing models is likely to provide the most accurate explanation for this 
combination of impairments (Tyson, 2012). Each theory could possibly, in turn, be 
linked to genetic, environmental, neurobiological or biochemical aetiologies. ‘On the 
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other hand, autism could turn out to be a behavioural syndrome without a single cause’ 
(Rutter, 1978). 
 
1.4.1 Neurocognitive Models in Autism Spectrum Disorder 
A number of cognitive theories for autism spectrum disorder have been proposed 
throughout child, adolescent and adult literature. Theories have included high arousal, 
lack of motivation, language impairment, perceptual problems and poor emotional 
perception (Ozonoff 1991, Frith 1994). Although agreement remains that autism 
spectrum disorder affects cognitive function, each of these theories have been 
sequentially disproven.  
While investigating anomalous ‘spiky’ IQ profiles, researchers noted recurring themes 
for individuals with autism spectrum disorder. Both child and adult samples 
demonstrated consistent strength in block design but poor performance on picture 
arrangement (Frith, 1994). This led to research into cognitive processing abilities in 
those with autism spectrum disorder and the currently accepted neurocognitive models 
for autism spectrum disorder were devised. These include theory of mind deficits, 
executive dysfunction and weak central coherence (Baron-Cohen 1989, Ozonoff 1991, 
Happé 1993, Frith 1994, Baron-Cohen 2001b, Frith 2001, Happé 2001a, Hill 2004a, 
Happé 2006, Rydén 2008b, Oldershaw 2011, Tyson 2012).  
 
Theory of Mind 
Theory of mind is the ability to recognise thoughts and feelings in others. It allows an 
individual to attribute mental states to themselves and others helping to explain and 
predict behaviour (Happé, 2001a). The terms theory of mind, mentalising, mind-
blindness, mind-reading and understanding other’s minds are used interchangeably 
throughout the literature. Theory of mind or mentalising requires the ability to 
understand others as independent from the self, to take an allocentric (he/she/they) 
stance, compared to the egocentric (me/I) stance where others are only understood in 
terms relating to oneself (Rydén 2008b, Raja 2009). 
The theory of mind model can account for many deficits in social functioning although 
it is not entirely applicable to non-social deficits in autism spectrum disorder (Happé, 
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2001a). Theory of mind can explain how an individual with autism spectrum disorder 
is capable of social approach; being present in the room with others or watching others 
engage in social interactions, but lacks the ability to mentalise another’s viewpoint 
preventing them partaking or sharing. Simon Baron-Cohen (1989) attempted to clarify 
this discrepancy by dividing theory of mind into first- and second-order functions. First-
order theory of mind refers to the ability to infer what another may be thinking while 
second-order requires the ability to predict what another person thinks someone else 
is thinking (Ozonoff, 1991). He rationalised that some individuals with autism spectrum 
disorder may pass a test relating to first-order theory of mind but all would fail testing 
of second-order theory of mind. Not only did Francesca Happé (1993) disprove Baron-
Cohen’s theory relating to first- and second-order theory of mind, Ozonoff et al (1991) 
also showed theory of mind could be attributed to illnesses other than autism spectrum 
disorder.  
On the whole, although successful in explaining most symptoms of autism spectrum 
disorder, theory of mind cannot successfully account for all symptoms or all individuals 
along the spectrum. Further research led to developments in this area by describing 
executive dysfunction and central coherence.  
 
Executive Dysfunction 
Executive function is an umbrella term for higher order problem-solving cognitive 
abilities required to achieve flexible and adaptive behaviour in the pursuit of goals (Hill 
2004a, Happé 2006). Interest in executive function deficits or executive dysfunction in 
autism spectrum disorder were born from the inconsistencies in the theory of mind 
model. Psychologists utilising the Tower of Hanoi and Wisconsin Card Sorting Test 
noted reproducible impairments in individuals with autism spectrum disorder (Frith, 
1994). Parallels were drawn with those suffering from acquired brain injury noting 
common deficits in planning, inhibition, monitoring and flexibility (Oldershaw, 2011). 
Tests of planning, the complex dynamic operation of sequencing an action, using the 
Tower of London test, is impaired in individuals with autism spectrum disorder (Hill, 
2004a). Likewise, poor mental flexibility is noted by their inability to shift from a 
particular thought or action, rigidity and perseveration is seen in set rituals and routines, 
poor generativity is noted in lack of imagination and poor self-monitoring is reflected in 
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social skill deficits such as difficulty with chit-chat and turn taking (Hill 2004a, Hill 
2004b). The higher-order ability of inhibition, though grouped within executive 
dysfunction for individuals with acquired brain injury, does not appear impaired in those 
with autism spectrum disorder. James Russell (2002) reasoned this inconsistency by 
deducing that a rule valid to the ASD brain is easily adhered to. Namely, if the request 
makes reasonable sense to the ASD individual, they agree and perform, falling back 
on their savant skills of consistency and preference for logic. 
However, similar to the concept of theory of mind deficits, researchers noted executive 
dysfunction to again fall short on explaining all ASD symptoms and difficulties (Ozonoff, 
1991).  
 
Weak Central Coherence 
The third and final neurocognitive theory of autism spectrum disorder, central 
coherence, was introduced by Uta Frith (1989) to bridge the gap in attempts by theory 
of mind and executive dysfunction to explain the continuum of impairments in autism 
spectrum disorder (Happé, 2001a).  
Central coherence is the ability to draw together diverse information to allow 
understanding of events as they arise (Frith, 1994). Strong central coherence confers 
ability to extract meaning but surface information, such as typos, are missed while 
weak central coherence allows excellent attention to detail with preference for parts 
over the whole, forgoing the meaning and overall context (Happé, 2001a). Frith (1989 
and 1994) felt those with autism spectrum disorder fell into the weak category, which 
would provide strength in ability to absorb local, fine detail information but sacrifice the 
‘bigger picture’ thereby losing the global meaning (Råstam, 2008). Both skill-sets have 
advantages and disadvantages which allow the central coherence model to address 
both weaknesses and strengths in autism spectrum disorder. By comparison, theory 
of mind and executive dysfunction only focus on impairments, without successfully 
accounting for savant skills (Happé, 2006).  
Happé (1993) tested the ability to distinguish homographs within written text to 
demonstrate weak central coherence in children with autism spectrum disorder. To 
successfully pronounce homographs, words spelled the same but of different meaning, 
one is required to assimilate the context from the sentence as it is read. She noted that 
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all participants with autism spectrum disorder failed to provide the correct, in context, 
pronunciation to words such as ‘tear’ and ‘bow’, typically providing the most frequently 
used pronunciation regardless of context. This deficit was consistent across groups 
irrespective of ability in first- and second-order theory of mind.  
To date, a neuroanatomical basis to each of the three cognitive models remains 
elusive. While attempts have been made to reconcile psychology’s findings with those 
of neuroscience and neuroimaging specialists, including tenuous links to the right 
hemisphere, medial prefrontal regions and posterior superior temporal regions, 
findings have been inconsistent (Frith 2001, Hill 2004a, Happé 2006, Oldershaw 2011). 
This is primarily attributed to the difficulties encountered in designing suitable 
mentalising tasks to distinguish between participants with autism spectrum disorder 
and neurotypical controls (Frith, 2001). 
Generally, although Baron-Cohen and colleagues continue to argue the all-inclusive 
nature of theory of mind, most researchers agree that a single cognitive deficit cannot 
account for a disorder as wide ranging and complex as autism spectrum disorder. 
Table 1.2 has been designed as part of this literature review to link the clinical 
syndrome of autism spectrum disorder, to each of the above neurocognitive models.  
 
Table 1.2 
 
Autism Spectrum Disorder as explained 
by the Neurocognitive Models 
Neurocognitive 
Model 
 
ICD-10 symptoms 
Theory of Mind  Failure to develop peer relationship that involve a mutual 
sharing of interests, activities and emotions 
 
 Lack of socio-emotional reciprocity as shown by an 
impairment or deviant response to other people's emotions 
 
 Lack of spontaneous seeking to share enjoyment, interests or 
achievements with other people 
 
 Lack of varied spontaneous make-believe play or social 
imitative play 
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Neurocognitive 
Model 
 
ICD-10 symptoms 
Executive Dysfunction  Relative failure to initiate or sustain conversational 
interchange in which there is reciprocal responsiveness to the 
communications of the other person 
 
 Stereotyped and repetitive use of language or idiosyncratic 
use of words or phrases 
 
 An encompassing preoccupation with one or more 
stereotyped and restricted patterns of interest 
 
 Apparently compulsive adherence to specific non-functional 
routines and rituals 
 
 Stereotyped and repetitive motor mannerisms that involve 
either hand or finger flapping or twisting or complex whole 
body movements 
 
Weak Central 
Coherence 
 Failure to use eye-to-eye gaze, facial expression, body 
posture and gestures to regulate social interaction 
 
 Preoccupations with part-objects of non-functional elements 
of play materials 
 
 
1.4.2 Neuroanatomical Aetiology in Autism Spectrum Disorder 
Multiple brain structures have been implicated in the aetiology of autism spectrum 
disorder (Abrahams 2010, Miles 2012). To date, such findings have been inconsistent 
(Toal, 2010) and studies identified as part of this literature review mirror this trend. It is 
hypothesised that inconsistent findings in the area of neuroanatomical research in 
autism spectrum disorder is most likely due to different methodologies and 
heterogeneity of study samples varying in age, gender, ASD subtype, intellectual 
capacity and presence or absence of a comorbid disorder. 
Neuroanatomical studies have looked at a number of potentially causative structural 
brain abnormalities in autism spectrum disorder. Probably the most researched is total 
brain volume. Total brain volume was initially implicated by Kanner when he described 
increased head size in five of his cases (Toal, 2005). Researchers have gone on to 
replicate findings of increased brain volume in children (Toal 2005, Miles 2012) though 
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findings in adult subjects are more inconsistent varying from increased volume (Toal, 
2010) to no difference (Murphy 2012, Rieldel 2014).  
In addition to variation in total brain volume, individuals with autism spectrum disorder 
show variation in brain structure. Gross changes in white and gray matter are noted in 
almost all lobes of the brain. Findings include increased gray matter in the frontal lobe, 
increased and reduced gray matter in the temporal lobes, reduced white matter in the 
temporal lobes, increased white matter in the parietal lobes and reduced gray matter 
in the occipital lobe (McAlonan 2002, Craig 2007, Toal 2009, Toal 2010). Subcortical 
structural abnormalities include reduced gray matter and increased white matter in the 
limbic system and normal sized, smaller and larger amygdala have been reported 
(Craig 2007, Maier 2015). Findings also vary in relation to the cerebellum which has 
been reported as of normal volume, smaller and larger in individuals with autism 
spectrum disorder compared to neurotypical controls (Toal, 2010). It is estimated that 
between 10% and 40% of children with autism spectrum disorder have abnormal brain 
structure (Miles, 2012). This literature review could not identify a percentage of affected 
adults with autism spectrum disorder. 
The absence of a single absolute diagnostic symptom makes it difficult to localise 
pathology to a specific brain region in adults with normal IQ autism spectrum disorder. 
Although abnormalities have been noted in the frontal, temporal, parietal and occipital 
lobes, limbic system and cerebellum no consistent structural abnormality has been 
identified in all individuals with autism spectrum disorder (Gargaro, 2011). 
 
1.4.3 Genetic Aetiology in Autism Spectrum Disorder 
Hans Asperger and Leo Kanner both noted similarities in disposition between the 
children under their care and their fathers, namely ‘eccentricity’ and ‘single-
mindedness’ (Wing 1981, Happé 2001b). They felt these common traits implied familial 
tendency and by extension, genetic inheritance. Over the following six decades, 
researchers have been in agreement that autism spectrum disorder is the ‘most 
strongly genetic’ of the multifactorial psychiatric illnesses (Bailey 1995, Howlin 1999, 
Happé 2001b, Murphy DG 2002, Newschaffer 2003, Stahlberg 2004, Ellefsen 2007). 
Autism spectrum disorder is now considered a genetic condition with a notably high 
heritability index (>0.90) (O’ Roak 2008, Miles 2012). Increased concordance among 
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monozygotic twins (36% - 95%) compared to dizygotic twins (0% - 10%) and a sibling 
recurrence rate of 8% indicate a significantly higher risk among first-degree relatives 
compared to the general population (Miles 2011, Miles 2012, CDC 2013). This is not 
unique to cohorts of mixed age and mixed IQ but also applicable to individuals with 
normal IQ autism spectrum disorder (Zafeiriou, 2013). The subsequent search for a 
genetic basis to autism spectrum disorder is an area of particular research interest due 
to its potential to provide a greater understanding of the underlying aetiology of this 
disorder, allow for genetic counselling, predict those patients at greatest risk for the 
disorder and possibly lead to new treatment modalities (Maestrini, 2000). Reliable and 
repeatable genetic markers however have been difficult to isolate. 
Approximately 10% of autism spectrum disorder is associated with a known medical 
disorder (Geschwind, 2008). The remainder of cases are considered to be of unknown 
aetiology. The mode of inheritance in such ‘idiopathic’ or ‘non-syndromal’ autism 
spectrum disorder is complex and believed to be polygenic or oligogenic rather than 
simple monogenic or Mendelian inheritance (Maestrini 2000, Wassink 2004, Ma 2005, 
Willsey 2015). Such a mode of inheritance has led to the identification of several 
susceptibility genes, each of only weak or moderate effect and individually unable to 
cause the disorder, but acting together could possibly give rise to the clinical phenotype 
of autism spectrum disorder (Maestrini, 2000). Some researchers suggest 17 of the 22 
autosomal chromosomes along with the X chromosome could be involved while the 
number of genes involved in the inheritance of autism spectrum disorder could range 
from three to more than one hundred (Wassink 2004, O’ Roak 2008, Willsey 2015). 
Original studies and review papers date from 1977 and outline hundreds of 
associations. Though unquestionably incomplete, those chromosome and gene 
associations identified as part of this literature review are outlined in Tables 1.3 and 
1.4. Despite genome-wide and candidate gene association studies replicating a 
number of chromosome and gene associations, results in this area are disappointing 
for the most part (Miles, 2011). Most mutations are considered to be de novo, rare and 
of small effect size. In essence, the true genetic aetiology of this profoundly 
heterogeneous disorder remains elusive and research in the area continues. 
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Table 1.3 
 
Genome Wide Screens in Autism Spectrum Disorder 
Author, Year of Publication Chromosomes 
 
The International Molecular 
Genetic Study, 1998 
Chromosomes 2q, 7q, 16p, 17q 
Philippe, 1999 Chromosomes 4q, 5p, 6q, 10q, 18q and Xq 
Risch, 1999 Chromosome   1p 
Collaborative Linkage Study 
of Autism, 1999 
Chromosomes 7q, 13q 
Ashley-Koch, 1999 Chromosome   7q 
Buxbaum, 2001 Chromosomes 1q, 6q, 19p 
Liu, 2001 Chromosomes 5q, 8q, 16p, 19p and Xq 
Alarcón, 2002 Chromosome   7q 
Auranen, 2002 Chromosomes 1q, 3q, 7q 
Shao, 2002 Chromosomes 2q, 3, 7q, 15q, 19 and X 
Yonan, 2003 Chromosomes 4q, 5p, 8q, 11p, 17q 
McCauley, 2005 Chromosomes 3p, 6q, 7q, 12p, 16p, 17q, 19p 
Liu, 2008 Chromosomes 11p, 15q 
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Table 1.4 
 
Chromosome and Gene Findings in Autism Spectrum Disorder 
Chromosome  Genes 
 
Ma, 2009 Chromosome   5p 
Weiss, 2009 Chromosomes 5p, 6q, 20p 
2p Neurexin 1 (NRXN1) 
2q Mitochondrial transporter (SLC25A12) 
3p CTN4 
Oxytocin Receptor gene (OXTR) 
4p GABAalpha4 
4q PCDH10 
5p NIPBL 
5q GABAalpha1 
6p CNTN3 
CNTN4 
RNF8 
7q AUTS2 
CNTNAP2 
EN2 
FOXP2  
IMMP2L 
LAMB1 
NRCAM 
NPTX2  
RAY1/ST7 
RELN 
TCAG_413353 
WNT2 
11p C-Harvey-ras-1 (HRAS1) 
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Chromosome Genes 
 
12p CACNAIC 
15q GABAA Receptor Subunit  α5, β3, γ3 
Ubiquitin Protein Ligase (UBE3A) 
16p Ataxin 2-binding protein 1 (A2BP1) 
CACNA1H 
17p Homeobox A1 (HOXA1) 
17q Homeobox B1 (HOXB1) 
Serotonin Transporter gene (5-HTT, SERT) 
22q SHANK3 
Xq Neuroligin 3 (NLGN3) 
MECP2 
Xp Neuroligin 4 (NLGN4) 
 
1.4.4 Medical Factors in Autism Spectrum Disorder 
A link between autism spectrum disorder and prenatal, perinatal or post-natal 
complications was first suggested over 30 years ago (Wing, 1981). Findings however 
remain largely contradictory. While some epidemiological studies, case reports and 
short series implicate prenatal rubella, cytomegalovirus, teratogens, anoxia, cerebral 
damage and post-natal toxin exposure, others show no significant causal relationship 
with obstetric factors, intrauterine exposure to medications, receipt of vaccinations, 
immigrant status, socioeconomic status or ethnicity (Muhle, 2004). Human and animal 
testing have suggested Thalidomide, Valproate, Ethanol and Misoprostol exposure in 
pregnancy as possible causes of autism spectrum disorder in offspring (Strömland 
1994, Narita 2002, Dufour-Rainfray 2011). Judith Miles (2011) suggests in utero 
exposure to Valproate could increase an offspring’s risk of autism spectrum disorder 
seven fold. Methylmercury exposure had also been postulated as a cause of autism 
spectrum disorder but long-term epidemiological data do not support this theory 
(Ellefsen, 2007).  
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Authors have considered maternal illness / infection during pregnancy, unfavourable 
prenatal conditions such as chemical exposure, birth complications, postnatal 
vaccination and parenting style as possible causes of the condition. Generally, all have 
been either discarded or discredited in favour of biological and genetic aetiology. An 
argument could possibly remain for intrauterine haemophilus influenza and 
cytomegalovirus infection in the early stages of pregnancy (Muhle, 2004) a theory 
which remains under review. 
It is believed that up to 10% of autism spectrum disorder is directly attributable to a 
chromosomal or genetically determined disorder however no single condition causes 
more than 1% of cases (Geschwind 2008, Riedel 2014). An average figure of 5.9% 
has been suggested by researchers and the terms ‘syndromal autism’ or ‘secondary 
autism’ are sometimes used to refer to such cases (Fombonne 2005, Mouridsen 2011). 
This ASD phenotype is present to varying degrees across multiple medical conditions 
however no medical condition shows 100% penetrance for ASD symptomatology 
(Muhle, 2004). Medical conditions as identified by this literature review are outlined in 
Table 1.5.  
 
Table 1.5 
 
Medical Conditions with Associated Autism Spectrum Disorder 
Medical Condition Chromosomal / Genetic Mutation 
 
Angleman syndrome UBE3A on 15q11 
Chromosome 2q37 deletion syndrome Deletion on 2q37 
Cohen syndrome VPS13B on 8q22 
Cornelia de Lange syndrome NIPBL on 5p13 
or SMC1A on Xp11 
or SMC3 on 10q25 
Cowden syndrome PTEN on 10q23 
Down syndrome Trisomy 21q22 
Duchenne Muscular Dystrophy DMD on Xp21 
Fragile X syndrome FMR1 on Xq27 
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Medical Condition Chromosomal / Genetic Mutation 
 
Joubert syndrome AH11 on 9q34 
Landau-Kleffner syndrome GRIN2A on 16p13 
Lujan-Fryns syndrome MED12 on Xp13 
Mitochondrial chain disorders Maternal mitochondria 
Moebius syndrome 13q12 
Myotonic Dystrophy DMPK on 19q13 
Neurofibromatosis 1 NF1 on 17q11 
Prader-Willi syndrome NDN or SNRPN on 15q11 
Rett syndrome MECP2 on Xq28 
San Filippo syndrome SGSH on 17q25 
Smith-Lemi-Opitz syndrome DHCR7 on 11q12 
Smith-Magenis syndrome RA1 on 17p11 
Sotos syndrome NSD1 on 5q35 
Timothy syndrome CACNA1C on 12p13 
Tuberous Sclerosis TS1 on 9q34 
or TS2 on 16p13 
Turner’s syndrome Deletion of Xq 
Velocardiofacial syndrome TBX1 on 22q11 
Williams-Beuren syndrome Microdeletion on 7q11 
 
 
1.4.5 Biochemical Factors in Autism Spectrum Disorder 
Although a tentative link has been made between oxytocin, vasopressin, secretin and 
symptoms of autism spectrum disorder (Hollander 2003, Walsh 2008) a clear 
evidence-based link is yet to be established (Tyson, 2012). It was hypothesised that 
these peptides played a role in social attachments, social communication and repetitive 
behaviour (Hollander, 2003) however fifteen further case-control studies failed to 
replicate a link (King, 2005). 
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Anomalies in the serotonergic system, serotonin transporter gene and dopaminergic 
systems have been implicated in a more robust manner in the aetiology of autism 
spectrum disorder (King 2005, Råstam 2008). The serotonergic system influences 
social behaviour, cognitive function, amygdala response to facial expression and 
repetitive behaviours (Wassink 2004, Murphy 2006). It is recognised that individuals 
with autism spectrum disorder both with and without associated intellectual disability 
show 25% - 50% higher serum concentrations of serotonin (Anderson, 2016). Despite 
strong evidence for a link between serotonin and autism spectrum disorder, 
researchers have found contradictory evidence when attempting to determine the 
mechanism of serotonin dysfunction in the disorder (Muhle, 2004) and the precise role 
of the serotonin transporter gene in ASD symptomatology remains under study. 
 
1.4.6 Environmental Theories in Autism Spectrum Disorder 
Suggested environmental aetiologies in autism spectrum disorder are many and 
varied. Early research, from the 1940s to 1960s, considered the possibility of emotional 
causes or abnormal child-rearing methods in the aetiology of autism spectrum 
disorder, especially where parents or siblings displayed similar features (Happé 2001b, 
Wing 2002a, Newschaffer 2003). It was once believed that ‘detached and sterile care 
of the infant’ led to autism spectrum disorder (Schain, 1960). It has since been clarified 
that there is no evidence to support such theories (Wing 1981, Happé 2001a, Wing 
2002a). 
Though retracted, another distressing aetiological association was that between the 
MMR vaccine and autism spectrum disorder. A 1998 publication by Wakefield et al 
detailing case reports of 12 children is probably the highest impact environmental link 
for autism spectrum disorder to date. Wakefield et al described 12 children, aged 6 - 
10 years who reportedly lost acquired skills in communication and developed 
gastrointestinal symptoms including abdominal pain, diarrhoea, bloating and food 
intolerance following receipt of the MMR vaccine. The group described the onset of 
behavioural problems on average 6.3 days following MMR vaccination. Wakefield and 
colleagues described the connection between intestinal and behavioural pathologies 
as ‘real and reflects a unique disease process’, relating to ‘an inflamed or dysfunctional 
intestine’ following ‘the measles, mumps and rubella immunisation’. Though the paper 
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was careful in advising a causal link had not been proven, they did warn that a rise in 
autism spectrum disorder could be anticipated following the introduction of the MMR 
vaccine. 
Although many researchers have attempted to replicate Wakefield et al’s (1998) 
findings, all found a significant lack of evidence to support a link between autism 
spectrum disorder and the MMR vaccine (Wing, 2002a). The General Medical Council 
also conducted a 217 day investigation of the authors’ purported findings and found 
that the paper lacked appropriate ethical approval and patients were not consecutively 
referred (Godlee, 2011). On these grounds, the Lancet retracted Wakefield et al’s 
paper. However, other authors investigating the publication outline further fraudulent 
reporting including skilful case selection, misrepresentation of the case histories, lack 
of symptoms to constitute a new disorder, falsified timing regarding the onset of bowel 
symptoms, documentation of behavioural problems prior to receipt of the MMR vaccine 
in some cases and Wakefield’s personal role in litigation against the vaccine’s 
manufacturer (Deer, 2011). Wakefield has since been branded ‘dishonest, unethical 
and callous’ by the General Medical Council and removed from the medical register. 
Unfortunately, the full impact of his fraudulent report will only become evident over the 
coming decade as public health physicians identify the impact the associated drop in 
vaccination rates has had on herd immunity (Godlee, 2011). Possibly, more significant 
to consider is the impact on the academic community, the time and finances lost in 
attempts to replicate findings and the stigma and fear consequently attached to autism 
spectrum disorder. 
Early this century, Wing and Potter (2002a) were quite clear that ‘not one of the 
possible environmental causes has been confirmed’. Given the current lack of general 
consensus among researchers and the clear retraction of certain proposed aetiologies 
their deduction is likely to remain valid into the future. 
 
1.5 Clinical Presentation of Autism Spectrum Disorder 
Autism spectrum disorder is the most common disorder in the group of conditions 
known as the neurodevelopmental disorders (Vannucchi, 2014a). Other 
neurodevelopmental disorders include intellectual disability, communication disorders, 
attention deficit hyperactivity disorder, specific learning disorder and motor disorders 
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(American Psychiatric Association, 2013). Autism spectrum disorder can be 
behaviourally defined by diagnostic criteria specifying pervasive qualitative 
abnormalities in social and communication skills and behaviour. However, as yet, there 
are no definitive diagnostic tests, biochemical, neuroimaging or otherwise to detect 
autism spectrum disorder. Hence, diagnosis relies heavily on detailed history and 
observation of behaviour by a skilled clinician using the ICD-10 and / or DSM-5 criteria.  
For decades, there was a lack of officially defined diagnostic criteria for early infantile 
autism and autistic psychopathy as publications consisted mostly of case studies. 
Some authors provided their impression of common symptoms across cohorts of case 
studies (Kanner 1943, Eisenberg 1956, Schain 1960, Creak 1961, Lotter 1966, Ornitz 
1968, Rendle-Short 1968, Tinbergen 1972, Wing JK 1976, Wing L 1976, Gillberg 
1989). Unfortunately, though somewhat similar, the criteria proposed by each were too 
diverse to allow accurate comparison of cases or research findings or to provide 
nosological certainty (Lotter 1966, Rutter 1978). Due to the passage of time, not all 
original articles could be sourced as part of this literature review. Details of early criteria 
proposed in available articles are outlined in Table 1.6. 
Table 1.6 
 
Defining Criteria for Autism Spectrum Disorder 
Author, Year 
of Publication 
 
Criteria 
Kanner,      
1943 
Ten common features: 
- An inability to develop relationships with people  
- Delay in speech acquisition 
- Non-communicative use of speech after it developed 
- Delayed echolalia 
- Pronoun reversal 
- Repetitive and stereotyped activities  
- Obsessive insistence on sameness 
- Lack of imagination 
- Good rote memory  
- Normal physical appearance 
Eisenberg, 
1956 
2 criteria and limit in age of onset: 
- Extreme aloneness 
- Preoccupation with the perseveration of sameness 
Limit for age of onset at 1 - 2 years 
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Author, Year 
of Publication 
Criteria 
 
Schain,      
1960 
 
3  criteria for diagnosis: 
- Evidence of a severe personality disorder characterized by 
extreme preoccupation with self and unrelatedness to people in 
his environment 
- Presence of a history indicating the onset of this disorder during 
the first 2 years of life as manifested by the failure to develop the 
expected patterns of relationships to the parents or other 
guardians 
Absence of a history of serious motor retardation such as is associated 
with most forms of gross brain defect 
Creak,        
1961 
 
Five common characteristics: 
- Marked unevenness in intellectual retardation 
- Bizarre mobility 
- Gross anxiety reactions 
- Clinging social behaviour 
- Unusual sensory sensitivities 
 
Lotter,         
1966 
Twenty four features: 
- Speech not used for communication 
- Reversal of pronouns 
- Echolalia 
- Repetition of phrases 
- Visual avoidance 
- Solitary 
- Ignores children 
- Aloof and distant 
- Walks / looks through people 
- Self-spinning 
- Jumping 
- Flapping 
- Toe walking 
- Other marked mannerisms 
- Behaves as if deaf 
- Covers ears 
- Distress at noise 
- Elaborate food fads 
- Lines and patterns with objects 
- Spinning objects 
- Other elaborate ritual play 
- Carrying, banging, twirling objects 
- Insistence on sameness (objects) 
- Insistence on sameness (events) 
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Author, Year 
of Publication 
Criteria 
 
Rendle-Short, 
1969 
Requires 7 of 14 behavioural symptoms as a screening test, followed by 
clinical examination, IQ assessment, EEG and urine amino acid testing 
to meet criteria for diagnosis. 
Gillberg,     
1989 
All six criteria must be met for diagnosis: 
Severe impairment in reciprocal social interaction (>2): 
- inability to interact with peers 
- lack of desire to interact with peers 
- lack of appreciation of social cues 
- socially and emotionally inappropriate behavior 
 
All-absorbing narrow interest (>1): 
- exclusion of other activities 
- repetitive adherence 
- more rote than meaning 
 
Imposition of routines and interests (>1): 
- on self, in aspects of life 
- on others 
 
Speech and language problems (>3): 
- delayed development 
- superficially perfect expressive language 
- formal, pedantic language 
- odd prosody, peculiar voice characteristics 
- impairment of comprehension including misinterpretations of 
literal / implied meanings 
 
Non-verbal communication problems (>1) : 
- limited use of gestures 
- clumsy / gauche body language 
- limited facial expression 
- inappropriate expression 
- peculiar, stiff gaze 
 
Motor clumsiness:  
- poor performance on neurodevelopmental examination 
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The ICD and DSM communities were slow to accept autism-like conditions and to 
describe them using independent diagnostic categories or criteria. In DSM-I and DSM-
II, autism-like illnesses were included under the concept of childhood schizophrenia. 
In ICD-8, although autism was introduced as a term, it remained a subgroup of 
schizophrenia (Wing, 2002a). It was not until 1980, that autism was provided with an 
independent diagnostic category when the DSM-III introduced ‘infantile autism’. From 
DSM-III to DSM-III-TR came the most significant diagnostic advances for autism when 
criteria became more concrete and measureable (Factor, 1989).  
Asperger’s syndrome was slower to gain recognition among nosologists as DSM and 
ICD did not publish diagnostic criteria for Asperger’s syndrome until some ten years 
later when DSM-IV set out five conditions within chapter one’s description of pervasive 
developmental disorders: autistic disorder, Rett’s disorder, childhood disintegrative 
disorder, Asperger’s syndrome and pervasive developmental disorder - not otherwise 
specified, including atypical autism (American Psychiatric Association, 1994). The 
evolution of the ICD and DSM autism-related diagnostic criteria are outlined in Table 
1.7. 
 
Table 1.7 
 
ICD and DSM: Evolution of Diagnostic Criteria for Autism Spectrum Disorder 
Publication 
 
Name of Condition 
1952, DSM-I Childhood schizophrenia 
1967, ICD-8 Infantile autism classified as a subgroup of schizophrenia 
1968, DSM-II Childhood schizophrenia 
1978, ICD-9 Infantile autism classified as a subgroup of childhood psychosis 
1980, DSM-III Infantile autism as a distinct diagnostic category 
1987, DSM-III-R Pervasive developmental disorders 
1992, ICD-10 Pervasive developmental disorders 
1994, DSM-IV Pervasive developmental disorders 
2000, DSM-IV-TR Pervasive developmental disorders 
2013, DSM-5 Autism spectrum disorder 
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The ICD-10 (World Health Organisation, 1992) and DSM-5 (American Psychiatric 
Association, 2013) now provide clinicians with useable diagnostic criteria, allowing 
more accurate assessment, diagnosis and research in the area of autism spectrum 
disorder compared to previously. Currently, the ICD-10 outlines eight conditions under 
F84: childhood autism, atypical autism, Rett’s syndrome, other childhood disintegrative 
disorder, overactive disorder associated with mental retardation and stereotyped 
movements, Asperger’s syndrome, other pervasive developmental disorders and 
pervasive developmental disorder, unspecified. Although Rett’s syndrome is included 
in the ICD-10 listing of autism spectrum disorder, its presence on the list is considered 
controversial and misplaced by many. Gillberg and Billstedt (2000) point out that 
although some individuals with Rett’s syndrome have autism-like symptomatology, the 
criteria for autism spectrum disorder are not fulfilled by all. Criteria for each subtype of 
pervasive developmental disorder as per ICD-10 and DSM-5 are outlined in Table 1.8. 
 
Table 1.8 
 
Diagnostic Criteria for Subtypes of Autism Spectrum Disorder 
 
 
International Classification of Diseases-10                                                              
(World Health Organisation, 1992) 
 
Childhood 
autism 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Abnormal or impaired development is evident before the age 
of 3 years in at least one of the following areas: 
1. receptive or expressive language as used in social communication 
2. the development of selective social attachment or of reciprocal 
social interaction 
3. functional or symbolic play 
 
B. A total of at least six symptoms from (1), (2) and (3) must be 
present, with at least two from (1) and at least one from each of 
(2) and (3) 
1. Qualitative Impairment in social Interaction are manifest in at least 
two of the following areas: 
a) failure adequately to use eye-to-eye gaze, facial expression, body 
posture and gestures to regulate social interaction 
b) failure to develop (in a manner appropriate for mental age, and 
despite ample opportunities) peer relationship that involve a mutual 
sharing of interests, activities and emotions 
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Childhood 
autism 
c) lack of socio-emotional reciprocity as shown by an impairment or 
deviant response to other people's emotions; or lack of modulation of 
behaviour according to social context; or a weak integration of social, 
emotional and communicative behaviours 
d) lack of spontaneous seeking to share enjoyment, interests or 
achievements with other people (e.g. a lack of  showing, bringing or 
pointing out to other people objects of interest to the individual) 
 
2. Qualitative abnormalities in communication as manifest in at 
least one of the following areas: 
a) delay in or total lack of development of spoken language that is not 
accompanied by an attempt to compensate through the use of 
gestures or mime as an alternative mode of communication (often 
preceded by a lack of communicative babbling) 
b) relative failure to initiate or sustain conversational Interchange (at 
whatever level of language skill is present) in which there is reciprocal 
responsiveness to the communications of the other person 
c) stereotyped and repetitive use of language or idiosyncratic use of 
words or phrases 
d) lack of varied spontaneous make-believe play or (when young) 
social imitative play 
 
3. Restricted, repetitive and stereotypes patterns of behaviour, 
interests and activities are manifested in at least one of the 
following:  
a) an encompassing preoccupation with one or more stereotyped and 
restricted patterns of interest that are abnormal in content of focus, or 
one or more interests that are abnormal in their intensity and 
circumscribed nature though not in their content or focus 
b) apparently compulsive adherence to specific non-functional 
routines and rituals stereotyped and repetitive motor mannerisms that 
involve either hand or finger flapping or twisting or complex whole 
body movements 
d) preoccupations with part-objects of non-functional elements of play 
materials (such as their order, the feel of their surface or the noise or 
vibration they generate) 
 
The clinical picture is not attributable to the other varieties of 
pervasive developmental disorders, specific development disorder of 
receptive language with secondary socio-emotional problems, 
reactive attachment disorder or disinhibited attachment disorder, 
mental retardation with some associated emotional or behavioural 
disorders, schizophrenia of unusually early onset and Rett’s 
syndrome 
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International Classification of Diseases-10                                                              
(World Health Organisation, 1992) 
 
Atypical autism A. Abnormal or impaired development is evident at or after the age of 
3 years 
B. There is insufficient demonstrable abnormalities in one or two of 
the three areas of psychopathology required for the diagnosis of 
childhood autism (namely reciprocal social interactions, 
communication or restrictive, stereotyped, repetitive behaviours) 
C. Atypical autism constitutes a meaningfully separate condition from 
childhood autism 
 
Rett’s syndrome Onset between age 7 and 24 months 
Loss of purposive hand movements and acquired fine motor 
manipulative skills 
Accompanying loss, partial loss or lack of development of language, 
distinctive stereotyped torturous wringing or ‘hand washing’ 
movements with the arms flexed in front of the chest or chin, 
stereotypic wetting of the hands with saliva, lack of proper chewing of 
food, hyperventilation, failure to gain bowel and bladder control, 
excessive drooling and protrusion of the tongue and loss of social 
engagement 
Retention of ‘social smile’, looking at or through people but not 
interacting socially in early childhood (although social interaction may 
develop later) 
Broad-based stance and gait, hypotonic muscles, poorly co-ordinated 
trunk movements, scoliosis or kyphoscoliosis 
Spinal atrophy with severe motor disability 
Rigid spasticity more pronounced in lower than upper limbs 
Associated epileptic fits, with general onset prior to age 8 years 
 
Asperger’s 
syndrome 
A. Diagnostic criteria 1 - 3 of B are fulfilled for childhood autism   
B. No evidence of general delay or retardation in language or 
cognitive development 
C. Generally associated with normal intelligence 
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Diagnostic and Statistical Manual of Mental Disorders-5                                     
(American Psychiatric Association, 2013) 
 
Autism 
spectrum 
disorder 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Persistent deficits in social communication and social 
interaction across multiple contexts, as manifested by the 
following, currently or by history: 
 Deficits in socio-emotional reciprocity 
 Deficits in non-verbal communicative behaviours used for social 
interaction 
 Deficits in developing, maintaining and understanding 
relationships 
 
B. Restricted, repetitive patterns of behaviour, interests, or 
activities, as manifested by at least two of the following, currently 
or by history: 
 Stereotyped or repetitive motor mannerisms, use of objects or 
speech 
 Insistence on sameness, inflexible adherence to routines or 
ritualised patterns of verbal or non-verbal behaviour 
 Highly restricted, fixated interests that are abnormal in intensity 
or focus 
 Hyper- or hypo- reactivity to sensory input or unusual interest in 
sensory aspects of the environment 
C. Symptoms must be present in early developmental period 
D. Symptoms cause clinically significant impairment in social, 
occupational or other important areas of current functioning 
E. These disturbances are not better explained by intellectual or global 
developmental delay 
 
Clearly, autism spectrum disorder and Asperger’s syndrome are more alike than they 
are different (Wing, 1981). The most recent version of the DSM diagnostic criteria, 
DSM-5  acknowledges this by combining autism, Asperger’s syndrome and pervasive 
developmental disorder into a single diagnosis and by changing the name of this group 
from ‘pervasive developmental disorders’ to ‘autism spectrum disorder’ (American 
Psychiatric Association, 2013). Although the category remains broad, with Asperger’s 
syndrome and PDD-nos now encompassed in the term autism spectrum disorder, 
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DSM-5 no longer divides conditions by criteria, instead a single set of criteria can be 
used to diagnose each patient.  
In DSM-5 also, the triad of symptoms seen in DSM-IV have been reduced to two, 
combining social and communication deficits into the single category of ‘deficits of 
social communication and social interaction’ alongside ‘restricted, repetitive patterns 
of behaviour, interests or activities’ (American Psychiatric Association 2013, Vannucchi 
2014a). Many agree this is a preferable means of diagnosis as differentiation between 
subgroups of ASD is clinically problematic and social and communication deficits are 
so closely linked as to be clinically inseparable (Konstantareas 2001, Wing 2011). It is 
interesting that DSM have chosen to combine the five diagnostic entities of pervasive 
developmental delay from DSM-IV into the single diagnosis of autism spectrum 
disorder in DSM-5. One could presume ICD will follow suit in their revision of the ICD-
10 into ICD-11, which is due for publication in 2018. 
An ongoing concern relating to the International Classification of Diseases is the strict 
hierarchical rules on which they are based. ICD assumes certain disorders to be more 
‘severe’, ‘basic’ or ‘pure’ than others causing certain major mental illnesses to trump 
others when providing a clinical diagnosis. Practically, this means that, on occasion, a 
patient cannot receive a diagnosis reflecting comorbidity as ICD states the co-
occurrence of particular illnesses are not permitted. This hierarchical framework can 
be helpful if researchers wish to study purer forms of autism spectrum disorder, 
although adherence to the guidelines can limit clinical provision of services and may 
not truly reflect the issues faced by real-life patients, their clinicians or families 
(Gillberg, 2000). 
Currently, ICD-10 discourages diagnosis of comorbidity in autism spectrum disorder 
by providing exclusion notes for two of the four subtypes of pervasive developmental 
disorder, namely childhood autism and Asperger’s syndrome. Exclusion notes for 
childhood autism include autistic psychopathy, referring to Asperger’s syndrome by its 
original title. Exclusion notes for Asperger’s syndrome include attachment disorders of 
childhood, obsessive compulsive disorder, anankastic personality disorder, 
schizotypal personality disorder and simple schizophrenia (World Health Organisation, 
1992). In essence, if strictly adhered to exclusion notes prevent psychiatrists from 
diagnosing particular co-occurring personality disorders, anxiety spectrum disorders 
and psychotic disorders in those suffering from Asperger’s syndrome.  
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A considerable need to revise the provision of comorbid psychiatric illness in autism 
spectrum disorder was proposed by Gillberg as early as 2000. Since that time, many 
authors have called for revision of the diagnostic criteria to more accurately reflect the 
socio-communication deficits and high comorbidity rates in autism spectrum disorder 
(Ghaziuddin 2002a, Stahlberg 2004, Van Os 2009, Gargaro 2011, Lugnegård 2012, 
Tyson 2012, Mazzone 2012). DSM-5 appears to have considered these 
recommendations providing only three exclusion criteria to the diagnosis of autism 
spectrum disorder ‘that symptoms must be present in the early developmental period, 
that symptoms cause clinically significant impairment in functioning and that symptoms 
are not better explained by intellectual disability or global developmental delay’ 
(American Psychiatric Association, 2013). No longer is there a specification to prevent 
diagnosis of comorbid Axis I or Axis II psychiatric illness in those with autism spectrum 
disorder. Likewise, autism spectrum disorder is no longer an exclusion criterion for 
schizophrenia, bipolar disorder, depressive disorder or anxiety spectrum disorders. 
However, a complex criterion clash continues for the DSM-5 definition of Cluster A 
personality disorders.  DSM-5 states that paranoid, schizoid and schizotypal 
personality disorders cannot ‘occur exclusively during the course of autism spectrum 
disorder’ (American Psychiatric Association, 2013). As autism spectrum disorder is a 
lifelong condition, this is in essence an absolute exclusion criterion.  
Similar to the provision of diagnoses in the years of early infantile autism and autistic 
psychopathy, contemporary authors can interpret the clinical symptomatology of ICD-
10 and DSM-5 differently. From 1999 to 2013, a wide variation in interpretation can be 
seen. Janet Lainhart (1999) interpreted the criteria as patients having difficulty reading 
the thoughts, beliefs, intent and emotions of other people, being unable to see the ‘big-
picture or gestalt of situations’, lacking day-to-day understanding of their world and 
unable to predict the future from past experience. Gena Barnhill (2007) described 
individuals with autism spectrum disorder as people who would struggle with the use 
of pragmatic language, providing the right information at the right time, use of social 
niceties, reading non-verbal cues and interpreting information literally. These examples 
highlight the significantly different degree of disability expected by each clinician.  
Table 1.9 describes the clinical symptomatology for each ICD-10 criterion expanding 
on those provided by Garland et al (2013). This is a useful approach as each criterion 
corresponds to the clinical approach used in tertiary ASD assessment centres. These 
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criteria, namely the triad of impairments in social and communication skills and 
repetitive behaviours, are equally applicable to diagnosis in childhood and adulthood 
(Hofvander, 2009). 
 
Table 1.9 
 
ICD-10 and DSM-5 Diagnostic Criteria with corresponding 
Clinical History and Mental State Findings 
ICD-10 Criterion 
 
 
Clinical Symptom / Sign 
 
Abnormal or impaired 
development is 
evident before the age 
of 3 years 
- Clear delay in use of speech to communicate 
- No single words by age 2 years 
- No phrased speech by age 3 years 
 
Qualitative impairment 
in social interaction 
- Few or no sustained relationships 
- Aloof, awkward interaction with others 
- Egocentric with limited empathy 
- Poor awareness of social norms 
- Lack of direct eye contact 
- Restricted or inappropriate range of facial expression 
- Lack of emotional expression 
- Absence of close sharing friendships or relationships 
- Dislike of physical contact and impaired ability to comfort  
  others 
- Lack of social chit-chat or ‘small talk’ 
- Abnormal play; dislike of shared play, lack of symbolic use of  
  toys in childhood 
 
Qualitative 
abnormalities in 
communication 
- Stilted, pedantic use of language 
- Non-reciprocal, one-sided interaction 
- Literal interpretation of what is heard 
- Restricted affect and limited use of gestures 
- Poor integration of gaze with content of speech 
- Lack of creativity and fantasy in thought  
- Lack of emotional response to another’s verbal and non- 
  verbal overtures 
- Impairs use of cadence of speech 
- Use of echolalia, neologisms and pronoun reversal 
- Lack of spontaneous conversation or sharing of personal  
  information 
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ICD-10 Criterion Clinical Symptom / Sign 
 
Restricted, repetitive 
and stereotypes 
patterns of behaviour, 
interests and activities 
- Circumscribed interest of limited practical or social  
  value 
- Obsessive pursuit of restricted interests 
- Strict daily routine and schedule 
- Deviation from daily structure causes distress 
- Resistance to change  
- Abnormal play; preoccupation with parts of objects 
- Lack of spontaneity, initiative and creativity 
- Lack of spontaneous imitation / mirroring of others 
- Unusual sensory seeking or avoidance behaviours 
- Increased sensitivity to noise 
 
 
1.6 The Importance of Diagnosing Autism Spectrum Disorder 
Although, there is no known treatment for the core impairments in autism spectrum 
disorder, morbidity can be reduced by appropriate management and education (Raja, 
2008). In addition, although it cannot be cured, early diagnosis and identification of 
autism spectrum disorder is central to implementing early interventions in an effective 
manner. Both children and adults can be helped by thoughtful ways of engaging their 
deficits and enhancing their strengths. Wing (1981) suggests that individuals with 
autism spectrum disorder respond best when there is a regular, organised routine, 
when carers communicate in ways the individual can understand, when supportive 
techniques are used to modify behaviour, when teachers ensure the child is not teased 
or bullied by their peers, when adults gain employment supported by sympathetic 
employers and workmates and when appropriate living conditions are sourced. 
Individuals with autism spectrum disorder endorse greater unmet social and healthcare 
needs than those seen in the general population (Garland, 2013). It is increasingly 
recognised that such unmet needs are associated with considerable carer burden. 
Studies looking at influences on carer burden have examined maternal and child 
variables in mixed age, mixed IQ samples. Factors associated with a reduction in carer 
burden include positive maternal affect, greater expression of maternal affection, 
higher maternal warmth, higher maternal self-esteem, lower maternal pessimism, 
higher reciprocated affection, better child health and fewer child maladaptive 
behaviours (Orsmond et al 2006). The severity of a child’s disability, nature of care 
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required, presence of behavioural difficulties, financial stress and carer’s physical 
health significantly increase carer burden (Weiss, 2010). Increased worry, stress and 
responsibility associated with caring for an individual with physical and / or mental 
illness further exacerbates carer burden (Kring 2010, Cadman 2012). Carer burden 
and distress can result in parental stress, marital discord, poor child-parent 
relationships, poor child-sibling relationships, lower quality of life and carer mental 
illness such as depression (Weiss, 2010).  
Increased mortality rates are noted among individuals with autism spectrum disorder 
compared to the general population (Howlin 2012, Hirvikoski 2016). Mortality rates are 
between 2 and 5.6 times higher than expected in the autism spectrum disorder 
population, especially among females, patients with comorbid epilepsy and those with 
intellectual disability (Howlin 2000, Barnhill 2007, Howlin 2012). Although a higher 
mortality rate associated with comorbid intellectual disability would be clinically 
expected, the strong U-shape association between mortality and IQ suggests 
increased mortality is in fact associated with both severely low and exceedingly high 
IQ scores in autism spectrum disorder (Barnhill, 2007). 
Early referral and diagnosis of individuals with normal IQ autism spectrum disorder is 
often not achieved despite widespread research indicating improved outcomes and a 
substantially better prognosis for those receiving earlier and more effective 
interventions (Constantino, 2015). Failure to recognise problems in individuals with 
Asperger’s syndrome in childhood has been shown to lead to a downward spiral of 
rejection and low self-esteem which could result in severe emotional and psychiatric 
problems (Howlin, 2000). Data suggest that appropriate evaluation, pre-drug workup, 
provision of a specific diagnosis, efficient measures of outcome and use of 
pharmacotherapy can provide a safe and efficacious means of reducing many 
symptoms suffered by individuals with autism spectrum disorder (Tsai, 1996). This 
approach is increasingly promoted in treatment recommendations and in some 
jurisdictions has become a legal obligation for policy makers (Department of Health 
UK, 2010).  
As many individuals with autism spectrum disorder only present to psychiatric services 
when they note personal limitations as adults, in areas such as obtaining employment 
despite high educational achievement, difficulty adjusting to occupational change or 
relationship failure a large cohort, especially those with Asperger’s syndrome, can 
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remain undiagnosed into adulthood (Tantam 2000, Barnhill 2007, Raja 2008). Some 
have argued that psychiatrists must accept their responsibility to diagnose autism 
spectrum disorder beyond the childhood phase and provide diagnostic, 
psychoeducational, medical and psychological treatments for the emotional and 
behavioural difficulties experienced by adults with autism spectrum disorder (Tantam 
2000, Barnhill 2007). As more adults seek assessment for autism spectrum disorder, 
corresponding healthcare services should be configured to meet their needs. 
 
1.7 Methods of Diagnosis and Assessment in Autism Spectrum Disorder 
When assessing for autism spectrum disorder, clinicians continue to rely on detailed 
history and observation to reach a diagnosis. A combination of history taking, collateral 
information taking and use of screening and diagnostic assessment tools is required. 
Clinical assessment of individuals with autism spectrum disorder can be difficult due to 
factors such as a reduced ability to describe emotions and symptoms of mental illness, 
reduced language skills and a tendency to interpret questions literally (Kannabiran, 
2009). It has been suggested that a high level of skill is required to ensure accurate 
assessment of individuals with normal IQ autism spectrum disorder, gathering of a 
reliable collateral history and competent application of standardised assessment tools 
(Lord 1989, Lord 1994, Baron-Cohen 2001a, Kannabiran 2009). Expert training and 
an opportunity to complete a large number of assessments are necessary to ensure 
clear-cut diagnosis in this complex patient group. 
Little specific literature is available on the healthcare needs of and resource utilisation 
by adults with autism spectrum disorder. One original study, one review paper, one 
health service report and one piece of legislation were sourced as part of this literature 
review. Venkat et al (2012) provide a review paper of the quality of healthcare available 
to individuals with autism spectrum disorder in Pittsburgh, USA. They report 
dissatisfaction among family and caregivers, quoting a lack of awareness of the 
condition among healthcare workers and poor quality assessment skills among 
physicians. Many carers attribute the health service’s inability to deliver effective 
healthcare to those with autism spectrum disorder to these factors (Venkat, 2012). 
Bruder et al (2012) surveyed 376 primary care physicians in the Northern United States 
of America. They found that physicians also acknowledge skill and resource deficits, 
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noting in particular a lack of training in the care of adults with autism spectrum disorder. 
Primary care physicians reported a desire for workshops and ASD specific 
conferences as a means of receiving such training (Bruder, 2012).  
The Autism Act was passed by the UK parliament in March 2010. It highlights a national 
shortage of healthcare services for individuals with autism spectrum disorder in the 
United Kingdom and places legislative responsibility on healthcare organisations to 
ensure increased awareness and understanding of autism spectrum disorder among 
all healthcare staff, increased availability of diagnosis for children and adults, a clear 
pathway for patients transitioning from child to adult healthcare services and increased 
opportunity for housing and employment for adults with autism spectrum disorder 
(Autism Act, 2009). 
A report commissioned by the Irish Health Service Executive (2012) broadly mirrored 
the findings of The Autism Act (2009). It highlighted a similar significant shortage of 
services for adults with autism spectrum disorder. Particularly noted were the lack of a 
defined pathway between child and adult services for those diagnosed with autism 
spectrum disorder in childhood, a lack of mental health services to diagnose and treat 
adults with suspected or confirmed autism spectrum disorder and a lack of training and 
education for healthcare providers. Probably most fundamental is the evidence from 
this report that the Irish health service do not have comprehensive information on the 
number of adults with autism spectrum disorder residing in the Republic of Ireland.  
 
1.7.1 Clinical Assessment of Autism Spectrum Disorder 
Individuals with autism spectrum disorder can be difficult to assess and diagnose for a 
multitude of reasons. This can lead to symptoms of one psychiatric illness being 
mistaken for another, especially if assessment is undertaken by a clinician superficially 
familiar with autism spectrum disorder (Raja, 2008). The wide overlap between some 
features of autism spectrum disorder and those of other mental illness may prevent the 
correct identification of psychiatric comorbidity in this population (Vannucchi, 2014a). 
Clinicians may find it difficult to determine whether symptoms can be accounted for by 
the diagnosis of autism spectrum disorder or reflect a second illness (Geurts, 2010). 
On occasion, psychiatric illness associated with autism spectrum disorder can be 
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characterised by atypical presentations leading to diagnostic, prognostic or therapeutic 
mistakes (Vannucchi, 2014a). 
It is important that core symptoms of autism spectrum disorder are not misdiagnosed 
as an Axis I or Axis II psychiatric illness when a neurodevelopmental diagnosis would 
be more appropriate (Vannucchi, 2014a). Symptoms such as new onset social 
withdrawal, interpersonal difficulties, appetite change, fluctuating mood, reduced self-
care, reduced adaptive functioning or poor coping could be considered part of the 
autism spectrum disorder clinical syndrome if not appropriately explored as an affective 
or psychotic illness. Eccentricity, emotional lability, anxiety, poor social functioning, 
repetitive behaviours and fixed habits, known to occur in those with autism spectrum 
disorder could result in unrequired additional diagnoses such as schizophrenia, bipolar 
affective disorder or obsessive compulsive disorder (Barnhill, 2007). Limited facial 
expression or emotions that shift quickly with exquisite sensitivity to small changes in 
the everyday environment, could be misdiagnosed as depression, mania (Lainhart, 
1999) or personality disorder. The need for strict rituals and routines could be mistaken 
for obsessive compulsive disorder (Van Elst, 2013). The core social and 
communication deficits of autism spectrum disorder could be difficult to differentiate 
from social phobia (Tyson, 2012). Complex stereotypies could be mistaken for tics 
leading to an inaccurate diagnosis of Tourette’s syndrome (Lainhart, 1999). When 
under stress, individuals with autism spectrum disorder can exhibit unusual behaviours 
or odd coping mechanisms that could be confused with psychosis. Bizarre idiosyncratic 
behaviours, poor expression of emotion or perceptual misunderstandings could be 
misdiagnosed as schizophrenia-like illness (Van Elst, 2013). ‘Disorganising anxiety’ 
could be mistaken for thought disorder of schizophrenia (Barnhill, 2007). Lack of 
initiating communication or poor socioemotional responses could be mistaken for 
poverty of speech attributed to schizophrenia (Lainhart, 1999). Likewise, intense 
preoccupations or magical thinking could be considered a delusion (Lainhart, 1999). 
Sometimes, due to sensory overload, patients with autism spectrum disorder can 
engage in deliberate self-harm in an attempt to self-regulate distress and social 
inadequacy, this could be mistaken for emotionally unstable personality disorder (Van 
Elst, 2013). Any psychiatrist confronted with a socially-isolated adult with unusual 
routines, rituals or obsessive pursuits who has not responded to treatment for their 
initial psychiatric diagnosis should suspect autism spectrum disorder (Tantam, 2003). 
Of interest, all four cases described by Asperger (1944) presented with behavioural 
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symptoms that could be classified as distinct psychiatric disorders (Ghaziuddin, 
2002a).  
Likewise, symptoms which fulfil criteria for an alternative psychiatric diagnosis should 
not be overshadowed by the diagnosis of autism spectrum disorder. This is probably 
most commonly seen in the diagnosis of Cluster A and C personality disorders (Wentz-
Nilsson, 1999). Longstanding avoidance behaviour, dependant traits or poor anger 
management could be included as ASD symptoms while a disabling personality 
disorder is missed. For these reasons, Oldershaw (2011) recommends all autism 
assessments be carried out by specialist clinicians trained in the area of 
neurodevelopmental psychiatry. 
Lainhart (1999) makes five recommendations for the accurate evaluation, assessment 
and diagnosis of autism spectrum disorder in high-functioning adults. Although almost 
17 years old, these recommendations remain useful in the assessment of those with 
autism spectrum disorder and comorbid illness today. Some have been reiterated by 
Constantino and Charman (2015).  
1. Assessors must start from the basic premise that psychiatric disorders are 
conceptually the same in adults with autism spectrum disorder as in those without a 
neurodevelopmental disorder, in that signs of the full clinical syndrome should be 
present and meet full diagnostic criteria. 
2. Assessors must have a full understanding of the limitations in affect, communication 
and social functioning which exist at ‘baseline’ for patients with autism spectrum 
disorder and avoid misdiagnosis of core ASD features as a secondary mental illness. 
3. Assessment requires direct evaluation of the patient’s mental state but also collateral 
information, as observed by others must be taken into account. 
4. Care should be taken in posing questions that can be understood by the patient but 
also time should be taken to accurately understand the reply and importantly the 
meaning of what the patient is saying. 
5. Initial diagnostic impression should be part of a differential diagnosis, inclusive of 
physical and neurological conditions, until these are carefully ruled out.  
The expertise of the assessor in understanding not only autism spectrum disorder but 
all psychiatric conditions including mood disorders, psychosis, anxiety spectrum 
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disorders and personality disorders as well as organic and medical conditions is vital 
in the assessment of patients with autism spectrum disorder. To train solely in 
identification of ASD features can lead to misinterpretation of symptoms more 
accurately attributed to other physical or psychiatric illness, while lack of awareness of 
neurodevelopmental conditions can equally result in misdiagnosis. Even when 
standardised measurement instruments are used, clinical expertise remains 
paramount (Lainhart, 1999).  Specialist diagnosis by a team familiar with the 
specificities of autism spectrum disorder allows accurate recognition and clear 
diagnosis (Van Elst, 2013).  
 
1.7.2 Screening Tools for Autism Spectrum Disorder 
Assessment tools fall into two categories; screening and diagnostic. Screening tools 
are typically completed by the patient prior to the initial assessment by a psychiatrist, 
psychologist or paediatrician. These are helpful in identifying those patients with a 
higher probability of receiving a diagnosis of underlying autism spectrum disorder 
(Baron-Cohen, 2001a) but they do not provide a definitive diagnosis. Diagnostic tools, 
on the other hand, are considered more reliable in assisting the clinician to reach a 
definitive diagnosis. These include the Autism Diagnostic Interview - Revised and the 
Autism Diagnostic Observation Schedule - Generic. 
Screening tools were designed and validated as a means for clinicians to quickly, yet 
reliably identify those at-risk individuals requiring further evaluation for likely autism 
spectrum disorder. They are also useful in the early stages of epidemiological research 
looking at very large population groups, as used by Brugha et al (2011) to determine 
the prevalence of autism spectrum disorder in adults living in households in the United 
Kingdom. They can also assist non-specialists in determining who best to refer for 
further assessment and by specialists to provide a baseline of deficits from which to 
progress further assessment. Many attempts have been made over the past six 
decades to develop reliable and generalisable assessment tools for autism spectrum 
disorder. The majority of research in this area was conducted in children, however 
more recently, tools have been developed for use with the adult population. A great 
number of assessment tools exist, as outlined in Table 1.10. Constantino and Charman 
(2015) comment that availability of a large range of screening tools is not necessarily 
helpful either clinically or in research. 
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Table 1.10 
 
History of Assessment Tools in Autism Spectrum Disorder 
Author, Year of 
Publication 
Name of Assessment Tool 
Rimland,        
1964 
Diagnostic Checklist for Behaviour - Disturbed Children 
Freeman,      
1978 
Behaviour Observation Scale 
Krug,            
1980 
Autism Behaviour Checklist 
Sparrow,        
1984 
Vineland Adaptive Behavioural Scales 
Freeman,       
1986 
Real Life Rating Scale 
Schopler,      
1986 
CARS, Childhood Autism Rating Scale  
Le Couteur,    
1989 
ADI, Autism Diagnostic Interview 
Lord,             
1989 
ADOS, Autism Diagnostic Observation Schedule 
Lord,              
1994 
ADI-R, Autism Diagnostic Interview - Revised 
Gilliam,         
1995 
GARS, Gilliam Autism Rating Scale 
Attwood,       
1997 
ASIS, Australian Scale for Asperger’s Syndrome 
Ehlers,          
1999 
ASSQ, Autism Spectrum Screening Questionnaire 
Rutter,               
1999 
ASQ, Autism Screening Questionnaire 
Baron-Cohen, 
2000 
CHAT, Checklist for Autism in Toddlers 
Luteijn,             
2000 
CSBQ, Children’s Social Behaviour Questionnaire 
Lord,                  
2000 
ADOS-G, Autism Diagnostic Observation Schedule - Generic 
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Author, Year of 
Publication 
Name of Assessment Tool 
Baron-Cohen, 
2001 
AQ, The Autism Spectrum Quotient 
Gillberg,           
2001 
ASDI, Asperger Syndrome (and high-functioning Autism) Diagnostic 
Interview 
Gilliam,             
2001 
GADS, Gilliam Asperger’s Disorder Scale 
Myles,               
2001 
ASDS, Asperger Syndrome Diagnostic Scale 
Nylander,          
2001 
ASDASQ, Autism Spectrum Disorder in Adults Screening 
Questionnaire 
Robins,             
2001 
M-CHAT, Modified Checklist for Autism in Toddlers 
Baron-Cohen, 
2002 
CAST, Childhood Autism Spectrum Test, previously known as the 
Childhood Asperger Syndrome Test 
Constantino, 
2002 
SRS, The Social Responsiveness Scale 
Wing,                
2002 
DISCO, The Diagnostic Interview for Social and Communication 
Disorders 
Baron-Cohen, 
2003 
SQ, Systematizing Quotient 
Krug,                
2003 
KADI, Krug Asperger Disorder Index 
Baron-Cohen, 
2004 
EQ, Empathy Quotient 
Skuse,              
2004 
3Di, The Developmental, Dimensional and Diagnostic Interview 
Baron-Cohen, 
2005 
AAA, Adult Asperger Assessment 
Cohen,            
2005 
PDDBI, PDD Behaviour Inventory 
Baron-Cohen, 
2006 
SQ-R, Systematizing Quotient Revised 
Matson,           
2007 
ASD-DA, Autism Spectrum Disorder - Diagnostic for Intellectually 
Disabled Adults 
Allison,            
2008 
Q-CHAT, Quantitative Checklist for Autism in Toddlers 
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Author, Year of 
Publication 
Name of Assessment Tool 
Bryson,             
2008 
AOSI, Autism Observation Scale for Infants 
Ritvo,              
2008 
RAADS, Ritvo Autism Asperger’s Diagnostic Scale 
Absoud,            
2011 
VISS, The Visual Impairment and Social Communication Schedule 
Kopp,                
2011 
ASSQ-REV, Autism Spectrum Screening Questionnaire - Revised 
Extended Version 
Ritvo,                  
2011 
RAADS-R, Ritvo Autism Asperger’s Diagnostic Scale 
Baron-Cohen, 
2012 
AAA-2, Adult Asperger Assessment Version 2 
Grodberg,        
2012 
AMSE, Autism Mental State Examination 
 
1.7.3 Diagnostic Tools for Autism Spectrum Disorder 
The development of diagnostic instruments has allowed statistically robust 
measurements to underpin clinical history and observation as a means of assessment 
in autism spectrum disorder. Le Couteuret al’s (1989) publication of the Autism 
Diagnostic Interview (ADI), allowed for the first time, assessment of developmental 
history in autism spectrum disorder to be standardised. The original ADI was intended 
for research purposes, best suited to the assessment of patients aged five years and 
older, with a minimum intellectual age of two years. Lord et al (1994) reorganised, 
shortened and linked the ADI to the ICD and DSM criteria forming the Autism 
Diagnostic Interview - Revised (ADI-R); a semi-structured, investigator-based interview 
for caregivers and parents of children and adults to assist in the diagnosis of autism 
spectrum disorder. New social and communication items were added and items 
considered to be redundant were removed. The order of questions was also adapted 
to allow caregivers describe positive aspects of their child’s behaviour and prevent 
repeated negative descriptions which could cause distress. Since that time, the ADI-R 
has become a commonly used clinical tool for evaluation of autism spectrum disorder 
(Lord, 1994).  
63 
 
Further progress in diagnostic capability came in 2000 when Lord et al published the 
Autism Diagnostic Observation Schedule - Generic (ADOS-G). The ADOS-G is a 
descendant of two previous observational instruments, the Autism Diagnostic 
Observation Schedule (ADOS) originally created by Catherine Lord in 1989 and the 
Pre-Linguistic Autism Diagnostic Observation Schedule (PL-ADOS) created by 
DiLavore, Lord and Rutter in 1995. An upgrade was considered necessary as the 
ADOS and PL-ADOS were not entirely suitable for the assessment of older children or 
adults or for use outside of the research setting (Lord, 2000). As a second standardised 
assessment tool, this time of observed behaviour, the ADOS-G was not considered 
sufficiently robust by its creator to function independently in the diagnosis of autism 
spectrum disorder. Lord et al (2000) felt it lacked sufficient assessment of restrictive 
and repetitive behaviours. For that reason, the ‘gold standard’ tools to clinically assess 
a patient for possible autism spectrum disorder are recommended to be the ADOS-G 
coupled with the ADI-R (Rydén, 2008a). 
Unfortunately, though effective and reliable, the ADI-R and ADOS-G can be time-
consuming and include questions or tasks which are not scored in the final algorithm. 
They require formal training, are best administered only in a structured setting, are 
expensive to purchase and train to use, are time-intensive to administer and require 
practitioners to maintain inter-rater reliability. Furthermore, neither instrument permits 
early termination and conclusion if the patient is without positive symptoms. Hence, 
despite their status as the gold standard in diagnosis, these factors limit their use in 
both clinical practice and epidemiological research. Overall, researchers are agreed 
that the judgement of the experienced clinician is the most reliable tool in diagnosing 
autism spectrum disorder (Constantino, 2015). 
 
1.8 Comorbid Illness in Autism Spectrum Disorder 
Comorbidity is defined as ‘the study of the association between two or more conditions, 
which may or may not be causally related’ (Ghaziuddin, 2002a), ‘the simultaneous 
presence of two chronic diseases or conditions in a patient’ (Oxford English Dictionary, 
2012) or ‘the occurrence of two or more forms of psychopathology in the same person’ 
(Mannion, 2014a). Although the term ‘comorbid’ is used throughout the literature in this 
area of research, Gillberg and Billstedt (2000) argue that the term ‘comorbidity’ is 
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contentious as it implies either a coincidental or causal link depending on the reader 
and perhaps the term ‘overlapping condition’ may be more acceptable. Mental 
disorders that co-occur with other disorders can also be referred to as ‘a dual diagnosis’ 
(Kronenberg, 2014). This study mirrors the majority of recently published research by 
using the term comorbid.  
As seen in medical clinics, where patients frequently present with a number of physical 
diagnoses, psychiatric patients including those with autism spectrum disorder are also 
susceptible to comorbid illness. Therefore, it is important to remain cognisant of the 
likelihood of comorbid illness when assessing adult patients with normal IQ autism 
spectrum disorder. Comorbid psychiatric illness can include any diagnosis as outlined 
by the ICD-10 or DSM-5. For the purposes of this study, the following conditions are 
considered: 
 Mood disorders including depression, dysthymia and bipolar affective disorder 
 Anxiety spectrum disorders including agoraphobia, social phobia, generalised 
anxiety disorder, obsessive compulsive disorder, specific phobia, somatoform 
disorder and post-traumatic stress disorder 
 Psychotic disorders including schizophrenia, delusional disorder and brief 
psychotic disorder 
 Attention deficit hyperactivity disorder and Tourette’s syndrome 
 Eating disorders including anorexia nervosa and bulimia nervosa 
 Personality disorders including paranoid, schizoid, schizotypal, antisocial, 
emotionally unstable, histrionic, anankastic, anxious-avoidant, dependent and 
narcissistic 
 Addiction including alcohol dependency syndrome and illicit drug use 
 
Comorbid physical illness can include any medical condition diagnosed by a general 
practitioner or medical consultant. For the purposes of this study, the following 
conditions are considered: 
 Cardiac conditions 
 Dermatological conditions 
 Ear, nose and throat conditions 
 Endocrine conditions 
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 Gastrointestinal conditions 
 Genitourinary conditions 
 Neurological conditions 
 Orthopaedic conditions 
 Respiratory conditions 
Co-occurrence of illness is an important area of research due to a number of factors: 
 To assess functional impact 
 To determine if each set of disorders are truly comorbid, namely that they co-
occur or if they are in actual fact a single condition, along a severity spectrum 
 To assess whether comorbid conditions present with the same 
symptomatology as each condition in its true form 
 To determine if comorbidity alters the course or prognosis of either condition 
 To determine if there is a causal link between conditions 
 To determine which, if any, is the primary condition 
 To determine the probability of suffering from a pure form of the illness, 
compared to presenting with comorbidity 
 To allow formulation of appropriate and targeted treatment plans 
 To investigate for biological risk factors for co-occurrence 
 To assess for environmental risk factors for co-occurrence 
In the clinical setting, to accurately understand the needs of those with comorbid 
illness, current comorbidity is considered more important than lifetime comorbidity 
(Kronenberg, 2014). For this reason, over the course of this study, the prevalence of 
current comorbidity is more frequently referred to than lifetime illness rates. 
 
1.8.1 Limited Research in Comorbidity of Autism Spectrum Disorder 
Thirty years ago, neurodevelopmental conditions were rarely, if at all, diagnosed 
among adult psychiatric patients (Nylander 2013, Van Elst 2013). Research on 
comorbidity focused on children, adolescent or intellectual disability groups 
(Ghaziuddin, 2008). As approximately 70% of individuals with autism spectrum 
disorder have an IQ in the learning disability range (Ghaziuddin 2002b, Newschaffer 
2003, Kannabiran 2009) and child and adolescent psychiatrists consider ASD 
diagnosis part for their general skills repertoire compared to their general adult 
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counterparts, research on both groups is prolific compared to adults with normal IQ. It 
is likely that adult comorbidity rates, outcomes and morbidity cannot be accurately 
extrapolated from childhood, adolescent or intellectual disability research as 
psychiatric disorders in childhood and adolescence can differ considerably from 
psychiatric illness in later life (Taurines, 2010). Although, there was a considerable 
increase in awareness of neurodevelopmental disorders and consequently 
identification of patients with the illness by adult psychiatrists from 1990 to 2000 
(Hofvander 2009, Nylander, 2013) very few research studies were completed on adults 
with autism spectrum disorder and normal intellectual ability (Barnhill 2007, Hofvander 
2009, Lugnegård 2011, Joshi 2013).  
One area highlighted by authors as particularly neglected is patterns of comorbidity as 
relatively little has been published on the topic (Ghaziuddin 1998, Gillberg 2000, 
Howlin 2000, Ghaziuddin 2002a, Ketelaars 2008, Ghaziuddin 2008, Nylander 2008, 
Rydén 2008a, Hofvander 2009, Skokauskas 2010, Strunz 2014). Though a number of 
particular conditions have been linked to autism spectrum disorder in child and learning 
disability populations (Van Elst, 2013), the true prevalence of such disorders among 
the adult, normal IQ, ASD population remains unknown. Lugnegård et al (2011) noted 
that their literature search was unable to source a single article looking at psychiatric 
comorbidity in adults with normal IQ clinically diagnosed with Asperger’s syndrome.  
A number of theories exist to explain the deficit of research in this area. For many 
years, psychiatrists appeared divided on the possible existence of comorbid psychiatric 
illness in patients diagnosed with autism spectrum disorder. Some suggest that 
comorbid psychiatric illness is highly prolific (Kanne, 2009) while others would argue 
that a comorbid illness, such as schizophrenia, obsessive compulsive disorder or 
certain personality disorders preclude a diagnosis of autism spectrum disorder (World 
Health Organisation, 1992). The presence of divided opinion has for many years 
restricted research in the area. 
Overall, it is now generally agreed that comorbid psychiatric illness is an important 
research question in psychiatry. As annual diagnosis rates are now exceeding those 
for juvenile diabetes, cancer and HIV/AIDS (Cheak-Zamora, 2014), it is becoming 
clearer that autism spectrum disorder is an important research and clinical issue for 
practitioners and policy makers alike. Interest in the area appears to be growing since 
the 1980’s (King, 2006) with the need for further clinical research in the area of 
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comorbidity highlighted in numerous publications (Gillberg 2000, Stahlberg 2004, 
Hofvander 2009) and researchers have called the deficit of available research an 
‘urgent need’ (Ghaziuddin, 2008). 
In more recent years, it has become more evident that autism spectrum disorder is not 
a singular condition and ASD patients actually suffer from a variety of mental health 
problems with more than one comorbid condition frequently occurring - autism 
spectrum disorder alone is no longer considered sufficient to account for every 
symptom and difficulty experienced by the ASD patient (Tsai 1996, Tantam 2000, 
Mouridsen 2008b, Kannabiran 2009). Some have even suggested that comorbidity is 
not only common but ‘indeed the rule’ in autism spectrum disorder (Gillberg, 2000). 
Previous studies comprised mainly of case reports or follow-up studies of adults 
diagnosed in childhood (Ghaziuddin, 2008) and many recommend further research to 
understand the nature of psychiatric comorbidity in ASD populations and its impact on 
outcome (Gargaro 2011, Buck 2014, Mannion 2014a, Vannucchi 2014a). 
If comorbidity is almost to be expected when making a diagnosis of autism spectrum 
disorder each psychiatrist working in the area of general adult psychiatry requires a 
working knowledge of the co-existence of autism spectrum disorder and psychiatric 
illness (Gillberg 2000, Mouridsen 2008a, Vannucchi 2014a). If rates were more 
accurately defined perhaps it would explain why adults with a diagnosis of autism 
spectrum disorder tend to make excessive use of psychiatric services (Lehnhardt, 
2012). As targeted health services are severely lacking for adults with autism spectrum 
disorder (Toal, 2005) such information, if made available, could also facilitate 
healthcare provision. 
 
1.8.2 The Importance of Diagnosing Comorbidity in Autism Spectrum Disorder 
Psychiatric and physical comorbid conditions, due to their associated functional 
impairment, have considerable impact on mental health, quality of life and 
psychosocial adaptation in adults with autism spectrum disorder (Howlin 2000, Stewart 
2006, Raja 2008, Taurines 2010, Buck 2014). Caution should be taken not to 
misdiagnose true comorbid psychiatric illness as simple exacerbations of ASD 
symptomatology (Davis, 2011). Defining and describing the range and magnitude of 
psychiatric comorbidity in adults with autism spectrum disorder can facilitate disorder-
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specific treatments in this vulnerable population (Joshi 2013, Nylander 2013). 
Superimposed psychiatric illnesses should be treated appropriately and positive 
outcomes are associated with timely diagnosis, treatment of comorbidity and 
appropriate access to support (Hare, 2014). Diagnosis of comorbid conditions in 
autism spectrum disorder is important because psychiatric comorbidity not only 
worsens the core symptoms of autism spectrum disorder but can have a greater impact 
on functioning and outcome than the core symptoms alone (Ghaziuddin 2008, Levy 
2009). Some authors also propose that comorbid psychiatric illness impacts on the 
success of psychosocial interventions in autism spectrum disorder (Joshi, 2013), 
although this has not been replicated in other studies (Huke, 2014).  
Currently, it is not possible to rely on measurement instruments to assess psychiatric 
comorbidity in those with autism spectrum disorder as tools have not been adequately 
validated (Tyson, 2012) or focus on minority groups within the ASD population. No 
measurement tool designed for the detection of comorbid psychiatric illness in adults 
with normal intelligence could be identified as part of this literature review. Six general 
tools for the detection of comorbidity in autism spectrum disorder were found, however 
two are designed for use in intellectually disabled adults while the other four are for 
use in child cohorts. These assessment tools are outlined in Table 1.11. 
Table 1.11 
 
Assessment Tools for Comorbid Psychiatric Illness in Autism Spectrum Disorder 
Author,   
Year of 
Publication 
Name of 
Assessment 
Tool 
Suitable 
Population 
 
Description 
Hansson, 
2005 
A-TAC, Autism - 
Tics, ADHD and 
other 
Comorbidities 
 
 
Children, IQ 
not specified 
A 178 item telephone interview 
conducted with parents. 
 
Questions include all symptoms listed 
in the DSM-IV for childhood onset 
neuropsychiatric conditions, a 
selection of other psychiatric illness 
and the Gillberg and Gillberg criteria 
for Asperger’s syndrome. 
 
Inter-rater reliability: ‘very good’ 
Test-retest reliability: ‘very good’ 
Internal consistency: not reported 
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Author,  
Year of 
Publication 
Name of 
Assessment 
Tool 
Suitable 
Population 
 
Description 
Leyfer,                   
2006 
 
ACI-PL, Autism 
Comorbidity 
Interview - 
Present and 
Lifetime Version 
 
Children 
with normal 
IQ or 
intellectual 
disability 
Modelled on the Kiddies Schedule for 
Affective Disorders and Schizophrenia 
(KSADS). 
 
Uses DSM-IV-TR diagnostic criteria 
for all psychiatric disorders. 
 
Inter-rater reliability: 0.70 - 0.80 
Test-retest reliability: 0.61 - 0.75 
Internal consistency: not reported 
 
Matson,                         
2007 
ASD-CA, The 
Autism Spectrum 
Disorders -
Comorbidity for 
Adults 
 
Adults with 
intellectual 
disability 
37 items over 5 subscales: 
 Anxiety / repetitive behaviours 
 Conduct problems 
 Irritability / behavioural 
excesses 
 Attention / hyperactivity / 
impulsivity 
 Depressive symptoms   
 
Inter-rater reliability: 0.30 - 0.77 
Test-retest reliability: 0.59 
Internal consistency: 0.91 
 
Helverschou,          
2009 
PAC, The 
Psychopathology 
in Autism 
Checklist 
 
Adults with 
intellectual 
disability 
42 items over 5 subscales: 
 Psychosis 
 Depression 
 Anxiety spectrum disorders 
 Obsessive compulsive disorder 
 General adjustment problems 
 
Inter-rater reliability: 0.53 - 0.67 
Test-retest reliability: not reported 
Internal consistency: 0.78 - 0.89 
 
Matson, 
2009a 
BISCUIT-Part 2, 
Baby and Infant 
Screen for 
Children with 
Autism Traits - 
Part 2 
Infants and 
toddlers, 
with normal 
IQ or 
intellectual 
disability 
65 items assessing for 5 comorbid 
conditions: 
 Attention deficit hyperactivity 
disorder 
 Tic disorder 
 Obsessive compulsive disorder 
 Specific phobia 
 Feeding difficulties 
 
Inter-rater reliability: 0.98 
Test-retest reliability: not reported 
Internal consistency: 0.97 
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Author,  
Year of 
Publication 
Name of 
Assessment 
Tool 
Suitable 
Population 
 
Description 
Matson, 
2009b 
ASD-CC, 
Autism 
Spectrum 
Disorders - 
Comorbidity for 
Children 
 
Children, IQ 
not specified 
49 items assessing for 7 comorbid 
conditions: 
 Depression 
 Conduct disorder 
 Attention deficit hyperactivity 
disorder 
 Tic disorder 
 Obsessive compulsive disorder 
 Specific phobia 
 Feeding difficulties 
 
Inter-rater reliability: 0.89 
Test-retest reliability: 0.96 
Internal consistency: 0.95 
 
 
 
1.8.3 Variable Prevalence Rates of Comorbid Psychiatric Illness in Autism 
Spectrum Disorder 
Variation in rates of detected comorbid psychiatric illness in ASD populations has been 
attributed to inconsistency in study sample, methodology and reporting methods by 
various authors (Buck, 2014). Lainhart (1999), Ghaziuddin et al (2002) and Stewart et 
al (2006) identified selection bias, use of clinically referred samples, differences in 
sample selection, small sample size, varying methods of inquiry, varying clinical 
experience of the interviewers, uncertainty regarding the degree of reliability and 
validity of standardised instruments and the flexible application of ASD diagnostic 
criteria as reasons for inconsistently reported rates.  
Although not outlined by previous researchers, other reasons for variations in reported 
rates became apparent over the course of this literature review. Some studies examine 
comorbidity rates among individuals diagnosed with autism spectrum disorder while 
others examine rates of autism spectrum disorder among individuals diagnosed with 
an Axis I or Axis II psychiatric illness or examine autism spectrum disorder and 
attention deficit hyperactivity disorder groups in unison. Some studies examine only 
current rates of psychiatric illnesses, namely diagnoses detected as part of the 
research assessment while others looked at both current rates and lifetime diagnoses. 
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This mixed reporting of lifetime prevalence and current comorbidity rates without clear 
distinction in the literature as to which is being reported offers conflicting conclusions 
as to how closely comorbidity rates in autism spectrum disorder relate to those of the 
general population. The heterogeneous limitations evident in published research not 
only distort the available information on comorbidity rates but also prevent accurate 
assimilation of available information due to an inability to separate the adult / normal 
IQ portion of each sample. 
Despite the varying approaches to research and the dual reporting method of current 
and lifetime illness, authors are generally agreed that psychiatric comorbidity rates are 
high among adults with autism spectrum disorder and normal range intellectual 
functioning (Hofvander 2009, Davis 2011, Howlin 2012, Joshi 2013, Van Elst 2013, 
Chen 2015). Estimated rates of comorbid psychiatric disorders in those with autism 
spectrum disorder, incorporating all ASD subtypes, vary from 9% to 84% (Hofvander 
2009, Howlin 2012). Reported comorbid conditions in normal IQ autism spectrum 
disorder include depression, anxiety, obsessive compulsive disorder, attention deficit 
hyperactivity disorder, tic disorder, psychotic symptoms and emotionally unstable 
personality disorder (Howlin 2012, Van Elst 2013). Typically depression and obsessive 
compulsive disorder are reported as most prevalent, followed by bipolar affective 
disorder and mania, while psychosis and schizophrenia-like illnesses are considered 
rare (Howlin, 2012). Paediatric literature identifies comorbid disruptive and hyperactive 
conditions such as attention deficit hyperactivity disorder as the most prevalent 
psychiatric comorbidity in childhood while depressive conditions are more common in 
adolescence (Ghaziuddin, 1998 and 2002a). 
Comparison between rates of psychiatric illness in those with autism spectrum disorder 
and the general population varies depending on whether one is comparing current 
comorbid conditions or lifetime prevalence. Examples of papers showing comparable 
current comorbidity rates but significantly increased lifetime rates include Joshi et al 
(2013) and Rydén and Bejerot (2008a). Both note lifetime prevalence rates to be 
significantly higher among high-functioning patients with autism spectrum disorder 
compared to their neurotypical counterparts, however, point prevalence or current 
rates were broadly similar (Joshi, 2013).  
Only a limited number of studies relating to rates of comorbid psychiatric illness in 
normal IQ adults with autism spectrum disorder could be identified as part of this 
72 
 
literature review and each study examined clinically recruited samples. The details of 
these studies are outlined in Table 1.12. To my knowledge, there are no published 
epidemiological studies looking at incidence or prevalence rates of comorbid 
psychiatric illness in normal IQ autism spectrum disorder.  
 
Table 1.12 
 
Prevalence Rates of Current Comorbid Psychiatric Illness in Autism Spectrum 
Disorder 
Author, 
Year of 
Publication 
Country of 
Origin 
Sample 
Characteristics 
Psychiatric Comorbidities 
Russell, 
2005 
London, 
England 
40 adults attending 
an adult 
neurodevelopmental 
clinic: 19 - 36 years 
 
Obsessive compulsive disorder 
25% 
Anckarsäter
2006 
Gothenburg, 
Sweden 
113 adults attending 
a child 
neuropsychiatric 
clinic: 19 - 60 years 
Obsessive-compulsive PD 46% 
Avoidant PD 34% 
Schizoid PD 32% 
Paranoid PD 26% 
Schizotypal PD 23% 
Borderline PD 11% 
Dependent PD 9% 
Narcissistic PD 6% 
Antisocial PD 0% 
Histrionic PD 0% 
 
Cath,     
2008 
Amsterdam, 
Netherlands 
12 adults attending 
an adult anxiety 
clinic: 24 - 44 years 
Obsessive compulsive disorder 
50% 
Social phobia 50% 
Depression 50% 
Dysthymia 8% 
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Author, 
Year of 
Publication 
Country of 
Origin 
Sample 
Characteristics 
Psychiatric Comorbidities 
Ketelaars, 
2008 
Groningen, 
Netherlands 
15 adults attending 
an adult 
neurodevelopmental 
clinic: 18 - 24 years 
Comorbid Axis I or II disorder 
53% 
Mood disorder 26% 
Social phobia 20% 
Substance abuse 20% 
Agoraphobia 13% 
Obsessive compulsive disorder 
7% 
Schizoid PD 7% 
Borderline PD 7% 
Avoidant PD 7% 
 
Rydén, 
2008a 
Stockholm, 
Sweden 
130 adults attending  
neurodevelopmental 
inpatient treatment 
centre: 20 - 40 
years 
Personality disorder 40% 
Attention deficit hyperactivity 
disorder 37% 
Suicide attempt 17% 
 
Hofvander, 
2009 
Gothenburg, 
Sweden 
and 
Paris,         
France 
122 adults attending 
two adult 
neuropsychiatric 
clinics: 16 - 60 years 
 
Mood disorder 53% 
Attention deficit hyperactivity 
disorder 43% 
Obsessive-compulsive PD 32% 
Avoidant PD 25% 
Obsessive compulsive disorder 
24% 
Schizoid PD 21% 
Tic disorder 20% 
Paranoid PD 19% 
Substance abuse 16% 
Generalised anxiety disorder 
15% 
Dyslexia 14% 
Schizotypal PD 13% 
Social phobia 13% 
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Author, 
Year of 
Publication 
Country of 
Origin 
Sample 
Characteristics 
Psychiatric Comorbidities 
   Psychotic disorder 12% 
Panic disorder 11% 
Borderline PD 9% 
Specific phobia 6% 
Somatoform disorder 5% 
Eating disorder 5% 
Dependent PD 5% 
Narcissistic PD 5% 
Antisocial PD 5% 
Histrionic PD 0% 
 
Lugnegård, 
2011 
Karlstad, 
Sweden 
54 adults attending 
an adult 
neurodevelopmental 
clinic and child 
neuropsychiatric 
clinic: 23 - 31 years 
Recurrent depressive disorder 
50% 
Attention deficit hyperactivity 
disorder 30% 
Social anxiety disorder 22% 
Generalised anxiety disorder 
22% 
Agoraphobia 15% 
Panic disorder 13% 
Recurrent hallucinations 13% 
Bipolar II 9% 
Past alcohol dependence 7% 
Past drug dependence 7% 
Past bulimia nervosa 4% 
Tourette’s syndrome 2% 
Schizophrenia 0% 
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Author, 
Year of 
Publication 
Country of 
Origin 
Sample 
Characteristics 
Psychiatric Comorbidities 
Lugnegård, 
2012 
Karlstad, 
Sweden 
54 adults attending 
an adult 
neurodevelopmental 
clinic and child 
neuropsychiatric 
clinic: 23 - 31 years 
Comorbid Axis II disorder 48% 
Schizoid PD 26% 
Obsessive-compulsive PD 19% 
Avoidant PD 13% 
Schizotypal PD 2% 
Paranoid PD 0% 
Antisocial PD 0% 
Histrionic PD 0% 
Borderline PD 0% 
Narcissistic PD 0% 
Dependent PD 0% 
 
Joshi,   2013 Massachusetts, 
USA 
63 adults attending 
an adult 
neurodevelopmental 
clinic: 18 - 63 years 
Lifetime major depression 77% 
Social phobia 40% 
Depression 31% 
Generalised anxiety disorder 
29% 
Lifetime bipolar I 25% 
Agoraphobia 24% 
Specific phobia 18% 
Obsessive compulsive disorder 
16% 
Substance abuse 14% 
Psychosis 8% 
Bipolar I 6% 
Post-Traumatic stress disorder 
5% 
Tourette’s disorder 5% 
Antisocial PD 5% 
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Author, 
Year of 
Publication 
Country of 
Origin 
Sample 
Characteristics 
Psychiatric Comorbidities 
Strunz, 
2014 
Berlin, 
Germany 
118 adults attending 
an adult 
neurodevelopmental 
clinic: 21 - 43 years 
Comorbid Axis I disorder 36% 
Mood disorder 24% 
Social phobia 14% 
 
 
 
1.8.4 Comorbid Axis I and Axis II Psychiatric Illness in Normal IQ Adults with 
Autism Spectrum Disorder 
 
Mood Disorders 
Although population based studies are lacking, research reporting on child, adolescent 
and adult, normal IQ and intellectual disability samples, suggests mood disorders as 
the most prevalent comorbid condition in autism spectrum disorder (Gillberg 2000, 
Ghaziuddin 2002b, Stahlberg 2004, Ketelaars 2008, Mouridsen 2008b, Munesue 
2008, Hofvander 2009, Lugnegård 2011, Ragunath 2011, Strunz 2014, Vannucchi 
2014b).  
Research in depression is more widely available than reports on bipolar affective 
disorder (Skokauskas, 2010). In a case series by Raja and Azzoni (2008), bipolar 
affective disorder was noted in three adult patients with normal IQ newly diagnosed 
with Asperger syndrome. The authors stress the importance of monitoring for bipolar 
II in patients with autism spectrum disorder and depression as well as highlighting a 
propensity towards antidepressant induced bipolarity (Raja, 2008). Vannucchi et al 
(2014b) highlight the risk of underdiagnosing bipolar I in adults with autism spectrum 
disorder as features of mania expressed by this population, including irritability, 
hostility, restlessness, perplexity, aggression, insomnia, hallucinations, psychotic 
interpretations and delusional ideas could easily be mistaken for schizophrenia. The 
authors also emphasise the difficulty in accurately identifying bipolar II in this 
population as excessive mood reactivity, irritability, increased activity and difficulty 
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modulating arousal could be attributed to core ASD symptoms such as insistence on 
sameness or difficulty in transitioning between tasks (Vannucchi, 2014b).  
Risk factors suggested for comorbid mood disorder in adults with autism spectrum 
disorder include less social impairment, higher cognitive abilities, higher rates of other 
psychiatric illness, better awareness of their difference from others and negative life 
events such as bereavement (Wing 1981, Ghaziuddin 2002b, Sterling 2008). Risk 
factors associated with childhood onset depression in those with Asperger’s syndrome 
also include better social awareness, higher level of intelligence and negative life 
events such as parental divorce (Ghaziuddin 2002b, Sterling 2008). This is relevant for 
both populations as those with higher IQ and better social skills are likely to be more 
aware of their differences from peers (Sterling, 2008), suffer greater emotional impact 
from peer victimisation or bullying (Hannon, 2013) and experience poor self-esteem 
and frustration (Tantam, 2000), each contributing to increased vulnerability to 
depression. Detection of depression in those with normal IQ autism spectrum disorder 
is important it has been shown to contribute to increased suicidal behaviour (Hannon, 
2013). 
It is suggested that depression and autism spectrum disorder share a common 
aetiology as both are highly heritable and share biological similarities such as reduced 
serum melatonin, disturbance of sleep and altered circadian rhythm (Munesue, 2008). 
Ragunath et al (2011) explored the genetic links between bipolar affective disorder and 
autism spectrum disorder. They reported high commonality between genes implicated 
in the two disorders which they refer to as the ‘Neuroactive Ligand Receptor Interaction 
Pathway’. The genes involved regulate mood and stress through neurotransmitters 
such as glutamate, dopamine, serotonin and noradrenaline (Ragunath, 2011). The 
authors speculate that disruption in this pathway due to genetic abnormality increases 
an individual’s risk for both autism spectrum disorder and bipolar affective disorder. 
However, identification of the common chromosome / gene marker remains elusive.  
 
Anxiety Spectrum Disorders 
Methodological approaches affect the recording of prevalence in anxiety spectrum 
disorders and factors such as gender, age, culture, urbanicity, conflict and economic 
status are felt to strongly influence rates in different populations, in different regions 
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and across the globe (Baxter, 2013). It is estimated that anxiety spectrum disorders 
affect between 0.9% and 28.3% of the general population (Baxter, 2013). Literature 
relating to individuals with autism spectrum disorder is much rarer. Only one article 
was identified as part of this literature review, Lugnegård et al (2011), which noted a 
rate of approximately 50% in 54 normal IQ Swedish adults with normal IQ autism 
spectrum disorder. 
Social phobia, sometimes referred to as social anxiety disorder, has a lifetime 
prevalence in the general population of 8% - 12% (Cath 2008, Tyson 2012). Growing 
evidence from mixed age, mixed IQ and trait studies indicates a considerable overlap 
between social anxiety disorder and high-functioning autism spectrum disorder 
(Tantam 2000, Gillott 2007, Cath 2008, Ghaziuddin 2008, Mazefsky 2008, Davis 2011, 
Kanai 2011, Lugnegård 2011, Howlin 2012, Tyson 2012, White 2012, Van Elst 2013, 
Buck 2014, Hare 2014, Hirvikoski 2014, Vannucchi 2014a). Areas of overlapping 
symptoms between autism spectrum disorder and social phobia include impaired eye 
contact, poor non-verbal communication, reduced social cognition, reduced emotional 
processing, difficulty relating in a social context and difficulty communicating in a social 
context (Tyson, 2012). 
Six studies recorded prevalence rates of social phobia in normal IQ adults with autism 
spectrum disorder. Five reported ‘social phobia’ rates between 13% and 50% (Cath 
2008, Ketelaars 2008, Hofvander 2009, Joshi 2013, Stunz 2014). One study termed 
the condition ‘social anxiety disorder’ and reported a prevalence rate of 22% 
(Lugnegård, 2011). Commonality in dysfunction within the fusiform face area, 
amygdala activity and the serotonin-transporter gene have been suggested as a 
reason for co-expression of autism spectrum disorder and social phobia (Tyson, 2012).  
Generalised anxiety disorder is a disabling illness, noted to be the most frequently 
presenting anxiety disorder in primary care with prevalence rates of 1.9% - 5.1% in the 
general population (Wittchen, 2002). Higher rates of generalised anxiety disorder have 
been noted in adults with autism spectrum disorder ranging from 15% - 29% 
(Hofvander 2009, Lugnegård 2011, Joshi 2013).  
Specific phobia is known to occur in 7.1% - 9.4% of the general population (Stinson, 
2007). Although Kanner (1943) did not highlight the prevalence of social phobia among 
his case studies, this literature review notes him to be the first to describe specific 
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phobia in individuals with autism spectrum disorder. Kanner noted specific phobias in 
five of the eleven children he reviewed. Donald T seemed to ‘almost have a horror of’ 
tricycles, Frederick W was ‘afraid of [the] eggbeater, perfectly petrified of [the] vacuum 
cleaner and elevators were a simply terrifying experience to him’, Herbert B was 
‘tremendously frightened by running water, gas burners and many other things’, Alfred 
L feared ‘a dog’s barking’ while Elaine C was also ‘afraid of the vacuum cleaner’. Rates 
of specific phobia reported in the literature pertaining to adult ASD populations range 
from 6% - 18% (Hofvander 2009, Joshi 2013).  
Obsessive compulsive disorder is another highly debilitating disease (Russell, 2005), 
considered by the World Health Organisation to be among the ten most disabling 
medical conditions worldwide (Anholt, 2010). Its lifetime prevalence in the general 
population lies between 1.5% and 3% (Cath 2008, Anholt 2010). It has been argued 
that high-functioning autism spectrum disorder and obsessive compulsive disorder 
have many symptoms in common (Råstam, 2008). Many also determine it difficult to 
distinguish certain features of obsessive compulsive disorder from the clinical 
symptoms of autism spectrum disorder (Bejerot, 2007). Obsessive compulsive 
disorder can be missed in those with autism spectrum disorder and likewise autism 
spectrum disorder can be missed in those with obsessive compulsive disorder if 
comorbidity is not adequately explored. However, with careful history taking and 
assessment, clinicians can distinguish the two disorders. The clinical picture of 
obsessive compulsive disorder typically shows relapse and remission whereas the 
repetitive and ritualistic behaviour of autism spectrum disorder is constant and 
unremitting (Jones, 2000). Adults with autism spectrum disorder also show higher 
frequencies of sexual obsessions (Anholt, 2010), fewer somatic obsessions and fewer 
checking compulsions compared to those with obsessive compulsive disorder alone 
(Russell, 2005). Such identification is important as co-existence of these conditions is 
linked to poorer outcome with comorbidity resulting in more severe and treatment 
resistant obsessive compulsive disorder (Bejerot, 2007). Correct identification of 
obsessive compulsive disorder, if comorbidity exists, is vital to ensure adequate 
treatment planning and prevent adverse outcomes (Russell 2005, Bejerot 2007, Cath 
2008, Anholt 2010). Studies looking at comorbid obsessive compulsive disorder in the 
ASD population have found that adults of average IQ with a diagnosis of autism 
spectrum disorder report a high frequency of both obsessions and compulsions as 
defined in standard nomenclature, i.e. experienced as intrusive, distressing and time-
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consuming (Russell, 2013). Prevalence rates are up to forty times higher than in the 
general population (Rydén, 2008a) varying from 7% - 50% (Russell 2005, Cath 2008, 
Ketelaars 2008, Hofvander 2009, Joshi 2013). While Lord et al (1994) differentiated 
between obsessive compulsive disorder and autism spectrum disorder by comparing 
ritualised behaviours, noting significant difference in quality of compulsions, Russell 
noted common deficits between the two disorders. Lord et al (1994) clarified that a 
compulsion, as seen in obsessive compulsive disorder, is a sequence of events 
towards an endpoint, different to the repetitive non-functional behaviours and 
resistance to change seen in autism spectrum disorder. Russell et al (2005) noted 
executive function deficits and a preference for local rather than global information in 
both conditions. Although a genetic link between obsessive compulsive disorder and 
autism spectrum disorder has not been established (Russell, 2005), Anholt et al (2010) 
describe obsessive compulsive disorder and autism spectrum disorder, along with 
attention deficit hyperactivity disorder, as a group of developmental basal ganglia 
disorders due to strong symptom overlap, suggesting common aetiology. 
Agoraphobia and panic disorder are reported to occur in less than 2% of the general 
population (Goodwin, 2005). Rates are significantly higher in adults with normal IQ 
autism spectrum disorder ranging from 15% - 24% for agoraphobia (Lugnegård 2011, 
Joshi 2013) and 11% - 13% for panic disorder (Hofvander 2009, Lugnegård 2011). 
Somatoform disorder is reported to be 2.7% among the general population (Lieb, 
2000). Its equivalent rate in adults with normal IQ autism spectrum disorder was 
reported by a single study, as 5% (Joshi, 2013).  
It is not feasible to determine a reliable prevalence rate for post-traumatic stress 
disorder among the general public given the significant number of confounding 
variables which impact reporting. These factors include gender, location of the study, 
recent occurrence of natural disaster or war, study of civilian or military participants, 
capacity for psychological adjustment and availability of post trauma support networks. 
One article provides a prevalence rate for post-traumatic stress disorder in normal IQ 
adults with autism spectrum disorder. Joshi et al (2013) report a figure of 5%, however 
they do not address the possible confounding factors outlined above.  
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Psychotic Disorders 
Autism spectrum disorder and psychotic disorders, particularly schizophrenia, have a 
complex and entangled history. The term ‘autism’ was originally used by Bleuler to 
refer to social withdrawal and progressive loss of communication in patients with 
schizophrenia praecox (Bleuler 1911, Vannucchi 2014a). Kanner’s use of the term was 
in reference to deficits in affective contact (Kanner, 1943). Unfortunately, Kanner’s 
choice of a term already recognised in medical terminology to refer to schizophrenia 
led to infantile autism being viewed as an early-onset variant of schizophrenia for many 
decades (Volkmar 1991, Stahlberg 2004). It was not until the DSM-III in 1980 that 
autism was designated a distinct diagnostic category (American Psychiatric 
Association, 1980). Over the decades, between Kanner’s misnomer and DSM-III’s 
inclusion of pervasive developmental disorder, many researchers worked diligently to 
separate the conditions, investigating presenting characteristics, intellectual 
functioning, gender distribution, organicity, socioeconomic status, age of onset and 
family history (Konstantareas, 2001). Unfortunately, these significant efforts again led 
to bias as the wedge between the conditions was over-estimated, this time naming 
schizophrenia as a specific exclusion criterion for autism spectrum disorder (American 
Psychiatric Association, 1980). With time, it is increasingly recognised that autism 
spectrum disorder does not protect against schizophrenia and although rare the 
conditions can co-present (Dykens 1991, Ghaziuddin 1998, Jones 2000, Nylander 
2008, Lugnegård 2011, Vannucchi 2014a). 
While autism spectrum disorder and schizophrenia with marked positive symptoms are 
clearly distinguishable, differentiation between the two conditions when negative 
symptoms are more pronounced can be difficult. Some features of autism spectrum 
disorder could be misidentified as negative symptoms of schizophrenia including 
diminished emotional expression and avolition, while other symptoms such as poor 
social skills, impairment in interpersonal relationships, language / communication 
abnormalities, deficits in abstract reasoning and poor problem-solving overlap 
(Goldstein 2002, Nylander 2008, Raja 2010). Poor stress tolerance resulting in 
disorganised behaviour could resemble a brief psychotic disorder (Nylander, 2008) 
while repetitive narrowly-focused ideas could resemble delusional disorder.   
Cognitive deficits are recognised in both autism spectrum disorder and schizophrenia 
(Nylander, 2008). Dysfunction in attention, memory, executive function and theory of 
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mind have been shown in both cohorts (Baron-Cohen 2001b, Happé 2001a, Hill 2004a, 
Nylander 2008). Likewise, language abnormalities are often noted in autism spectrum 
disorder including poverty of speech, reduced content of speech, perseveration and 
lack of reciprocity which could reflect negative features of schizophrenia (Dykens 1991, 
Nylander 2008, Raja 2010). Features of positive thought disorder as seen in 
schizophrenia including derailment, illogicality and loss of goal are rarer in autism 
spectrum disorder (Dykens, 1991). 
Konstantareas et al (2001) examined 28 adult males, 14 with autism spectrum disorder 
and 14 with schizophrenia to determine the features which best differentiate between 
the two conditions. The authors noted far greater difficulties among the ASD group in 
the areas of stereotypical and repetitive behaviour, resistance to environmental 
change, visual preoccupations and deficits in non-verbal communication.  
Van Os and Kapur (2009) suggest that genomic variants (copy number variants) occur 
at a higher rate in autism spectrum disorder and schizophrenia compared to controls, 
suggesting a shared neurodevelopmental pathway. Further evidence supporting this 
hypothesis stems from genetic studies into velocardiofacial syndrome or 22q11 
deletion syndrome, which is often comorbid with autism spectrum disorder and 
schizophrenia (Murphy KC, 2002). Other shared genetic anomalies include 
microdeletions and microduplications of chromosome 16p and deletions, disruptions 
and missense mutations in Neurexin 1 (Raja 2010, Hallerbäck 2012). An MRI imaging 
study by Toal et al (2009) comparing adults with autism spectrum disorder, with and 
without psychosis, to healthy controls, showed that subjects with autism spectrum 
disorder differed from controls in brain regions common to schizophrenia. The authors 
suggest developmental brain abnormalities common to the two disorders. 
 
Attention Deficit Hyperactivity Disorder 
Attention deficit hyperactivity disorder is a neurodevelopmental disorder with onset in 
childhood which persists into adulthood for up to 60% of patients (Taurines, 2010). 
Symptoms include failure to give close attention to details or making careless mistakes 
in schoolwork, at work, or with other activities, having trouble holding attention on tasks 
or play activities, not appearing to listen when spoken to directly, not following through 
on instructions and failing to finish schoolwork, chores or duties in the workplace, 
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having trouble organising tasks and activities, avoiding, disliking or being reluctant to 
do tasks that require mental effort over a long period of time, often losing things 
necessary for tasks and activities, being easily distracted, being forgetful in daily 
activities, fidgeting with or tapping hands or feet, or squirming in seat, often leaving 
one’s seat in situations when remaining seated is expected, running or climbing in 
situations where it is not appropriate (adolescents or adults may be limited to feeling 
restless), unable to play or take part in leisure activities quietly, often "on the go" acting 
as if "driven by a motor", talking excessively, blurting out an answer before the question 
has been completed, having trouble waiting his / her turn and often interrupting or 
intruding on others (American Psychiatric Association, 2013). The worldwide 
prevalence of adult attention deficit hyperactivity disorder is estimated to be 5.29% 
(Polanczyk, 2007).  
Although ICD states that attention deficit hyperactivity disorder and autism spectrum 
disorder cannot be diagnosed in a single individual, many agree that considerable 
overlap exists between the two conditions with comorbid prevalence rates as high as 
14% - 78% (Stahlberg 2004, Anholt 2010, Gargaro 2011, Chen 2015). Gargaro et al 
(2011) examined the anatomical, neuroimaging, executive function and clinical 
similarities between attention deficit hyperactivity disorder and autism spectrum 
disorder and showed a strong biological basis for their co-existence. Chen et al (2015) 
also showed a strong shared genetic susceptibility between the disorders as well as a 
link to depressive disorder, bipolar affective disorder and schizophrenia. Both studies 
successfully argue that the diagnostic criterion excluding comorbidity between the two 
conditions is groundless.  
In fact, attention deficit hyperactivity disorder was the second most prevalent lifetime 
condition in a group of normal IQ adults with autism spectrum disorder studied by Joshi 
et al (2013), who noted a lifetime prevalence rate of 47% - 68%. Studies of current 
prevalence places estimates between 37% and 43%, considerably higher than rates 
seen in the general population (Rydén 2008a, Hofvander 2009). A thorough 
assessment looking for dual diagnosis is strongly advised as patients with both autism 
spectrum disorder and attention deficit hyperactivity disorder suffer higher 
interpersonal, school, family and cognitive difficulties, compromised ability to learn and 
interpret their environment and considerable functional and psychosocial impairments 
(Ghaziuddin 1998, Taurines 2010, Roy 2013, Chen 2015).  
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Eating Disorders 
In 1985, when researching autism spectrum disorder and eating disorders in children, 
Christopher Gillberg suggested a possible common aetiology to the two conditions, 
proposing hereditary genetic vulnerabilities interacting with environmental factors to 
cause anorexia nervosa in females and autism spectrum disorder in males. Since then, 
research in the field has taken two directions. Some authors interested in autism 
spectrum disorder have looked at comorbid eating disorders in individuals with autism 
spectrum disorder, while other authors with an interest in eating disorders have 
examined the comorbidity rates of autism spectrum disorder in those with anorexia 
nervosa and / or bulimia nervosa. Despite this combined approach, research on eating 
disorder in adults with normal IQ autism spectrum disorder is scarce (Råstam, 2008).  
As part of this literature review, only a single study could be identified listing a 
prevalence rate for eating disorder in normal IQ autism spectrum disorder, namely 
Hofvander et al (2009), who quoted the current rate of eating disorder as 5%. Two 
research papers reporting on prevalence rates of autism spectrum disorder in adults 
with a previously diagnosed eating disorder were identified. Wentz-Nilsson et al 
reported an 18% comorbidity rate in 1999. In 2005 the same research group noted a 
rate of 23% in females with severe and enduring eating disorder. Given the low 
population prevalence of autism spectrum disorder and a known male predominance 
for the condition, this rate of comorbid autism spectrum disorder in a group of female 
patients is extremely high. Interestingly, only anorexia nervosa patients endorsed 
features of autism spectrum disorder, no patients with bulimia nervosa reached 
diagnostic criteria. 
An overlap between anorexia nervosa and autism spectrum disorder was initially 
proposed in the 1980’s on the basis of clinical and behavioural observations 
(Oldershaw, 2011). Autism spectrum disorder and anorexia nervosa share some 
characteristics including obsessiveness, insistence on sameness, social skills deficits, 
refusal of particular foods, dislike of texture or certain types of food, unusual behaviours 
at mealtimes, weaknesses in empathising, executive dysfunction and an inability to 
observe the bigger picture (Råstam 2008, Oldershaw 2011). However, individuals with 
autism spectrum disorder and anorexia nervosa differ in their ability to problem solve 
and form relationships. In a study of 22 adult females with anorexia nervosa and normal 
IQ, Hambrook et al (2008) noted that anorexia nervosa patients did not differ 
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significantly from healthy controls on the Systemizing Quotient questionnaire or the 
Empathy Quotient questionnaire. This indicated that their drive to analyse problems 
and construct systematic relationships in non-social domains was similar to healthy 
controls. Wentz-Nilsson et al (1999) speculate that autism spectrum disorder and 
obsessive compulsive personality disorder could be premorbid conditions, enhancing 
one’s risk of developing an eating disorder. It is important to identify comorbid ASD 
and anorexic symptoms in order to prevent poor outcomes among this population 
(Wentz-Nilsson 1999, Wentz 2005). Young people with autism spectrum disorder and 
eating disorder could benefit from a tailored treatment programme designed to meet 
their ASD-related needs compared to receiving treatments targeted at individuals 
suffering from an eating disorder alone (Wentz-Nilsson, 1999).  
 
Personality Disorders 
A personality disorder is an ‘enduring, inflexible and pervasive pattern of inner 
experience and behaviour that deviates markedly from the expectations of the 
individual’s culture, manifesting in deficits in cognition, affectivity, interpersonal 
functioning or impulse control, of stable and long duration, leading to clinically 
significant distress or impairment, not better attributable to another mental, medical or 
physiological disorder’ (American Psychiatric Association, 2013). There are currently 
ten defined personality disorders, falling into three clusters: Cluster A - paranoid, 
schizoid and schizotypal; Cluster B - antisocial, borderline / emotionally unstable, 
histrionic and narcissistic; and Cluster C - anxious-avoidant, dependent and anankastic 
/ obsessive-compulsive. 
There is considerable overlap between characteristic symptoms of autism spectrum 
disorder and those of some personality disorders. Schizoid, schizotypal, avoidant, 
anankastic, narcissistic and emotionally unstable personality disorders have many 
features which can overlap with autism spectrum disorder (Råstam 2008, Rydén 
2008b, Vannucchi 2014a, Strunz 2015). The division of psychiatry into child and adult 
specific teams has hindered true understanding of the link between the developmental 
aspects of personality formation occurring in childhood and the expression of 
personality disorder as diagnosed in adulthood (Anckarsäter, 2006). Less again is 
known about co-occurring personality disorders and autism spectrum disorder in 
adulthood (Strunz, 2015). Up to the year 2000, no studies existed on the incidence of 
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personality disorder in autism spectrum disorder (Gillberg, 2000). However, the current 
concept of personality disorder in autism spectrum disorder could possibly explain 
some of the noted ‘odd’ engagement style (Rydén, 2008a).  
Studies on personality characteristics in individuals with autism spectrum disorder 
have elicited distinct temperament profiles. Autism spectrum disorder is associated 
with a more introverted and inhibited interaction style, lower novelty seeking, lower 
openness to new experience, inner feelings and emotions, lower reward dependence, 
poorer self-directedness, unco-operativeness and lower agreeableness, lower levels 
of sentimentality, lower altruism and poorer attachment to others, stronger harm 
avoidance, improved emotional regulation, increased self-transcendence, higher 
degrees of personal organisation, compulsivity and conscientiousness along with 
greater straight-forwardness and honesty (Anckarsäter 2006, Sizoo 2009, Strunz 
2015). Given the high degree of associated personality traits in autism spectrum 
disorder, care should be taken as the condition, if not diagnosed in childhood, could 
be misdiagnosed as a personality disorder in adulthood (Rydén, 2008a). 
Personality traits are important comorbid symptoms in adults with autism spectrum 
disorder as these characteristics represent poorly matured character and could be 
considered risk factors for personality disorder, anxiety spectrum disorders, social 
detachment and increased resistance to change (Tani 2003, Sizoo 2009). 
 
Self-injurious and Suicidal Behaviour 
Suicidal behaviour refers to deliberate self-harm (any deliberate non-lethal act of self-
injury), suicidal ideation (thoughts of how to commit suicide), suicide attempt and 
completed suicide (Hannon, 2013). Deliberate self-harm is commonly referred to as 
self-injurious behaviour in the literature examining individuals with autism spectrum 
disorder, possibly due to the crossover between general population and intellectual 
disability nomenclature in this group. Global rates of suicidal behaviour have increased 
consistently over recent decades with a recent World Health Organisation publication 
quoting lifetime prevalence figures for suicidal ideation and attempts as 9% and 3% 
respectively (Borges, 2010). Research shows the association with comorbid 
psychiatric illness to be considerable and autism spectrum disorder is now considered 
one of these conditions (Phillips 2010, Raja 2011). 
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Studies examining rates of suicidal behaviour in normal IQ adults with autism spectrum 
disorder are rare (Bennett, 2015). However, the condition is recognised and examples 
include head banging, self-biting, self-hitting, hair pulling and eye-poking (Gillberg, 
2000). Care should be taken to differentiate between deliberate self-harm, self-
injurious behaviour, core symptoms of autism spectrum disorder and catatonic 
symptoms such as motor stereotypies when a patient with autism spectrum disorder 
presents with injury to avoid diagnostic overshadowing and under-reporting (Hannon, 
2013).  
Within the general population, accepted risk factors for attempted and completed 
suicide include male gender, unmarried, unemployment, low educational attainment, 
low income, presence of psychiatric illness or chronic physical illness, childhood 
adversity, vulnerability and stressful life events (Balfe 2010, Crump 2014). High 
prevalence for each of these factors has been identified among the ASD population. 
When reporting on 587 adults admitted via the Emergency Department for attempted 
suicide, Kato et al (2013) identified 7.3% of patients with autism spectrum disorder. 
They noted that this subgroup of psychiatric admissions were more likely to be 
younger, single and living alone, with higher rates of comorbid adjustment disorder, 
requiring longer hospitalisation and to have used more lethal methods (jumping from a 
height, cutting / stabbing and carbon monoxide poisoning) when attempting suicide. 
ASD patients were also less likely to attribute their suicide attempt to a stressor 
occurring in the preceding 24 hours. Takara and Kondo (2014) examined a group of 
336 adults with mood disorders following attempted suicide and noted that 11% fulfilled 
diagnostic criteria for autism spectrum disorder on the SCID-I. They noted agitation, 
history of suicidal behaviour and high-functioning autism spectrum disorder to be 
significantly associated with increased rates of suicide attempt. They also confirmed 
Kato et al’s (2013) finding relating to use of more lethal methods.   
Other risk factors for suicidal behaviour in autism spectrum disorder have been 
identified through case studies, including low self-esteem, interpersonal difficulties, 
social isolation, lack of peer support, life stresses, life changes and comorbid 
depression, anxiety and substance misuse (Hannon 2013, Richa 2014). Child and 
adolescent studies have also noted normal IQ, poor problem solving, impulsivity, lack 
of emotional awareness, history of physical and / or sexual abuse and bullying as 
relevant risk factors (Hannon, 2013). Although rates of suicidal behaviour fluctuate 
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depending on the study population, it would appear that both suicidal ideation and 
suicide attempts are considerably higher in adults with autism spectrum disorder than 
the general population. Matthew Bennett (2015) stresses the importance of discussing 
these experiences with adult ASD patients to ensure a clearer understanding among 
clinicians and to test the effectiveness of proposed treatment approaches. 
 
Substance Use Disorder 
Recent prevalence rates for alcohol and drug dependence among the general 
population are difficult to ascertain as studies in recent years focus on particular 
ethnicities or age groups. Although almost 26 years old, Regier et al (1990) published 
prevalence rates of 13.5% for alcohol dependence and 6.1% for drug dependence. In 
2005, Harford et al reported much lower alcohol dependency rates, with a 2.5% 
prevalence in males and 1.4% in females. More recent literature focusing on the 
general population is difficult to locate. Research published as recently as 2012 
continues to refer to prevalence rates from the 1990s (Miles, 2012). Likewise 
substance and alcohol abuse in those with autism spectrum disorder is an under-
researched area (Sizoo 2010, Singh 2012, Kronenberg 2014, Van Wijngaarden-
Cremers 2014).  
Known risk factors for substance use disorder in the psychiatric population include 
early onset of smoking, disruptive behaviour in childhood and a parental history of 
substance misuse (Sizoo, 2010). Specific risk factors relating to those with normal IQ 
autism spectrum disorder are not widely researched. Sizoo et al (2010) were the first 
to examine whether these risk factors also applied to the ASD population. They noted 
that early onset smoking and parental substance misuse were also relevant risk factors 
for those with autism spectrum disorder. However, contrary to other psychiatric 
cohorts, childhood maltreatment did not increase risk of substance use disorder in 
adults with normal IQ autism spectrum disorder. Miles and McCarthy (2012) later 
identified a maternal history of alcohol addiction as a significant risk factor for alcohol 
dependency in adults with autism spectrum disorder.  
As substance use disorder and autism spectrum disorder do not share common clinical 
features, it has been difficult to elucidate possible common aetiological factors (Miles, 
2012). Possible links in maternal dopamine β-hydroxylase alleles and dysregulation of 
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the neurotransmitter systems for GABA have been suggested but not replicated (Miles, 
2012). Possibly, a more robust finding is the proposed link to genes regulating neural 
cell adhesion (Neurexin 1 and 3) and to dysregulation of the ‘cognitive’ cortico-striatal 
loop regulating inhibition and impulse control in both disorders (Miles 2012, Van 
Wijngaarden-Cremers 2014). 
 
Tic Disorders, including Tourette’s syndrome 
Tic disorders include Tourette’s syndrome, persistent (chronic) motor or vocal tic 
disorder and provisional tic disorder (American Psychiatric Association, 2013). Knight 
et al (2012) reported a prevalence of childhood Tourette’s syndrome, following a large 
systematic review and meta-analysis as 0.77%. Wentz et al (2005) suggested the 
prevalence rate among adults in the general population to be one tenth that of the child 
rate, approximately 0.1%. The condition has been reported to occur in association with 
many neurological and psychiatric illnesses including autism spectrum disorder 
(Kumar, 1997) with the estimated prevalence rate for comorbid Tourette’s syndrome 
in adults with normal IQ autism spectrum disorder ranging from 2% - 20% (Hofvander 
2009, Joshi 2013). 
Distinguishing tics from stereotyped repetitive behaviours in autism spectrum disorder 
can be difficult but historical paediatric research has provided a number of insights that 
remain helpful in distinguishing the two disorders. This research suggests (Lainhart, 
1999): 
- Tics tend to be more sudden, rapid and brief and have an involuntary quality 
compared to stereotyped movements 
- Complex stereotypies are rhythmical while complex tics are usually spasmodic 
- Stereotyped movements commonly involve the hands, fingers or whole body 
while tics usually involve the face, neck, shoulders and arms 
- Those with stereotypies may appear preoccupied or amused while children with 
tics are more likely to appear distressed 
- Stereotyped movements are less variable than tics and less influenced by 
psychosocial factors 
- Tics tend to wax and wane while stereotypies are more regular in pattern of 
occurrence 
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It has not yet been established if tic disorder, Tourette’s syndrome and autism 
spectrum disorder are associated or predisposing conditions. Researchers 
hypothesise that genetic inheritance plays a significant role in the co-expression of 
these disorders and that a pre-existing diagnosis of autism spectrum disorder could 
lend causality to the development of a tic disorder following minor head trauma 
(Lainhart, 1999).  
 
Catatonia 
Catatonia was first described by Karl Kahlbaum in 1873 as a distinct disease 
expressed as cyclical symptoms of melancholia, mania, stupor, confusion and 
dementia (Realmuto 1991, Tandon 2013). In the early 1900s, it was linked with 
hebephrenia and dementia paranoids, renaming its clinical manifestation ‘dementia 
praecox’ (Tandon, 2013). As the diagnostic criteria for schizophrenia evolved, 
catatonia became a subtype of the illness. This reduced the ability of many clinicians 
to recognise the illness in the absence of psychotic symptoms. It was not until the 
DSM-IV that catatonia was again recognised as potentially occurring in the context of 
a major mood disorder or a physical / neurological illness as well as schizophrenia 
(Tandon, 2013). Currently, it is agreed that catatonia can manifest in association with 
many illnesses including neurodevelopmental disorders, brief psychotic disorder, 
schizophreniform disorder, schizophrenia, schizoaffective disorder, bipolar disorder, 
major depressive disorder, conversion reactions, Tourette’s syndrome, anti-NMDA 
encephalitis, Parkinson’s disease, neurosyphilis, tuberculosis, tetanus, typhoid fever, 
rabies, lupus erythematosus, epilepsy, viral encephalopathy, cerebral arterial 
malformation, cerebral infarction, posterior fossa atrophy, midbrain abnormality, 
Wernicke’s encephalopathy, subdural haematoma, hyperparathyroidism, myxoedema, 
Addison’s disease, hypocalcaemia and use of recreational drugs (Realmuto 1991, Fink 
2009, Venkat 2012, American Psychiatric Association 2013). To my knowledge, the 
only exclusion disorder is delirium (American Psychiatric Association, 2013). 
Catatonia is defined as a motor dysregulation syndrome in which patients are unable 
to move normally, despite absence of physical incapacity, occurring in 7% - 15% of 
acutely hospitalised psychiatric patients (Fink, 2009). Current diagnostic criteria for 
catatonia outline a clinical picture dominated by three or more of the following 
symptoms; stupor, cataplexy, waxy flexibility, mutism, negativism, posturing, 
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mannerism, stereotypy, agitation, grimacing, echolalia and echopraxia (American 
Psychiatric Association, 2013). This combination of symptoms is frequently under-
recognised by clinicians (Tandon, 2013). Literature suggests the presence of mutism, 
akinesia and cataplexy indicates severe catatonia while increased slowness, difficulty 
initiating or completing actions, reliance on prompting, passivity, reversal of day / night, 
parkinsonian features, excitement, agitation and repetitive behaviour suggests a milder 
variant (Wing 2000, Wing 2006). 
Many symptoms of catatonia overlap with the clinical features of autism spectrum 
disorder. These include odd hand posture, interruption, freezing of movement, difficulty 
completing tasks, catatonic excitement, motor stereotypies, mannerisms, rituals, 
echolalia and negativism (Realmuto 1991, Dhossche 1998, Wing 2000, Hare 2004, 
Nylander 2008). Some authors even suggested catatonia could be misdiagnosed as 
autism spectrum disorder (Mazzone, 2014). 
Although there is increasing recognition of catatonia as a comorbid syndrome of autism 
spectrum disorder (Ghaziuddin 2005, Nylander 2008, Mazzone 2014), prevalence 
estimates are difficulty to determine. Studies located as part of this literature review 
refer to child and adolescent populations, mixed age and mixed IQ populations or case 
reports on adults. To my knowledge, there are no published studies examining the 
prevalence rate of catatonia in adults with normal IQ autism spectrum disorder. 
Prevalence rates as reported in mixed age and mixed IQ populations are possibly the 
closest estimate to prevalence in normal IQ adults. This would suggest a general 
estimate ranging from 6% - 18% (Wing 2000, Bailine 2007, Kakooza-Mwesige 2008, 
Ghaziuddin 2012). 
The presence of catatonic symptoms increases the severity of ASD symptomatology, 
increases carer burden and is a frequent cause of deteriorating skills and behaviour 
(Wing 2000, Ghaziuddin 2005, Fink 2009). Many authors advise care in assessing for 
comorbid physical, neurological or psychiatric conditions which could increase the risk 
of catatonia in patients with autism spectrum disorder (Realmuto, 1991). However, no 
true identifiable risk factors have been repeatedly reported in the literature (Wing, 
2006). A single study suggesting a link between catatonia and low IQ was identified as 
part of this literature review (Wing 2000).  
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1.8.5 Comorbid Physical Illness in Normal IQ Adults with Autism Spectrum 
Disorder 
 
Epilepsy 
Epilepsy, as defined in the ASD literature, requires the occurrence of two or more 
unprovoked seizures of any type (Tuchman, 2002). Seizures in the course of illness, 
trauma or due to an underlying metabolic disorder cannot be considered when 
assessing for comorbid epilepsy in autism spectrum disorder. In this context, a history 
of febrile convulsions does not constitute a history of epilepsy, rather existing as an 
exclusion criterion (Bolton, 2011). Furthermore, almost all information noted as part of 
this literature review related to epilepsy as seen in child or young adult populations, 
intellectual disability or mixed IQ cohorts. A significant deficit in normal IQ adult 
literature was noted. 
The association between autism spectrum disorder and epilepsy has been noted from 
as early as Kanner’s first publication on early infantile autism when two of his original 
eleven children developed seizures (Kanner, 1943). Consistently throughout the 
intervening decades, an association between epilepsy and autism spectrum disorder 
has been reported. Rutter (1967, 1973 and 1978) found that those with a diagnosis of 
autism spectrum disorder frequently developed epilepsy. Lainhart (1999) reported a 
‘seizure disorder’ prevalence rate of 25% - 30% and Wing and Potter (2002a) noted 
‘epileptic fits’ to be common. Reporting has continued into the 21st century as 
researchers note prevalence rates from 11% - 39% (Bolton 2011, Howlin 2012). This 
variation in prevalence rates is considered by many authors to be due to the 
heterogeneous nature of the samples studied. When individuals at increased risk of 
comorbid epilepsy are included in a study the prevalence is noted to be higher and 
likewise when these individuals are excluded the prevalence is lower. Factors which 
increase the prevalence of comorbid epilepsy include gender, age, intelligence level, 
degree of language skill deficits, associated neurological conditions, medication use 
and presence of behavioural disturbance. The prevalence is highest amongst females, 
adolescents and young adults, those with moderate to profound intellectual disability, 
those with severe receptive language deficits particularly verbal auditory agnosia, 
individuals with Rett’s syndrome, childhood disintegrative disorder or cerebral palsy, 
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those on prescribed antipsychotic medication and individuals with increased rates of 
behavioural disturbance (Tuchman 2002, Canitano 2007, Bolton 2011, Howlin 2012).  
Although epilepsy can be diagnosed at any age, seizure onset is considered to have a 
bimodal distribution in those with autism spectrum disorder, typically peaking in two 
age brackets; those aged under 5 years (early childhood) and those aged 10 - 15 years 
(adolescence) (Tuchman, 2002). Bolton et al (2011) reported a third peak in a group 
of 150 mixed IQ adults, noting an increase in onset aged 20 - 25 years. All seizure 
types have been linked to autism spectrum disorder with mixed reports as to the most 
commonly occurring. As a result, researchers advise observation for simple or complex 
partial seizures, atypical seizures, tonic-clonic seizures and myoclonic seizures as no 
single seizure type can be expected (Canitano, 2007).  
Epilepsy is not considered a causal condition for autism spectrum disorder rather a 
comorbid disorder due to common brain dysfunction (Mouridsen, 2011). Several 
markers on chromosome 15q11-13 have been linked independently to both epilepsy 
and autism spectrum disorder strengthening the argument for common aetiology 
(Canitano, 2007). However, as yet, the mechanism underlying comorbidity of the two 
conditions remains unclear (Bolton, 2011). 
As seizures can influence emotional and behavioural expression, evidenced by poorer 
outcomes for those with epilepsy, the illness should be routinely considered and 
investigated (Billstedt 2005, Canitano 2007). Factors indicating a new seizure disorder 
in adults with autism spectrum disorder include deterioration in language skills, social 
skills, cognitive function, mood or behaviour, new onset hallucinations or new onset 
stereotyped repetitive movements (Lainhart, 1999). Treatment of epilepsy in autism 
spectrum disorder parallels treatment options in the neurotypical population, namely 
prescription of antiepileptic medication. Further to seizure control, other beneficial 
effects seen in those with autism spectrum disorder include reduced affective 
instability, impulsivity and aggression (Tuchman, 2002). 
 
Sleep Difficulties 
Sleep is defined as ‘a condition of body and mind which typically recurs for several 
hours every night, in which the nervous system is inactive, the eyes closed, the postural 
muscles relaxed and consciousness practically suspended’ (Oxford English Dictionary, 
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2012). It is one of the human circadian rhythms, alongside body temperature, allergy 
susceptibility, hormone production and general activity (Hare, 2006b). One’s sleeping 
pattern is gradually established as one ages, graduating from infancy into early 
childhood. In infancy, it is recognised that sleep occurs in a polyphasic manner with 
multiple naps and a more sustained period of sleep overnight, by age three months the 
infant sleeps more regularly availing of two naps per day and from toddlerhood to age 
three years a single daytime nap is required (Richdale, 1999). From early childhood 
into adulthood a stable sleep pattern is established that will hold unless disrupted by 
physical illness, psychiatric illness, medication or environmental disturbances. Aging, 
in turn, is associated with a deterioration in sleep quality, increased sleep 
fragmentation, early morning waking and reduced slow wave sleep (Crowley, 2011).  
‘Sleep problems’ is defined as sleep behaviour that is disturbing to the individual, their 
sleep partner, family or others, these can include settling difficulties and night waking. 
‘Sleep disturbance’ is a collective term used to describe difficulties relating to sleep 
attributed to factors other than aging (Richdale 1999, Reynolds, 2011). ‘Sleep disorder’ 
refers to sleep disturbance due to underlying physiological dysfunction, including 
insomnia and parasomnias (Richdale, 1999). Insomnia is defined by DSM-5 as the 
complaint of dissatisfaction with sleep quality or quantity associated with difficulty 
initiating sleep, difficulty maintaining sleep or early morning waking (American 
Psychiatric Association, 2013). Sleep parasomnias include non rapid eye movement 
(NREM) and rapid eye movement (REM) sleep disorders. NREM sleep parasomnias 
include sleep walking, sleep terrors, sleep talking and nightmares while REM 
parasomnia is defined as repeated episodes of arousal during sleep associated with 
vocal or motor movements due to absence of normal REM sleep atonia (American 
Psychiatric Association, 2013). 
Sleep is an important clinical parameter to measure. Chronic sleep impairment in 
neurotypical children is associated with inattention, hyperactivity, maternal stress, 
parental sleep disruption and parental depression (Reynolds 2011, Mannion 2014b). 
In neurotypical adults it is linked to increased daytime sleepiness, poor memory, 
executive dysfunction, inattention, learning difficulty, impaired emotional control and 
poorer social functioning (Hare 2006a, Crowley 2011). In those with intellectual 
disability it has been associated with challenging behaviour and communication 
difficulties (Galli-Carminati, 2009). In individuals with autism spectrum disorder, sleep 
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disturbance has been put forward as the third marker of abnormal neural function, 
following epilepsy and intellectual disability, and connected to higher overall autism 
severity scores, increased repetitive behaviours and stronger insistence on sameness 
(Limoges 2005, Reynolds 2011). 
Findings of research in normal IQ individuals with autism spectrum disorder from 1999 
to 2015 are outlined in Table 1.13. 
 
Table 1.13 
 
Sleep Disturbance in Normal IQ Autism Spectrum Disorder 
Author, 
Year of 
Publication 
Country 
of Origin 
Sample 
Characteristics 
Sleep Disturbance Described 
Godbout,  
2000 
Montréal, 
Canada 
8 patients 
attending a 
specialised ASD 
clinic 
 
Mixed age  
(7 - 53 years) 
 
Normal IQ 
Difficulty initiating sleep 
Difficulty maintaining sleep 
 
↑ shifts into REM sleep from waking 
epoch 
↑ REM sleep disruption 
Pathological index of PLMS 
↓ sleep time in first ⅔ of the night 
↓ sleep spindles on EEG 
 
Normal REM sleep rapid eye 
movements 
Normal K complexes on EEG 
 
Tani,  
2003 and 
2004 
Helsinki, 
Finland 
20 patients 
attending a 
specialised ASD 
clinic 
 
Adults  
(19 - 34 years) 
 
Normal IQ 
Insomnia - initial, middle and terminal 
 
↑ variation in night-to-night sleep 
parameters 
↑ θ power in slow wave sleep 
 
↓ sleep quality 
↓ Δ power in slow wave sleep 
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Author, 
Year of 
Publication 
Country 
of Origin 
Sample 
Characteristics 
Sleep Disturbance Described 
Limoges,  
2005 
Québec, 
Canada 
27 patients 
attending a 
specialised ASD 
clinic 
 
Adults 
(16 - 27 years) 
 
Normal IQ 
Insomnia 
Earlier bed and rise times 
 
↑ Sleep latency 
↑ Nocturnal awakenings 
 
↓ Sleep efficiency 
↓ NREM sleep 
↓ slow wave sleep 
↓ Stage 2 sleep spindles 
↓ rapid eye movements during REM 
sleep 
Normal K complexes on EEG 
 
No evidence of daytime napping 
No difference in sleep apnoea 
No difference in periodic leg movement 
syndrome (PLMS) 
 
Hare, 
2006a 
North-
West 
England 
10 patients 
attending a 
specialist 
independent 
service for ASD 
 
Adults 
(23 - 38 years) 
 
Normal IQ 
Delayed circadian rhythm of 24½ hours 
Less stable circadian rhythm 
Less link between circadian rhythm and 
environmental synchronisers (zeitgebers) 
 
↑ sleep latency 
↑ sleep fragmentation 
 
↓sleep efficiency 
 
 
 
Eating Disturbance 
Eating disturbance is a change in eating pattern which is similar to but less severe than 
an eating disorder and does not reach diagnostic criteria for anorexia nervosa or 
bulimia nervosa. It is considered common in all individuals, neurotypical as well as 
those with autism spectrum disorder, from age two to six years and typically resolves 
from middle childhood (Kuschner, 2015). In autism spectrum disorder however, it is 
noted to frequently persist into adulthood. Eating disturbance in autism spectrum 
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disorder is a wide ranging symptom with many phenotypes and constitutes a research 
question that is largely unanswered (Whiteley 2000, Råstam 2008, Mannion 2014a). 
Detection of eating disturbance in adults with a normal IQ autism spectrum disorder is 
clinically relevant due to the associated physical complications including gastric acid 
erosion of tooth enamel, malnutrition, vitamin and mineral deficiencies, oesophageal 
disease, diarrhoea and constipation (Råstam 2008, Venkat 2012). It is also 
psychosocially relevant as eating disturbance can lead to limited social engagement, 
poorer social skills and obesity with associated low self-confidence. 
Eating disturbance in autism spectrum disorder can include (Lainhart 1999, Råstam 
2008, Venkat 2012): 
 Food neophobia, the fear of new foods 
 Food refusal 
 Low body weight 
 Pica, the eating inedible non-food substances 
 Requirement for supervision to ensure nutritionally balanced dietary intake 
 Rumination, the repetitive regurgitation of ingested food into the mouth with 
subsequent spitting, remastication or swallowing 
 Selective eating, the restriction of food by number, colour, texture  or brand 
 Vomiting       
 
Although, the aetiology of eating difficulties in autism spectrum disorder remains 
unclear, it is most likely multifactorial and linked to the core symptoms of the condition 
itself including hyper- or hypo- sensitivity to smell, taste, feel or the visual appearance 
of food, sensory processing difficulties, oral and fine motor impairments, rigid routines, 
restricted interests and insistence on sameness. Furthermore, it has been suggested 
that social and communication deficits reduce the ASD individual’s ability to engage in 
the social ritual of dining leading to poorer dietary intake (Råstam 2008, Kuschner 
2015). 
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Motor Skills 
Although, motor skill deficits in autism spectrum disorder appear to be present from 
early infancy (Fournier 2010, Fabbri-Destro 2013) and persist into adulthood (Gowen 
2012, Bejerot 2013) the condition is wide ranging and difficult to define. Available 
literature uses a variety of terms when referring to motor skill deficits, complicating both 
research methodologies and research findings. A selection of terms includes 
clumsiness, disorders of locomotion, poor motor co-ordination, movement disorder, 
motor dysfunction and sensory-motor skill deficits. Apraxia is generally reserved for 
acquired neurological movement disorders of adulthood while dyspraxia is used to 
refer to a less severe developmental impairment often seen from childhood (Miller, 
2014). Fine motor skills refers to manual dexterity and visuomotor control while gross 
motor skills include walking, throwing, posture and balance (Gowen, 2012). Over the 
decades, ‘motor skill deficit’ in autism spectrum disorder has become a far reaching 
term to include absence of facial expression, poor fine motor co-ordination, lack of 
fluency in locomotion, poorly co-ordinated movements, odd posture, hypotonia, 
postural instability, muscle rigidity, akinesia and bradykinesia (Raja 2009, Weiss 2013).  
Early literature believed motor skill deficits in autism spectrum disorder to be 
sufficiently common as to warrant inclusion in the diagnostic criteria. Researchers 
noted an abnormal pattern of righting and lack of protective reflexes in infancy, 
abnormal limb and hand posturing, marked asymmetry in crawling, delayed onset of 
walking and ultimately an abnormal gait, reduced range of motion at the ankle and in 
some studies features in common with Parkinson’s disease such as slow gait, short 
steps and stooped posture (Hallett 1993, Hardan 2003, Nayate 2005). The 
multifaceted nature of these findings led researchers to hypothesise neurological 
aetiology in the cerebellum, frontal lobe and basal ganglia strengthening the argument 
for a neurological basis to autism spectrum disorder (Hallett 1993, Hardan 2003, 
Nayate 2005). 
In 2003, the possible link between basal ganglia pathology, specifically focusing on the 
caudate nucleus and putamen was ruled out by Hardan et al in a neuroimaging study 
of 40 normal IQ individuals (aged 8 - 45 years) with autism spectrum disorder. They 
concluded the only possible remaining neuroanatomical aetiology was that of the 
cerebellum and frontal lobes. More recently, research has focused on motor skill 
deficits in the areas of gesture imitation, gesture to command and tool-use, with reports 
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of associated lack of empathy and deficits in theory of mind (Dziuk 2007, Fabbri-Destro 
2013). This has led researchers to propose a link between autism spectrum disorder 
and the mirror neuron system. Mirror neurons are found in the inferior frontal, 
precentral and inferior parietal cortex. These neurons fire when an individual is 
undertaking an action or when observing another perform an action, allowing one to 
experience the thoughts and feelings required to effectively understand the event 
taking place. This understanding is based on receiving and interpreting information and 
on the ability to experience empathy and utilise social communication. Increased 
activity in one’s mirror neuron system is linked with increased ability to empathise and 
socialise. By extension, reduced firing in one’s mirror neuron system is linked to 
reduced empathy, reduced theory of mind and deficits in social skills (Society for 
Neuroscience, 2013). Impaired mirror neuron functioning has been demonstrated in 
empathy and non-verbal communication tasks in individuals with autism spectrum 
disorder (Roy, 2013).  
Although no longer viewed as a core deficit of autism spectrum disorder, it is 
acknowledged that motor problems can impact on multiple facets of an ASD 
individual’s life from infancy through to old age (Fournier, 2010). The finding that motor 
skill deficits are present before the onset of social and communication skill deficits 
supports this argument (Nayate 2005, Fabbri-Destro 2013). In childhood, gross and 
fine motor skills such as walking, running, jumping, climbing and cycling a bicycle are 
required to allow a child to interact with their world. Fine motor skills such as grasping, 
speaking, writing and typing facilitate cognitive development and social interaction. 
Impaired motor skills can impact on one’s ability to engage in meaningful activity, effect 
mood, enjoyment and the formation of relationships. A link between poor motor skills 
and peer victimisation or bullying in childhood, most notably in girls, has been 
established by Bejerot and Humble (2013) when looking at 277 patients with pervasive 
developmental delay in Stockholm, Sweden. Simple skills such as using a knife and 
fork, cycling, driving or engaging in recreational activity, use of hand gestures, facial 
expressions, chewing and hand-eye co-ordination can be limited for adults with autism 
spectrum disorder. Limited ability to interact with one’s physical and social environment 
could result in poor social communication, reduced occupational performance and 
impaired relationship development for individuals with autism spectrum disorder over 
and above that experienced by neurotypical individuals.  
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Smoking 
Smoking is an established risk factor for physical and psychiatric illness. It has been 
associated with depression, alcohol and drug abuse, personality disorder and anxiety 
spectrum disorders, particularly agoraphobia, cancer, coronary heart disease, 
myocardial infarction, cerebrovascular accident, peripheral vascular disease, chronic 
obstructive pulmonary disease, pneumonia and infertility (Bejerot 2003, NHS Choices 
2015). Prevalence rates for smoking among the general population in the United 
Kingdom were last reported in 2012 as males 22%, females 19% and total population 
20% (OECD, 2012). Smoking rates have been measured among the psychiatric 
population also and were noted to be at least double that of the general population for 
all types of psychiatric illness and particularly higher in patients with schizophrenia (El-
Guebaly 2002, Lê Cook 2014).  
By contrast, available research on smoking rates in those with autism spectrum 
disorder is sparse (Mattila, 2010). Bejerot and Humble (2013) reported smoking rates 
of 15.8% and Joshi et al (2013) reported a rate of zero percent. Interestingly, both rates 
are lower than rates seen in the respective general population for each nation under 
study.  
 
Gastrointestinal Disease  
Considerable controversy exists in relation to the association between autism 
spectrum disorder and gastrointestinal disease. Studies vary by age and IQ cohort but 
also by definition of gastrointestinal disease. Although practicing physicians would 
generally use the term to refer to disease involving any portion of the gastrointestinal 
tract from the oesophagus to the anus, this literature review noted a tendency for ASD 
literature to use the term to refer solely to diarrhoea and constipation. One particularly 
controversial paediatric gastroenterologist, Arthur Krigsman has dedicated a large 
portion of his career to proving a link between gastrointestinal disorders and autism 
spectrum disorder. His 2007 paper outlines thirteen different gastrointestinal lesions 
noted on endoscopic examination of children with autism spectrum disorder, including 
lymphonodular hyperplasia, eosinophil-laden oesophagitis, gastroesophageal reflux 
disease, Barrett’s oesophagitis, gut hypomobility, inflammatory gastric polyps, nodular 
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gastritis, non-specific duodenitis, colitis, colonic ulceration, inflammatory colonic 
polyps, ulcerative colitis and Crohn’s disease.  
Probably the most controversial association between gastrointestinal disease and 
autism spectrum disorder was proposed by Wakefield et al (1998). Wakefield and 
colleagues proposed a ‘real’ and ‘unique’ gastrointestinal disease process leading to 
abdominal pain, diarrhoea, bloating and food intolerance in twelve children aged 6 - 10 
years following receipt of the MMR vaccine in infancy. These findings were clearly 
refuted by later research, the article redacted by its publishing journal and Wakefield 
removed from the medical register by the General Medical Council ruling (Godlee, 
2011). Paediatric studies which could possibly be considered more robust note a 
prevalence rate of 9% - 91% for gastrointestinal disease in children with autism 
spectrum disorder with a narrower prevalence rate of 24% - 42% for chronic diarrhoea 
and constipation (Venkat 2012, Mannion 2014c).  
This literature review sourced two published studies relating to rates of gastrointestinal 
disease in adults with autism spectrum disorder. Both included adults with intellectual 
disability. No study relating to normal IQ adults could be identified. Galli-Carminati et 
al (2006) investigated rates of gastrointestinal disease in 75 adults (age 26 - 48 years) 
with an intellectual disability compared to 43 adults with intellectual disability alone, 
reporting higher rates of upper gastrointestinal symptoms such as dyspepsia, 
gastroesophageal reflux disease, oesophagitis and gastritis. Mouridsen et al (2010) 
compared 118 adults (age 27 - 57 years) with autism spectrum disorder, 71% of whom 
had an intellectual disability, to 336 healthy controls in Copenhagen, Denmark. 
Findings showed equal rates of gastrointestinal disease in both groups. Only dental 
problems were statistically more likely in the group with autism spectrum disorder. Of 
interest, when dental problems were excluded, individuals with autism spectrum 
disorder were noted to suffer from less gastrointestinal disease than their neurotypical 
counterparts. Dental problems have been shown to correlate highly with intellectual 
disability, reducing the significance of their finding. 
Overall, the nature and frequency of gastrointestinal disease in both children and 
adults with autism spectrum disorder remains undecided. Research findings are 
inconsistent and significant controversy in the area has prevented the drawing of 
reliable conclusions. On balance, this literature review was unable to establish a 
reliable link between normal IQ autism spectrum disorder and gastrointestinal disease. 
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1.9 Aims and Hypotheses of the Study 
Despite the significant psychiatric and physical comorbidities associated with autism 
spectrum disorder, as outlined above, there is a notable lack of literature referring to 
adults with a normal IQ suffering from the disorder. This study was undertaken to 
determine if further clarification could be made in relation to comorbid illnesses in this 
specific population. The aims of this study are: 
1. To determine the frequency of Axis I and Axis II comorbid psychiatric illness in 
adults with normal IQ autism spectrum disorder 
 
2. To determine the frequency of reported physical illness in adults with normal IQ 
autism spectrum disorder 
 
3. To determine the frequency of psychiatric and physical illness by specific ASD 
subgroup 
 
4. To determine the frequency of psychiatric and physical illness by gender 
 
5. To draw comparison between the rates of psychiatric and physical illness 
among the ASD population and reported rates among the general population 
 
This study tested the following hypotheses: 
1. In a sample of adults with normal IQ suffering from autism spectrum disorder 
the rate of comorbid psychiatric illness will be higher compared to the general 
population 
 
2. In a sample of adults with normal IQ suffering from autism spectrum disorder 
the rate of comorbid physical illness will be higher compared to the general 
population 
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1.10 Summary of Introduction 
Autism spectrum disorder is a pervasive neurodevelopmental disorder characterised 
by deficits in social skills, impaired communication style and characteristic repetitive 
and ritualised behaviours. It was first described almost simultaneously by Leo Kanner 
and Hans Asperger in the 1940s. From that time, autism spectrum disorder has 
undertaken many evolutionary steps to reach the illness as understood today.  
Current prevalence rates estimate up to 1% of the population suffer from autism 
spectrum disorder with a larger, as yet undefined, population falling into the wider 
phenotype. Much progress has been made in determining the aetiology of autism 
spectrum disorder, especially in the areas of genetic and neuroanatomical research. 
However, given the significant heterogeneity of the disorder, research continues to 
search for the definitive causative factor. 
Criteria for diagnosis of autism spectrum disorder are outlined by both the ICD-10 and 
DSM-5. These are enhanced by a wide array of screening tools and two gold standard 
diagnostic instruments now available to diagnosticians. Despite the low volume of 
literature in the area, works are emerging showing adults with autism spectrum 
disorder most likely suffer from disorders of mood, thought and behaviour at 
significantly higher rates that those seen in the general population. Relatively few 
studies investigate the rates of psychiatric and physical comorbidity in normal IQ adults 
with autism spectrum disorder. It is as yet unclear if particular comorbid conditions are 
more prevalent in adults with autism spectrum disorder, whether a gender imbalance 
is present or if conditions are seen more frequently in certain subtypes of autism 
spectrum disorder.  
Awareness of the potential for diagnostic overshadowing in this area is crucial to 
ensure accurate diagnosis, formulation, care planning and treatment. If psychiatric and 
physical comorbidity is shown to commonly occur in those with autism spectrum 
disorder, care must be taken to ensure accurate diagnosis of autism spectrum disorder 
in those suffering from a psychiatric or physical illness and likewise diagnosis of 
comorbid psychiatric and physical illness in patients diagnosed with autism spectrum 
disorder. 
Internationally, legislation has been required to increase diagnostic services and 
improve treatment options for those with autism spectrum disorder. Closer to home, 
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the increase in public awareness has yet to translate into government policy or 
increased healthcare services and it is frequently shown that access to crucial 
treatment opportunities for individuals with autism spectrum disorder, wanes 
significantly after the age of 18 years. It is hoped, that as support for those with autism 
spectrum disorder improves among both clinicians and the general public, so too will 
funding and policy driven care by health service providers. Further research will assist 
access to diagnosis and treatment and lead to better outcomes for those with this 
highly debilitating illness. 
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Chapter 2: Materials and Methods 
 
2.1 Overview 
This chapter outlines the methods used to undertake a literature review on the subject 
of autism spectrum disorder in adults with normal range intellectual functioning, 
development of an SPSS dataset and codebook and sourcing of the clinical sample. It 
outlines the preassessment screening process and diagnostic tools used in this study, 
ethical approval, data gathering methods, inclusion and exclusion criteria, methods of 
statistical analysis and methods of reporting.  
The timeline for this study is outlined in Table 2.1 
Table 2.1 
 
Ghant Chart 
Date 
 
Activity 
August 2012 - October 2012 Initial literature review 
 
October 2012 - December 2012 Application for MD student placement 
Development of SPSS codebook 
 
January 2013 - March 2013 Data gathering from chart records 
 
March 2013 - August 2013 Manual review of 364 reports 
 
September 2013 Publication: 
Garland J, O’ Rourke L, Robertson D (2013) Autism 
spectrum disorder in adults: clinical features and the 
role of the psychiatrist. Advances in Psychiatric 
Treatment, 19(5):378-391. 
August 2013 - February 2014 Off books, due to maternity leave 
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Date 
 
Activity 
February 2014 - September 2015 Manual review of remaining 96 reports 
Upload of 96,140 variables to SPSS 
 
February 2015 - July 2016 Literature review 
Data analysis 
Writing of thesis 
 
July 2016 Thesis submission 
 
 
2.2 Literature Review 
The literature review for this study was performed by the author in August 2012 and 
repeated in February 2015. Databases searched included Medline Pubmed, Google 
Scholar, PsychInfo and PsychNet. Terminology was defined for each search using 
terms related to the research question. Terms were expanded using clinical synonyms, 
psychiatric nomenclature, medical nomenclature and medical literature. Search 
terminology is listed in Table 2.2. The author searched each term individually and 
repeated searches using combinations of search terms. When a new synonym or 
phrase was identified from sourced literature, it was added to the search terms. 
Reference lists for each article were manually searched for related articles by the 
author. 
Certain topics which the autor wished to address in the literature review were under-
researched with few published articles available for review. In these circumstances, 
the author broadened the search criteria to include child cohorts and mixed IQ 
populations. These references are explicitly named in the text. No intellectual disability 
only studies were included. To allow a comprehensive search of the literature all study 
designs were included and the search was not limited by publication date. Studies in 
all languages were considered relevant. The author accessed the abstracts of these 
articles in the English language and where available the full article was accessed. 
When more than one paper was published relating to the same study sample, the 
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author reviewed all papers and included each separately. Examples include Brugha et 
al (2007 and 2011), Lugnegård et al (2011 and 2012) and Tani et al (2003 and 2004). 
Articles are referenced using the Harvard Referencing System. On occasion, books or 
articles that could no longer be sourced are cited. In each case reference is made to 
the original author, as found in the more recent publication. Online articles, summaries 
and presentations are referenced by web address and date of access. 
Table 2.2 
 
Terminology of Literature Review 
Search Topic 
 
 
Search Terms 
 
ASD Terminology  Asperger 
 Asperger’s syndrome 
 Autism 
 Autism spectrum disorder 
 Childhood autism 
 PDD 
 Pervasive developmental delay 
Intelligence Quotient 
Terminology 
 High-functioning 
 Intellectual functioning 
 Intelligence 
 Intelligence quotient 
 IQ 
Comorbid Terminology  Comorbid 
 Comorbidity 
 Co-occurring 
Age Terminology  Adult 
 Adulthood 
Psychiatric Illness 
Terminology 
 
 
 
 
 
 
 
 
 
 
 
 
 Psychiatric illness 
 Mental illness 
 Mood 
 Affective 
 Bipolar 
 Depression 
 Hypomania 
 Mania 
 Anxiety spectrum disorders 
 Generalised anxiety 
 Hypochondriasis 
 Obsessive compulsive disorder 
 Panic disorder 
 Post-Traumatic stress disorder 
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Psychiatric Illness 
Terminology 
 
 Social anxiety 
 Social phobia 
 Somatisation 
 Somatoform 
 Psychotic 
 Psychosis 
 Delusional 
 Schizoaffective 
 Schizophrenia 
 Eating disorder 
 Anorexia 
 Bulimia 
 Personality 
 Anankastic 
 Antisocial  
 Dissocial 
 Anxious-avoidant 
 Dependent 
 Borderline 
 Emotionally-unstable 
 Histrionic 
 Narcissistic 
 Paranoid 
 Schizoid 
 Schizotypal 
 Neurodevelopmental 
 Attention deficit hyperactivity disorder 
 Tic disorder 
 Tourette’s syndrome 
 Gender identity disorder 
 Addiction 
 Substance use disorder 
 Alcohol 
 Catatonia 
 Self-harm 
 Self-injury 
 Suicide 
 Suicidal behaviour 
 Sleep 
 Sleep difficulties 
 Insomnia 
 Appetite 
 Diet 
 Eating disturbance 
 Eating behaviours 
 Eating habits 
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Search Topic 
 
 
Search Terms 
Physical Illness 
Terminology 
 Physical illness 
 Medical illness 
 Medical condition 
 Motor skills 
 Clumsiness 
 Dyspraxia 
 Dyslexia 
 Epilepsy 
 Gastrointestinal 
 Head injury 
 Hypertension 
 Smoking 
 Medication 
 Sedative 
 Hypnotic 
 Allergy 
 Food 
 
Other Terminology 
 
 
 
 
Other Terminology 
 Assessment 
 Causality 
 Epidemiology 
 Prevalence 
 Age 
 Gender 
 Genetics 
 History of autism spectrum disorder 
 MMR vaccine 
 Mortality 
 Neuroimaging 
 Outcomes 
 Prevalence 
 Stress 
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2.3 Development of an SPSS Codebook 
The author uploaded, stored and analysed data using Statistical Package for Social 
Science (SPSS), version 22. The key to the SPSS dataset and codebook are outlined 
in Table 2.3. The original dataset included 51 variables. This was extended to 209 
variables over the course of data entry to allow for accurate recording of particular 
psychiatric and physical conditions and to allow detailed data analysis. For all 
variables, 777 reflects unanswered questions, 888 for nonapplicable questions and 
999 for ‘do not know’ replies.  
Table 2.3 
 
Key to SPSS Codebook 
Variable Type of Data 
 
Codes 
 
Assessment Information: 
Initials of consultant 
completing assessment 
Categorical 0. CM 
1. DM 
2. DR 
3. IJ 
4. JZ 
5. MC 
6. MCA 
7. QD 
Date of assessment Continuous Dates ranged from 22.09.2009 to 
21.10.2012 
Referring clinician Categorical 1. General practitioner 
2. Consultant psychiatrist 
3. Clinical psychologist 
Accompanying person Categorical 0. Alone 
1. Parents 
2. Mother 
3. Father 
4. Sister 
5. Brother 
6. Spouse / partner 
7. Carer / CMHT member 
8. Interpreter 
9. Friend 
10. Child 
11. Grandparent 
12. Aunt 
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Variable Type of Data 
 
Codes 
 
Assessment Information: 
 
Date of birth Continuous Dates ranged from 09.02.1939 to 
08.12.1995 
 
Age at assessment Continuous Age ranged from 14 - 70 years 
 
Gender Categorical 0. Male 
1. Female 
 
Marital status Categorical 0. Single 
1. Partner 
2. Engaged 
3. Married 
4. Separated 
5. Divorced 
6. Widowed 
 
 
Parental marital status Categorical 0. Single 
1. Partner 
2. Engaged 
3. Married 
4. Separated 
5. Divorced 
6. Widowed 
 
 
Employment status Categorical 0. No 
1. Yes 
 
Accommodation status 
 
 
Categorical 0. Alone 
1. Parents 
2. Mother 
3. Father 
4. Sister 
5. Brother 
6. Spouse / partner 
7. Carer / supported 
accommodation 
8. Sibling(s) 
9. Friend 
10. Child(ren) 
11. Grandparents 
12. Homeless 
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Variable Type of Data 
 
Codes 
 
Assessment Information: 
 
History of delay in motor 
milestones 
Categorical 0. No 
1. Yes 
 
History of delay in speech 
milestones 
Categorical 0. No 
1. Yes 
Type of schooling Categorical 1. Mainstream 
2. Mainstream with statement 
3. Special needs school 
4. Mainstream with SNA 
5. Home-schooled 
 
Bullying in school Categorical 0. No 
1. Yes 
Third level education Categorical 0. No 
1. Yes 
 
Psychiatric Information: 
Prior contact with 
community mental health 
team 
Categorical 0. No 
1. Yes 
Past psychiatric history Categorical 0. No 
1. Yes 
 
Previous diagnosis of 
autism spectrum disorder 
Categorical 0. No 
1. Yes 
History of deliberate self-
harm 
Categorical 0. No 
1. Yes 
 
History of self-injurious 
behaviour 
Categorical 0. No 
1. Yes 
 
Diagnosis of autism 
spectrum disorder given 
at assessment 
Categorical 0. No 
1. Yes 
 
ICD-10 ASD diagnosis Categorical 0. No 
1. Yes 
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Variable Type of Data 
 
Codes 
 
Psychiatric Information: 
Diagnosis of other 
psychiatric disorder at 
assessment 
Categorical 0. No 
1. Yes 
Neurodevelopmental 
disorder diagnosed at 
assessment 
Categorical 0. No 
1. Yes 
Mood disorder diagnosed 
at assessment 
Categorical 0. No 
1. Yes 
Anxiety spectrum disorder 
diagnosed at assessment 
Categorical 0. No 
1. Yes 
Psychotic disorder 
diagnosed at assessment 
Categorical 0. No 
1. Yes 
Personality disorder 
diagnosed at assessment 
Categorical 0. No 
1. Yes 
Addictive disorder 
diagnosed at assessment 
Categorical 0. No 
1. Yes 
Other psychiatric disorder 
diagnosed at assessment 
Categorical 0. No 
1. Yes 
Learning disability 
diagnosed at assessment 
Categorical 0. No 
1. Yes 
Family history of autism 
spectrum disorder 
Categorical 0. No 
1. Yes 
Family history of 
psychiatric illness 
Categorical 0. No 
1. Yes 
 
 
Medical Information: 
Past medical history Categorical 0. No 
1. Yes 
 
History of sleep difficulties Categorical 0. No 
1. Yes 
 
 
History of eating 
disturbance 
Categorical 0. No 
1. Yes 
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Variable Type of Data 
 
Codes 
 
Medical Information: 
 
Current medications Categorical 0. No 
1. Yes 
 
Allergies Categorical 0. No 
1. Yes 
Weekly alcohol intake Continuous Units consumed per week 
 
Illicit drug use Categorical 0. No 
1. Yes 
 
Family history of medical 
illness 
Categorical 0. No 
1. Yes 
 
Questionnaires: 
Autism Quotient - self Continuous Total result entered numerically 
 
Autism Quotient - other Continuous Total result entered numerically 
 
Obsessive Compulsive 
Inventory, Revised 
Continuous Total result entered numerically 
Hospital Anxiety and 
Depression Scale 
Continuous Total result entered numerically 
Barkley Screening 
Questionnaire - self 
Continuous Total result entered numerically 
Barkley Screening 
Questionnaire - other  
Continuous Total result entered numerically 
Autism Diagnostic 
Interview, Revised 
Continuous Total result entered numerically 
Autism Diagnostic 
Observational Schedule, 
Generic 
Continuous Total result entered numerically 
Full scale IQ 
 
Continuous Total result entered numerically 
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2.4 The Behavioural Genetics Clinic 
This study involved access to case records of patients attending The Behavioural 
Genetics Clinic (BGC) in the outpatient department of the Maudsley Hospital, London. 
The BGC is a purpose designed clinic for the assessment and diagnosis of adults with 
suspected autism spectrum disorder. The clinic functions as the outpatient assessment 
unit of the Autism Assessment and Behavioural Genetics Service within the South 
London and Maudsley Trust. The clinic has ‘pioneered the development of specialist 
services for assessment and treatment of autism spectrum disorder and other 
neurodevelopmental disorders in adults’ (National Services NHS, 2015) offering single 
day assessments to patients from across the United Kingdom. It accepts referrals from 
consultant psychiatrists, general practitioners and clinical psychologists. Self-referrals 
are not accepted. 
Each referral is triaged by a consultant psychiatrist and offered an assessment 
appointment if appropriate. Inclusion criteria include age over 17 years and 4 months, 
male or female, suspected or confirmed autism spectrum disorder, possible genetic / 
chromosomal abnormalities or psychiatric comorbidity, engaged with a local 
community mental health team or forensic psychiatry service and in receipt of funding 
for assessment. Exclusion criteria include referral reports of current use of street drugs 
or not engaged with a local community mental health team / forensic psychiatry service 
(National Services NHS, 2015).  
Outpatient assessments are a half-day procedure consisting of a detailed psychiatric 
interview by a trained non-consultant hospital doctor, the Autism Diagnostic 
Observation Schedule - Generic (ADOS-G) and / or the Autism Diagnostic Interview - 
Revised (ADI-R) by a trained and accredited clinical psychologist or psychiatric nurse 
practitioner, consensus meeting with a consultant psychiatrist and provision of a 
diagnosis, formulation and treatment recommendations. When required, patients also 
undergo genetic screening, blood testing, neuroimaging and neuropsychological 
assessment depending on suspected comorbid illness.  
The detailed psychiatric examination consists of clinical observation and a semi-
structured diagnostic interview by a psychiatric registrar with training in the assessment 
of autism spectrum disorder in a normal IQ adult population. Some registrars will have 
further experience in intellectual disability or inpatient care of adults with autism 
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spectrum disorder and comorbid psychiatric illness. Diagnosis is based on the ICD-10 
criteria. For the duration of this study, version 10 of the International Classification of 
Diseases was used. No new criteria were devised / revised over this period, providing 
stable diagnostic criteria throughout. A structured ADI-R and / or ADOS-G is 
undertaken by a qualified psychologist or psychiatric nurse practitioner with training in 
both ADI-R and ADOS-G assessment and previous clinical and research experience 
in using both diagnostic tools. The ADI-R is completed with the patient’s primary 
caretaker or parent.   
Once the clinical interview, collateral history and initial impressions are complete, a 30 
minute to 1 hour meeting takes place involving the registrar, psychologist / psychiatric 
nurse practitioner and consultant general adult psychiatrist, specialising in the 
assessment of autism spectrum disorder and mental illness, to reach a consensus 
diagnosis. Diagnoses include a primary diagnosis of autism spectrum disorder or 
neurotypical development where applicable and secondary diagnoses of comorbid 
psychiatric illness. Following discussion of the team’s findings, the patients and carer 
are further interviewed by the consultant psychiatrist, in the company of the registrar 
and psychologist / psychiatric nurse practitioner, to confirm any points of disagreement 
or discrepancies allowing a consensus to be reached regarding diagnosis. 
The consensus team use a combination of preassessment screening questionnaires 
including the Obsessive-Compulsive Inventory - Revised (OCI-R), the Hospital Anxiety 
and Depression Scale (HADS), the Barkley Adult ADHD Rating Scale (BAARS), ICD-
10 diagnostic criteria, the Autism Diagnostic Interview - Revised, the Autism Diagnostic 
Observation Schedule - Generic, collateral information from a parent or caregiver, a 
comprehensive psychiatric history, mental state examination and clinical expertise to 
arrive at a confirmed diagnosis. This diagnostic strategy exceeds methods employed 
to diagnose autism spectrum disorder in previous studies on autism spectrum disorder 
identified as part of the literature review for this study for rigour and completeness. 
Interviewers are not blinded to the preassessment screening tool results but are 
blinded to the findings of their colleagues as the psychiatric assessment and collateral 
history plus ADI-R are completed simultaneously. Although, ICD-10 diagnostic criteria 
provide exclusion notes for childhood autism and Asperger’s syndrome as well as other 
psychiatric illnesses consultant psychiatrists at the Behavioural Genetics Clinic are 
unanimous in their decision to opt for the non-hierarchical approach to diagnostic 
117 
 
criteria and provide named diagnoses for each condition meeting diagnostic criteria. 
This allows for more comprehensive assessment and accurate recording of 
comorbidity rates. 
A BGC medical report is compiled by the consensus team including all acquired 
information and forwarded to the referrer following assessment. Reports are inclusive 
documents following  a standard template consisting of: Opening Summary, 
Background History, History of Presenting Complaint, Reciprocal Social Interaction, 
Language and Communication, Interests and Routines, ADHD Symptoms, Anxiety 
Symptoms, OCD Symptoms, Mood Symptoms, Psychotic Symptoms, Past Psychiatric 
History, Past Medical History, Family History, Personal and Developmental History, 
Current Social Situation, Educational History, Forensic History, Drug and Alcohol 
History, Mental State Examination including subheadings of Appearance and 
Behaviour, Mood, Speech, Thoughts, Perceptions, Cognitions, Insight and Risk to self, 
to others and from others, Summary, Formulation and Recommendations. 
Each BGC medical report includes the ICD-10 criteria for the autism spectrum disorder 
subtype diagnosis received by the patient and for each individual psychiatric 
comorbidity highlighting in bold the symptoms present to support the diagnosis. The 
ADI-R report and / or the ADOS-G report are included as appendices. Each report is 
signed by the NCHD, clinical psychologist / psychiatric nurse practitioner and 
consultant psychiatrist involved in the assessment. An anonymised report has been 
attached to this thesis as Appendix 6.1 to show the detail in which each report is written 
and the availability of required data to complete data extraction for this study. This 
assessment method has been revised and developed over the lifetime of the 
Behavioural Genetics Clinic by practising clinicians who ensure it is sufficiently 
sensitive to differentiate between disorders. 
All assessments included in this study were completed in the above format and 
undertaken from September 2009 to October 2012. Eight consultant psychiatrists, 
thirty two non-consultant hospital doctors and thirteen clinical psychologists or 
psychiatric nurse practitioners worked in the clinic during this time. Each patient was 
assessed by two or three practitioners, as on occasion a consultant completed the 
NCHD history or the ADOS-G / ADI-R. While working in the Behavioural Genetics 
Clinic, from July 2011 to July 2012, the author completed one assessment per week, 
totally approximately 40 assessments. Each patient is approached regarding consent 
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to participate in research and varying numbers agree. A full list of practitioners and the 
number of patients assessed by each who consented to research is outlined in the 
results section of this thesis, the author’s input is listed among the thirty two NCHDs. 
 
2.4.1 Preassessment Screening Tools used in this study 
 
The Autism Spectrum Quotient (AQ); Baron-Cohen, 2001 
The AQ was designed by the University of Cambridge as a brief, self-administered 
instrument aimed at measuring the degree to which adults with normal intelligence 
have the traits associated with autism spectrum disorder (Baron-Cohen 2001a, 
Hambrook 2008). It was designed to serve as a ‘short, easy to use, easy to score and 
useful instrument in identifying the extent of autistic traits shown by an adult of normal 
intelligence’. Baron-Cohen et al (2001a) propose its use in identifying persons in 
distress who warrant a referral to expert clinicians for full diagnostic assessment. 
The AQ is available is three forms, the AQ-50, AQ-21 and AQ-10. The AQ-50 as used 
in this study is the original format and generally referred to as the AQ. It is a 50 item, 
self-administered questionnaire allowing patients of normal intelligence to rate their 
preferences in five domains corresponding to the autism triad (Baron-Cohen 2001a, 
Hambrook 2008, White 2012, Roy 2013). Ten questions are used per domain 
assessing social skill, attention switching, attention to detail, communication and 
imagination. Participants score items on a four point Likert scale, as ‘definitely agree’, 
‘slightly agree’, ‘slightly disagree’ or ‘definitely disagree’. This four point scale is then 
collapsed to two categories, as a binary manner of rating, such that a score of one is 
given for responses indicating ASD traits and a score of zero is given for responses 
which are not consistent with autism spectrum disorder (Baron-Cohen 2001a, Hurst 
2007, White 2012). A maximum score of 50 is possible and Baron-Cohen et al (2001a) 
have suggested that a score of 32 or greater in a person suffering distress merits 
referral to an expert clinician for a full diagnostic assessment. Higher scores indicate 
more severe symptomatology, lower scores trend towards the neurotypical, inferring 
where an individual can be placed in the continuum from neurotypical to autism 
spectrum disorder (Hambrook 2008, White 2011, Roy 2013).  
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Researchers publishing on their experience of using the AQ demonstrate excellent 
test-retest reliability, moderate to high internal consistency, good diagnostic validity, 
good inter-rater reliability, reasonable face validity and reasonable construct validity 
(Hurst 2007, Roy 2013). Hambrook et al (2008) showed the internal consistency of the 
AQ to be high (α=0.82). The suggested cut-off score of >32 has been identified as 
sufficiently sensitive to capture over 79% of those with autism spectrum disorder and 
sufficiently specific in that only 2% of those without autism spectrum disorder are 
erroneously captured (White 2012, Roy 2013). In summary, the AQ has been shown 
to strongly predict diagnosis of autism spectrum disorder (Roy, 2013).  
 
Barkley Adult ADHD Rating Scale (BAARS-IV); Barkley, 2011 
The Barkley Adult ADHD Rating Scale is a behavioural assessment of symptoms of 
attention deficit hyperactivity disorder designed for use in adults (Barkley, 2011). It is 
based on the DSM-IV-TR criteria for attention deficit hyperactivity disorder. Its authors 
describe the BAARS-IV as ‘empirically-based, reliable, valid and exceptionally 
convenient to use’ (Barkley, 2011). The tool is most useful as an initial screening tool, 
identifying individuals at high risk of attention deficit hyperactivity disorder, prompting 
more detailed clinical assessment.  
The Barkley Adult ADHD Rating Scale consists of 18 items based on the DSM 
diagnostic criteria for attention deficit hyperactivity disorder. The items alternate from 
inattentive to hyperactive-impulsive symptoms covering nine of each. Patients self-
report difficulties pertaining to each item on a four point Likert scale of never / rarely, 
sometimes, often and very often. Items marked often and very often are rated one point 
each. Items marked never / rarely and sometimes are scored as zero. Scoring is 
completed by adding each point scored on inattentive items and each point scored for 
hyperactivity items. A score greater than six relating to difficulties in childhood and four 
relating to difficulties in adulthood suggest further assessment of attention deficit 
hyperactivity disorder is warranted.  
The Barkley Adult ADHD Rating Scale shows good internal consistency (0.72 - 0.94) 
and reasonable test-retest reliability (0.66 - 0.88) (Barkley, 2011). 
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Hospital Anxiety and Depression Scale (HADS); Zigmond, 1983 
The Hospital Anxiety and Depression Scale is a 14-item measure of anxiety and 
depressive symptoms in individuals to determine the severity of an individual’s 
symptom experience. The HADS is recommended as a screening questionnaire not 
as a case identifier (Spinhover, 1997). Anxious and depressed feelings are rated on a 
four point Likert scale and a cut-off score of eight indicates anxiety or depressive 
feelings which warrant further investigation (Hare, 2014). The HADS is quick to 
administer and patient friendly, it can be completed in two to six minutes and scored 
within one minute. It is accessible to and useable by both psychiatrists and non-
psychiatric medical and nursing staff alike (Herrmann, 1997).  
Internal consistency is good to excellent (0.78 - 0.93), with sensitivity and specificity of 
over 0.80 and test-retest reliability of 0.86 (Herrmann 1997, Spinhoven 1997, Mykletun 
2001, Bjelland 2002, Hansson 2009).  
 
Obsessive-Compulsive Inventory - Revised (OCI-R); Foa, 2002 
The OCI-R is a brief, self-report measure devised from the Obsessive-Compulsive 
Inventory, as designed by Foa et al in 1998. Foa et al (2002) adapted their original 
assessment tool by reducing the number of assessment items from forty two to 
eighteen, removing the frequency scale, eliminating overlap between items and 
simplifying the scoring mechanism. The OCI-R differentiates between individuals with 
and without obsessive compulsive disorder using eighteen items across six subscales 
(Foa, 2002). Subscales include washing, checking / doubting, obsessing, mental 
neutralising, ordering and hoarding assessed by three questions each.  
The OCI-R boasts good internal consistency (0.34 - 0.72), good to excellent test-retest 
reliability (0.74 - 0.91) and correlates strongly with the long version of the OCI (Foa, 
2002). Its authors recommend the OCI-R replace the OCI in clinical use. 
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2.4.2 Diagnostic Tools used in this study 
 
Autism Diagnostic Interview - Revised (ADI-R); Lord, 1994 
The ADI-R is a standardised, semi-structured, investigator-based interview conducted 
with parents, caregivers or carers of an individual with suspected autism spectrum 
disorder. The original format, the Autism Diagnostic Interview (ADI), was designed for 
research purposes but came to be used in clinical work, prompting its revision to the 
ADI-R (Lord 1994, Wing 2002b). The ADI-R interview contains 93 questions on early 
development, language, social interest, play and behaviours across five sections: 
opening questions, communication, social development and play, repetitive and 
restricted behaviours and general behaviour. Answers are coded as 0 indicating no 
abnormality, 1 for possible abnormality, 2 for definite abnormality or 3 for severe 
abnormality. Cut-off scores in each domain of social, communication and repetitive 
behaviour allow for diagnosis (Lord, 1989). This diagnostic algorithm was generated 
by selecting items which most closely matched diagnostic criteria as set out by the 
ICD-10 and DSM-IV (Lord, 1994).  
The ADI-R is designed for use as part of a multidisciplinary assessment and has 
adequate test-retest reliability, proven inter-rater reliability (0.64 - 0.89) and good 
internal consistency (0.69 - 0.95) (Lord, 1994). Intra-class correlations were also 
shown to be very high. The ADI-R is suitable for use with persons aged 18 months to 
adulthood, is a comfortable experience for parents / caregivers and with practice, 
administration time can be reduced to 1 - 1½ hours (Lord 1994, Baron-Cohen 2001a, 
Wing 2002b).  
 
The Autism Diagnostic Observation Schedule - Generic (ADOS-G); Lord, 2000 
The ADOS-G is a semi-structured, standardised assessment of communication, social 
interaction, play and imaginative use of materials (Lord, 2000). It contains schedules 
of activities designed to highlight social deficits pertaining to autism spectrum disorder 
through direct one-to-one engagement between assessor and patient and through 
observation of the patient’s social, communication and other behaviours. Each 
specifically designed social occasion is called a ‘press’ designed to elicit spontaneous 
social, communication or repetitive behaviours which can be rated in a standardised 
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manner (Lord, 2000). Four modules were designed, each for use with a particular age 
group of differing cognitive ability. Module 1 for those who are preverbal or use single 
words, module 2 for those with phrased speech, module 3 for children and adolescents 
with fluent speech and module 4 for adolescents and adults with phrased speech. 
Module 4 differs from module 3 in that it assesses high-functioning adolescents and 
adults, who are not interested in playing with toys, for ASD features. Module 4 rates 
ASD features through 31 questions across five domains and cut-off scores allow for 
diagnosis (Lord, 2000). 
The ADOS-G demonstrates good to excellent inter-rater reliability (0.41 - 0.66), test-
retest reliability (1.19 - 1.78), internal consistency (0.47 - 0.91) and agreement between 
assessors (88%) (Lord, 2000). Efficient use of the ADOS-G relies on the skill of the 
examiner and requires practice and consensus rating of the assessor’s ability (Lord, 
2000). Coupled with the 45 minutes required for each assessment, the 30 - 40 minute 
report writing time, on-going training and inter-rater reliability consensus meetings, 
testing can be time consuming.  
 
2.5 Ethical Approval  
The BGC is attached to The Department of Forensic and Neurodevelopmental 
Sciences (FANS) for research purposes. The FANS department specialises in 
research in autism spectrum disorder from neuroimaging and neuropsychiatric 
disorders through to clinical research in symptomatology and new treatment 
opportunities. Patients and healthy controls are recruited through both advertising 
campaigns in UK media and from the patient group attending the Behavioural Genetics 
Clinic. 
As part of their preassessment questionnaire pack, patients awaiting assessment at 
the BGC receive a postal invitation to join research projects underway within the 
Department of Forensic and Neurodevelopmental Sciences. This includes a written 
consent form, a participant information sheet and an invitation letter requesting 
permission for clinical information collected at assessment to be included in a data 
bank within the research department. 
The Clinical Research of Developmental Disorders Database is a list of all patients 
who agree to contribute data to research projects within the FANS department. It 
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identifies patients by initials and medical record number. Ethical approval was granted 
by the National Research Ethics Service, Health Research Authority, London. All forms 
associated with this recruitment process were devised in 2012 by Dr SW under the 
supervision of Professor DM. Parties interested in undertaking research with the 
department can request access to The Clinical Research of Developmental Disorders 
Database.  
 
2.6 Data Collection 
In late 2012, the author was granted access to The Clinical Research of Developmental 
Disorders Database for the purposes of this research. At the time of access, the 
dataset dated from 08.04.2003 to 21.10.2012. The most recent 460 participants were 
selected. Patient records were accessed through the Electronic Medical Records 
System at the Behavioural Genetics Clinic by two researchers, the author and my 
colleague JG (who was undertaking research on the same population group relating 
to a different project). BGC medical reports, as described above, were sourced on each 
of the 460 participants. These reports were stored on a password protected desktop 
computer for the duration of the study. 
The author reviewed each report systematically, phrase by phrase, and extracted data 
by hand. A total of 23,460 data items were extracted in the initial phase. These were 
expanded to 96,140 data items over the course of data gathering, by means of 
redefining string to numerical data and by repeat review of reports to include extra 
variables which became evident over the course of the study. These data items were 
then entered into the newly devised SPSS Codebook by the author. 
 
2.7 Inclusion and Exclusion Criteria 
Inclusion criteria for this study: 
- Male and female patients attending the Behavioural Genetics Clinic who 
consented to their data being available on The Clinical Research of 
Developmental Disorders Database 
- Participants aged over 18 years 
- Participants with an intelligence quotient greater than 70 
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Exclusion criteria for this study: 
- Participants with known or likely genetic disorders which have been linked to 
ASD symptomatology (for example Tuberous Sclerosis, Fragile X syndrome 
and Neurofibromatosis) 
- Participants with known or likely intellectual disability 
- Participants aged under 18 years 
 
2.8 Statistical Analysis 
Data recording, processing and statistical analysis was conducted using Statistical 
Package for Social Science (SPSS), version 22. All analysis was undertaken by the 
author. This included thirteen demographic data items, forty seven psychiatric illness 
data items and eighty one physical illness data items. Descriptive analysis was used 
to provide results relating to demographic data. Comparisons were made using cross-
tabulation and Pearson’s chi-squared testing. Data were tested by diagnostic group 
and for difference using Pearson’s chi-squared tests for independence. For tables 
larger than 2 by 2, Cramer’s V was reported to show effect size. Values of 0.10 denote 
a small effect size, 0.30 a medium effect size and 0.50 a large effect size (Cohen, 
1988). Mann-Whitney U testing was undertaken on all continuous variables, namely 
age and alcohol intake. Where a p-value was statistically significant, it was corrected 
for multiple comparisons using the Bonferroni Correction method. The Bonferroni 
critical value was calculated by adjusting for the number of tests carried out at each 
analysis. 
Rates of psychiatric and physical illness were determined for the participants with 
autism spectrum disorder, participants without autism spectrum disorder, between 
subtypes of autism spectrum disorder, by age and by gender. A p-value of <0.05 was 
regarded as a statistical difference between groups. The sample size was sufficiently 
large to allow division of the participant group by age, by gender and by ASD subtype. 
Age profile was divided in three ways: a median split (at age 29 years) to compare 
younger adults to older adults (Davis, 2011), at age 50 years to determine rates of 
comorbid psychiatric illness in the ‘older’ adult (Howlin 2012, Gray 2012, Mannion 
2014a) and at age 30 years to determine rates of physical illness in younger versus 
older adults (Howlin, 2012). Comparison was undertaken between genders to 
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determine gender differences in comorbidity. Group comparisons were undertaken 
according to subtype of autism spectrum disorder to assess outcome and rates of 
psychiatric and physical comorbidity in individuals with less severe forms of autism 
spectrum disorder such as Asperger’s syndrome, PDD-nos and atypical autism 
compared to more severely symptomatic cases of childhood autism (Howlin, 2000).  
 
2.9 Reporting Methods 
The prevalence of psychiatric and physical comorbidity is reported as percentages 
instead of rates per thousand. Reporting as percentages was chosen as it was felt to 
read better throughout the text. Due to rounding of decimal points, percentages in the 
tables or figures may not add exactly to 100%. Rounding was upward if the percentage 
was greater than or equal to 0.5 and down if it was below 0.5. Likewise, cumulative 
figures within the text may not match equally to figures if added from the tables or 
figures, due again to the use of rounding or the presence of missing data. Percentages 
are quoted to a single decimal place, which is rounded up or down as above. The term 
‘significance’ is used in two ways, to represent statistical significance and to represent 
clinical significance. Attempts are made throughout the text by the author to clearly 
differentiate which meaning is intended. 
Missing values occurred for four reasons; the patient may not have known the 
information when asked by the Behavioural Genetics Clinic interviewer, the screening 
or assessment tool may not have been completed by the patient, the Behavioural 
Genetics Clinic medical report may have not contained the information or the report 
may have described the information in an ambiguous manner that could not be clearly 
categorised during data collection. 
 
2.10 Summary of Materials and Methods 
This study is a cross-sectional survey examining the prevalence of comorbid 
psychiatric and physical illness in adults with normal IQ autism spectrum disorder. 
Participants were selected from a list of consenting adult males and females on The 
Clinical Research of Developmental Disorders Database. Patients contributing to this 
database each attended the Behavioural Genetic Clinics at the Maudsley Hospital, 
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London. There each completed a semi-structured interview and mental state 
examination with a registrar in psychiatry, an ADOS-G and / or ADI-R with a 
psychologist or psychiatric nurse practitioner and was reviewed by a consultant 
psychiatrist specialising in the diagnosis of autism spectrum disorder in adults with 
normal IQ. 
Patients also completed screening questionnaires including the AQ, BAARS-IV, HADS 
and OCI-R. All clinical information and consensus diagnoses was reported as a 
standardised medical report varying in length from 14 to 26 pages and saved to the 
patient’s electronic medical record. The author worked as a registrar in psychiatry with 
the BGC for a one year period undertaking mental state and clinical assessment of 
patients, participating in two clinics per week. 
For the purposes of this study, initials and MRN information relating to 460 clinic 
attendees were selected from the database. The author, along with my colleague, 
sourced the BGC medical reports for each patient through the electronic medical 
records system. The author read each medical report phrase by phrase and extracted 
51 data variables from each to answer the research questions. The author found it 
necessary to expand this number to 209 variables for each of the 460 participants to 
allow clarification of detail prior to entering all data for analysis into SPSS, version 22. 
Descriptive analysis provided demographic data while comparisons were made using 
cross-tabulation, Pearson’s chi-squared tests and Mann-Whitney U testing. The author 
used the data to test the hypothesis that rates of psychiatric and physical illness among 
adults with a normal range IQ and autism spectrum disorder would be greater than 
rates reported in the literature for the general population. 
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Chapter 3: Results Chapter 
 
3.1 Overview 
The following chapter describes the variables analysed by the author and outlines the 
demographic data relating to the study sample as a single group followed by 
demographics of the sample of participants diagnosed with autism spectrum disorder 
and then those who did not meet criteria for autism spectrum disorder. 
The chapter goes on to outline the rates of psychiatric illness in the study sample. 
Results are reported for the study sample as a whole and those individuals with autism 
spectrum disorder. Results for individuals with autism spectrum disorder are further 
reported by ASD subtype, age and gender. 
Lastly, the chapter describes the rates of physical illness in the study sample. Results 
are reported for the study sample as a whole and those individuals with autism 
spectrum disorder. Results are further reported by ASD subtype, age and gender. 
Other physical ailments reported include rates of sleep difficulty, appetite disturbance, 
allergies and use of prescribed medication.  
 
3.2 Data Relating to Study Sample 
Behavioural Genetic Clinic medical reports for four hundred and sixty serial clinic 
attendees provided the basis for this study. These clinic attendees / study participants 
were selected by two data collectors (LOR (myself) and JG) from the Clinical Research 
of Developmental Disorders Database. The first identified participant was the most 
recent clinic attendee recorded on the database. Each preceding participant was 
included until a total of 460 participants was reached. Following completion of the 
dataset, the author reviewed all data and excluded 47 participants from the final 
dataset; 32 due to a suspected or confirmed diagnosis of comorbid intellectual 
disability, 5 with suspected or confirmed chromosomal / genetic abnormality, 6 as their 
BCG medical reports lacked vital data such as diagnosis and 4 further participants as 
they were aged less than eighteen years. The sample profile is outlined in Figure 3.1. 
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Figure 3.1 
 
Sample Profile 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age <18 years,                   
n=4 
 
Final sample, n=413 
 
Initial sample, n=460 
 
Diagnosis of intellectual disability, 
n=32 
 
Data missing from BGC report, 
n=6 
 
Diagnosis of genetic disorder, 
n=5 
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A final sample of four hundred and thirteen participants were included in this study. As 
each BGC medical report was written to a standardised template, the quality of 
information available in the analysed reports was very high. This resulted in good to 
high availability of the data needed to address the questions posed by this study. 
Acquisition rates for demographic, psychiatric and medical information are outlined in 
Table 3.1.  
 
Table 3.1 
 
Study Variables and Missing Data 
Variable Type of Data Percentage of Data 
Acquired 
 
 
Assessment Information: 
Initials of consultant completing 
assessment 
Categorical 100% 
Initials of NCHD completing 
assessment 
Categorical 100% 
Date of assessment Continuous 100% 
Referring clinician Categorical 100% 
Accompanying person Categorical 99% 
 
Demographic Information: 
Date of birth Continuous 99% 
Age at assessment Continuous 100% 
Gender Categorical 100% 
Marital status Categorical 94% 
Parental marital status Categorical 70% 
Employment status Categorical 97% 
Accommodation status Categorical 91% 
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Variable Type of Data Percentage of Data 
Acquired 
 
 
Childhood Information: 
A history of delay in motor 
milestones 
Categorical 94% 
A history of delay in speech 
milestones 
Categorical 94% 
Type of schooling Categorical 98% 
A history of being bullied in school Categorical 89% 
Progress to third level education Categorical 93% 
 
Psychiatric Information: 
Prior contact with a community 
mental health team 
Categorical 99% 
Details of past psychiatric history Categorical 98% 
Record of previous diagnosis of 
autism spectrum disorder by 
another service 
Categorical 99% 
A history of deliberate self-harm Categorical 99% 
A history of self-injurious behaviour Categorical 99% 
If a diagnosis of autism spectrum 
disorder was given following BGC 
assessment 
Categorical 100% 
The ICD-10 ASD diagnostic code Categorical 100% 
If a diagnosis of other psychiatric 
disorder was given following BGC 
assessment  
Categorical 99% 
If a diagnosis of 
neurodevelopmental disorder was 
given following BGC assessment 
Categorical 99% 
If a diagnosis of mood disorder was 
given following BGC assessment 
 
 
Categorical 99% 
131 
 
Variable Type of Data Percentage of Data 
Acquired 
 
 
Psychiatric Information: 
If a diagnosis of anxiety spectrum 
disorder was given following BGC 
assessment 
Categorical 99% 
If a diagnosis of psychotic disorder 
was given following BGC 
assessment 
Categorical 99% 
If a diagnosis of personality disorder 
was given following BGC 
assessment 
Categorical 99% 
If a diagnosis of substance use 
disorder was given following BGC 
assessment 
Categorical 99% 
If a diagnosis of another psychiatric 
disorder was given following BGC 
assessment 
Categorical 99% 
Was a learning disability suspected 
following BGC assessment 
Categorical 100% 
A known family history of autism 
spectrum disorder 
Categorical 87% 
A known family history of psychiatric 
illness 
Categorical 92% 
 
Medical Information: 
Past medical history Categorical 
 
97% 
A history of sleep difficulties Categorical 
 
79% 
A history of eating disturbance Categorical 
 
96% 
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Variable Type of Data Percentage of Data 
Acquired 
 
 
Medical Information: 
List of current medications Categorical 89% 
Documented allergies Categorical 69% 
Weekly alcohol intake in units Continuous 93% 
Current or history of illicit drug use Categorical 93% 
A known family history of medical 
illness 
Categorical 93% 
 
As not all patients attending the BGC undergo both an ADI-R and AGOS-G 
assessment, acquisition rates for those variables appear falsely low. However, when 
examining rates of participants who completed either the ADI-R, the ADOS-G or both, 
acquisition rates rise to 97%. Only 3% (14 participants) did not undergo an ADI-R or 
ADOS-G assessment. Acquisition rates for data relating to the ADI-R and ADOS-G are 
outlined in Table 3.2. 
 
Table 3.2 
 
Acquisition Rates for Data Relating to Diagnostic Tools 
Variable Type of Data Percentage of Data 
Acquired 
Autism Diagnostic Interview, 
Revised 
(ADI-R) only 
Continuous 42% 
Autism Diagnostic 
Observational Schedule, 
Generic 
(ADOS-G) only 
Continuous 51% 
ADI-R or ADOS-G or both 
 
Continuous 97% 
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Assessments in the BGC were undertaken by eight consultant psychiatrists (CM, DM, 
DR, IJ, JZ, MC, MCA and QD), thirty two non-consultant hospital doctors (AK, AM, AV, 
BS, BSR, CM, CO, FM, FO, GMA, IJ, JJ, JK, JKH, JZ, KL, LOR (myself), MAM, MF, 
MP, PB, PJ, RA, RT, SC, SK, SM, SS, ST, SW, TL and WK) and thirteen psychologists 
/ clinical nurse practitioners (CM, DS, DW, EW, GR, HD, HH, HQ, MJD, NG, PJ, TC 
and TL), as outlined in Figure 3.2, 3.3 and 3.4. There was no relationship between the 
consultant psychiatrist assessing each participant in the BGC and receipt of a 
diagnosis of autism spectrum disorder, a comorbid psychiatric or rates of reported 
physical illness. 
 
Figure 3.2 Pie Chart Representing Number of Participants Assessed by each 
Consultant Psychiatrist 
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Figure 3.3 Pie Chart Representing Number of Participants Assessed by each 
Non-consultant Hospital Doctor 
 
 
 
 
Figure 3.4 Pie Chart Representing Number of Participants Assessed by each 
Psychologist or Clinical Nurse Practitioner 
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3.3 Results of Analysis of Demographic Variables 
 
3.3.1 Characteristics of Study Sample 
The study group, of 413 participants, consisted of 299 (72%) males and 114 (28%) 
females, with a male-to-female ratio of 2.6:1. Demographic results are outlined in Table 
3.3. The study group comprised of adults only, ranging in age from 18 - 70 years (mean 
age 32 years, SD 11.6 years). Of these, 253 (61%) were single, 115 (28%) were in a 
relationship (partner, engaged or married), 20 (5%) were separated, divorced or 
widowed and marital status was unavailable for 25 (6%). Two hundred and five (50%) 
participants were unemployed, 122 (30%) were recorded as in gainful employment, 52 
(13%) were in education, 18 (4%) were active volunteers and 1 participant was retired.  
Study participants were referred to the assessment clinic by their community mental 
health team (67%) or general practitioner (33%) for assessment of autism spectrum 
disorder. Two hundred and ninety four (71%) attended their assessment with a 
companion, typically a first degree relative (58%) while 112 (27%) participants 
attended alone. 
A previous diagnosis of autism spectrum disorder, provided by another clinical team, 
was noted for 56 individuals in the study group, 50 of which were upheld and 6 were 
refuted. Two hundred and thirty seven participants received the diagnosis of autism 
spectrum disorder for the first time at the Behavioural Genetics Clinic, that is they were 
diagnosed for the first time in adulthood. 
Three hundred and twenty four (79%) participants in the total study group were found 
to have a comorbid psychiatric illness at the time of assessment. Three hundred and 
thirty three (81%) participants reported a previously diagnosed physical illness, 165 
(40%) reported sleep difficulties and 87 (21%) described appetite disturbance. A total 
of 223 (54%) participants were taking medication to treat a psychiatric or physical 
illness. Two hundred and sixty five (64%) participants had a family history of other 
psychiatric illness while 110 (27%) were noted to have a positive family history of 
autism spectrum disorder. 
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Table 3.3 
  
Characteristics of Study Sample 
Characteristic 
 
Study Group 
Total number 
 
413 
Age in years 
 
Range 18 - 70 
Mean 32 
(SD 11.6) 
Gender ratio; M:F 
 
2.6:1 
Referral source CMHT 67.3% 
GP 32.7% 
Marital status Single 61.3% 
Relationship 27.8% 
Accommodation;  
Participant living with… 
Alone 19% 
Family 55.6% 
Partner 17.6% 
*Other 7.8% 
Employment status Unemployed 49.6% 
In fulltime education 12.6% 
Volunteer 4.4% 
Employed 29.5% 
Bullied in school Yes 61.3% 
No 38.7% 
Progressed to third level 
education 
 
Yes 33.2% 
No 59.8% 
Forensic history Yes 31% 
No 62% 
Smoking status Smoker 15.3% 
Non-smoker 63.2% 
137 
 
 
Characteristic 
 
Study Group 
Alcohol intake per week in 
standard unit measures 
 
Range 0 - 280 units 
Mean 7.8  
(SD 26.3) 
Current use of illicit substances 
 
Current drug user 9% 
 
Historical use of illicit 
substances 
 
Previous drug user 36.8% 
*Other accommodation includes: psychiatric inpatient unit, supported accommodation, living with friends or 
homeless accommodation 
 
3.3.2 Characteristics of Participants with Autism Spectrum Disorder 
Two hundred and eighty eight (70%) individuals in the study group were confirmed to 
have autism spectrum disorder following assessment at the Behavioural Genetics 
Clinic. They are referred to as the ‘ASD group’ throughout this results chapter. The 288 
individuals under study as the ASD group consisted of 212 (74%) males and 76 (26%) 
females; the male-to-female ratio was 2.8:1. Age ranged from 18 - 67 years (mean age 
31 years, SD 11.1 years). 
Asperger’s syndrome was the most frequent diagnosis, at 144 participants (35%), 
followed by 77 participants with atypical autism (19%), 35 with childhood autism (9%) 
and 32 with pervasive developmental delay-not otherwise specified (8%). No patient 
received a diagnosis of Rett’s syndrome or childhood disintegrative disorder. 
One hundred and eighty four (64%) participants with autism spectrum disorder were 
single, 77 (27%) were in a relationship (partner, engaged or married), 10 (3%) were 
separated or divorced and 1 participant was widowed, marital status was unavailable 
for 16 (6%) participants. One hundred and fifty one (52%) participants in the ASD group 
were unemployed, 78 (27%) were recorded as in gainful employment, 38 (13%) in 
fulltime education, 13 (5%) participants were active volunteers and 1 individual was 
retired. 
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Participants in the ASD group were referred for assessment by their community mental 
health team consultant psychiatrist (65%), general practitioner (33%) or community 
mental health team psychologist (2%). 
Two hundred and nineteen (76%) participants in the ASD group were found to have a 
comorbid psychiatric illness at the time of assessment. Two hundred and forty one 
(84%) participants reported a previously diagnosed physical illness. One hundred and 
twenty one (42%) reported sleep difficulties while 71 (25%) described appetite 
disturbance. One hundred and sixty four (57%) participants were taking a medication 
to treat a psychiatric or physical illness. Eighty six (30%) participants were noted to 
have a positive family history of autism spectrum disorder while 186 (65%) had a family 
history of other psychiatric illness. 
 
3.3.3 Comparing Characteristics by Autism Spectrum Disorder Subtype 
Participants with autism spectrum disorder received definitive ICD-10 subtype 
diagnoses following assessment by the multidisciplinary team. Of the 288 participants 
with autism spectrum disorder, 144 (35%) received a diagnosis of Asperger’s 
syndrome, 77 (19%) were identified as atypical autism, 35 (9%) as childhood autism 
and the remaining 32 (8%) with PDD-nos.  
There were no statistically significant differences between the four groups in terms of 
age, gender, source of referral, marital status, living conditions and progression to third 
level education. At initial analysis, they did however show statistical differences in 
employment rates, likelihood of being bullied in school, smoking status and forensic 
history. Individuals with childhood autism were least likely to be smokers, those with 
Asperger’s syndrome were more likely to be in employment and least likely to have a 
forensic record and those with PDD-nos were most likely to have a forensic record. 
Due to the large number of tests involved in calculating differences between ASD 
subtypes across 13 variables, Bonferroni correction reduced the statistically significant 
p-value to 0.009. Following correction for multiple testing, statistical significance was 
lost for each of these four comparisons. 
Characteristics of participants by ASD subtype are outlined in Table 3.4. 
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Table 3.4 
  
Characteristics of Participants by ASD Subtype 
Characteristic Asperger’s 
Syndrome 
Atypical 
Autism 
Childhood 
Autism 
 
PDD-nos p-value 
BFC: 
n=52, 
p<0.009 
Total 
 
144 77 35 32 - 
Age in years Range 18-65 
mean 31  
(SD 10.8) 
Range 18-65 
mean 29  
(SD 10.9) 
Range 18-50 
mean 30  
(SD 9.7) 
Range 19-67 
mean 37 
(SD 12.7) 
0.03 
Gender ratio, M:F 
 
2.2:1 4.1:1 4:1 2.6:1 0.29 
Referral source CMHT 65.3% 
GP 34.7% 
CMHT 64.9% 
GP 35.1% 
CMHT 71.5% 
GP 28.6% 
CMHT 75% 
GP 25% 
0.84 
Marital status 
 
Single 66% 
Relationship 
30.5% 
Single 64.9% 
Relationship 
26% 
Single 71.4% 
Relationship 
25.7%  
Single 43.8% 
Relationship 
46.8% 
0.37 
Accommodation;  
Participant living.. 
 
Alone 35.4% 
  
Alone 29.9% 
  
Alone 28.6% 
  
Alone 43.8% 
  
0.27 
Employment 
status 
Unemployed 
66% 
Employed 
32.6% 
Unemployed 
71.4% 
Employed 
24.7% 
Unemployed 
82.9% 
Employed 
17.1% 
Unemployed 
78.1% 
Employed 
15.6% 
0.04 
(Cramer’s 
V 0.16, 
small effect 
size)  
Bullied in school Yes 63.2% 
No 26.4% 
Yes 66.2% 
No 22.1% 
Yes 54.3% 
No 37.1% 
Yes 59.4% 
No 31.3% 
0.17 
Progressed to 
third level 
education 
 
Yes 31.3% 
No 62.5% 
Yes 36.4% 
No 50.6% 
Yes 28.6% 
No 65.7% 
Yes 40.6% 
No 53.1% 
0.62 
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Characteristic Asperger’s 
Syndrome 
Atypical 
Autism 
Childhood 
Autism 
 
PDD-nos p-value 
BFC: 
n=52, 
p<0.009 
Forensic history Yes 22.9% 
No 70.8% 
Yes 55.8% 
No 33.8% 
Yes 37% 
No 57% 
Yes 43.8% 
No 50% 
0.02 
(Cramer’s V 
0.20, small 
effect size) 
Smoking status Smoker 
13.9% 
Non-smoker 
68.1% 
Smoker  
9.1% 
Non-smoker 
66.2%  
Smoker 
11.4% 
Non-smoker 
68.6% 
Smoker 
15.6% 
Non-smoker 
56.3% 
0.89 
Alcohol intake per 
week in standard 
unit measures 
 
Range 0-210 
Mean 8.10 
(SD 24.86) 
Range 0-280 
Mean 10.84 
(SD 41.17) 
Range 0-32 
Mean 2.06 
(SD 5.78) 
Range 0-24 
Mean 3.37 
(SD 6.45) 
0.01 
Current use of 
illicit substances 
Current drug 
user 4.2% 
 
Current drug 
user 11.7% 
 
Current drug 
user 5.7% 
 
Current drug 
user 12.5% 
 
0.13 
Historical use of 
illicit substances 
Previous drug 
user 28.5% 
 
Previous drug 
user 35.1% 
Previous drug 
user 28.6% 
Previous drug 
user 43.8% 
0.29 
 
3.3.4 Characteristics of Participants without Autism Spectrum Disorder 
One hundred and twenty five (30%) individuals in the study group did not fulfil 
diagnostic criteria for autism spectrum disorder. These individuals are referred to as 
the ‘nonASD group’ in this results chapter. The nonASD group consisted of 87 (70%) 
males and 38 (30%) females; ratio of males to females was 2.3:1, ranging in age from 
18 - 70 years (mean age 34 years, SD 12.7 years). 
Sixty nine (55%) participants in the nonASD group were single, 38 (30%) were in a 
relationship (partner, engaged or married), 9 (7%) were separated or divorced and 
marital status was unavailable for 9 (7%) participants. Fifty four (43%) participants in 
the nonASD group were unemployed, 45 (36%) were recorded as in gainful 
employment, 14 (11%) in fulltime education and 5 (4%) participants were active 
volunteers. 
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Participants were referred for assessment by their community mental health team 
consultant psychiatrist (63%), general practitioner (33%) or community mental health 
team psychologist (4%). 
Although no participant in the nonASD group was diagnosed with autism spectrum 
disorder, 105 (84%) received a diagnosis of an alternative psychiatric illness, 19 (15%) 
were not diagnosed with a psychiatric illness and data were missing in relation to one 
participant. Forty eight (38%) individuals were diagnosed with an anxiety spectrum 
disorder, 37 (30%) with attention deficit hyperactivity disorder, 26 (21%) with a mood 
disorder, 17 (14%) with a personality disorder, 10 (8%) with schizophrenia, 5 (4%) with 
a substance use disorder, 2 with an eating disorder and one each for attachment 
disorder, cognitive impairment, gender identity disorder and psychosexual disorder.  
Ninety two (74%) participants reported a previously diagnosed physical illness. Forty 
four (35%) reported sleep difficulties while 16 (13%) described appetite disturbance. 
Fifty nine (50%) participants were taking medication to treat a psychiatric or physical 
illness. Twenty four (19%) participants were noted to have a positive family history of 
autism spectrum disorder and 79 (63%) had a family history of other psychiatric illness. 
 
3.3.5 Comparison between the ASD and NonASD Groups 
Comparing the ASD to nonASD samples, demographics between the groups were 
largely similar. However, there was a statistical difference in employment rates, 
likelihood of being bullied in school, smoking status and historical use of illicit 
substances. Participants with autism spectrum disorder were statistically more likely to 
report a history of childhood school-yard bullying and statistically less likely to have a 
history of illicit drug use. There was also a non-significant trend among the ASD group 
towards being unemployed, living in the company of others and non-smoking. 
Characteristics of ASD and nonASD groups are outlined in Table 3.5. 
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Table 3.5 
  
Characteristics of ASD and NonASD Groups 
Characteristic 
 
ASD group NonASD group p-value 
BFC: n=13, p<0.004 
Total 
 
288 125 - 
Age in years Range 18 - 67 
Mean 33 
(SD 11.1) 
Range 18 - 70 
Mean 31 
(SD 12.7) 
0.09 
 
Gender ratio, M:F 
 
2.8:1 2.3:1 0.40 
Referral source CMHT 67.4% 
GP 32.6% 
CMHT 67.2% 
GP 32.8% 
0.68 
Marital status Single 63.9% 
Relationship 
26.8% 
Single 55.2% 
Relationship 
30.4% 
0.11 
Accommodation;  
Participant living 
with… 
Alone 19% 
Family 57% 
Partner 16.5% 
Other 7.5% 
Alone 19.3% 
Family 52.3% 
Partner 20.1% 
Other 8.3% 
0.08 
Employment status Unemployed 
52.4% 
In education 
13.2%  
Volunteer 4.5%  
Employed 27% 
Unemployed 
43.2% 
In education 
11.2% 
Volunteer 4% 
Employed 36% 
0.03 
(Cramer’s V 0.11, small 
effect size) 
*Bullied in school Yes 62.5% 
No 27.1 % 
Yes 36% 
No 51.2% 
<0.001* 
(Cramer’s V 0.27, small to 
medium effect size) 
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Characteristic 
 
ASD group NonASD group p-value 
BFC: n=13, p<0.004 
Progressed to third 
level education 
 
Yes 33.3% 
No 58.7% 
Yes 32.8% 
No 62.4% 
0.74 
Forensic history Yes 30.6% 
No 62.2% 
Yes 32% 
No 61.6% 
0.81 
Smoking status Smoker 12.5% 
Non-smoker 66.3%  
Smoker 21.6% 
Non-smoker 56% 
0.01 
(Cramer’s V 0.14, small 
effect size) 
Alcohol intake per 
week in standard unit 
measures 
 
Range 0 - 280 
Mean 7.64 
(SD 28.2) 
Range  0 - 140  
Mean 8.17 
(SD 21.4) 
0.85 
Current use of illicit 
substances 
 
Current drug user 
7.3% 
Current drug user 
12.8% 
0.68 
*Historical use of illicit 
substances 
 
Previous drug user 
31.9% 
Previous drug user 
48% 
0.001* 
(Cramer’s V 0.17, small 
effect size) 
* Statistically significant results after correction for multiple testing are marked with an asterisk 
 
3.4 Results of Analysis of Psychiatric Illness Variables 
 
3.4.1 Results for Comorbid Psychiatric Illness in Study Sample 
A total of 324 participants in the overall study group were diagnosed with a comorbid 
psychiatric illness by the BGC consensus group. Two hundred and nineteen (76%) 
participants in the ASD group received a diagnosis of comorbid psychiatric illness. 
Comparatively, 105 (84%) of the nonASD participants were diagnosed with a 
psychiatric illness. One hundred and thirty six (62%) ASD group participants received 
a single comorbid diagnosis alongside the diagnosis of autism spectrum disorder, 65 
(30%) participants were diagnosed with two comorbid psychiatric illnesses, 14 (6%) 
with 3 psychiatric illnesses, 2 (1%) with 4 psychiatric diagnoses and 1 participant 
received 7 comorbid psychiatric diagnoses. At initial analysis a statistical difference 
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was noted in rates of comorbid psychiatric illness between the groups with individuals 
with autism spectrum disorder statistically more likely to suffer from comorbid 
psychiatric illness compared to those without an ASD diagnosis. On correction for 
multiple testing this statistical significance was lost. However OCD remained 
statistically more likely in participants with autism spectrum disorder. Interestingly, this 
was the only psychiatric illness to trend towards the ASD group. In fact, participants in 
the nonASD group, those without a diagnosis of autism spectrum disorder, were more 
likely to have a comorbid psychiatric illness. Personality disorder was statistically more 
likely among the nonASD group. Psychotic disorder also trended towards the 
neurotypical participants, however this finding did not retain statistical significance 
following correction for multiple testing.  
Rates of current psychiatric illness as seen in the study group of adults with and without 
autism spectrum disorder are outlined in Table 3.6 and Figure 3.5.  
Table 3.6 
 
Current Comorbid Psychiatric Disorders in Adults  
with and without Autism Spectrum Disorder 
Diagnosis 
 
ASD group 
n (%) 
NonASD group 
n (%) 
p-value 
BFC: n=9, p<0.006 
Comorbid psychiatric 
illness 
219 (76%) 105 (84.4%) 0.05 
*Anxiety spectrum 
disorders 
142 (49.3%) 48 (38.4%) Agoraphobia 0.09 
Social phobia 0.77 
GAD 0.17 
OCD 0.001*            
(Cramer’s V 0.16,                 
small effect size) 
Specific phobia 0.29 
Somatoform 
disorder 0.91 
PTSD 0.35 
Attention deficit 
hyperactivity disorder 
79 (27.4%) 37 (29.6%) 0.65 
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Diagnosis 
 
ASD group 
n (%) 
NonASD group 
n (%) 
p-value 
BFC: n=9, p<0.006 
 
Mood disorder 72 (25%) 26 (20.8%) Depression 0.43 
Bipolar 0.59 
History of deliberate 
self-harm 
 
71 (24.7%) 34 (27.2%) 0.59 
History of self-injurious 
behaviour 
 
44 (15.3%) 17 (13.6%) 0.46 
Psychotic illness 11 (3.8%) 10 (8%) 0.05  
 
 
*Personality disorder 7 (2.4%) 17 (13.6%) <0.001*  
 
(Cramer’s V 0.23, small 
to medium effect size) 
Substance use 
disorder 
 
6 (2.1%) 5 (4%) Alcohol dependency 
0.87 
Tic disorder / 
Tourette’s syndrome 
 
3 (1%) 0% 0.31 
Eating disorder 
 
1 (0.3%) 2 (1.6%) 0.17 
Catatonia 
 
0% 0% n/a 
* Statistically significant results after correction for multiple testing are marked with an asterisk 
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Figure 3.5 Diagnosis of Comorbid Psychiatric Illness in Participants with Autism 
Spectrum Disorder Compared to those without Autism Spectrum Disorder 
 
 
 
 
3.4.2 Results for Comorbid Psychiatric Illness in ASD Group 
Anxiety spectrum disorders were the most common comorbid psychiatric diagnosis in 
participants with autism spectrum disorder. Almost half of the ASD group (49%) 
suffered from a comorbid anxiety spectrum disorder. Obsessive compulsive disorder 
was the most frequent at 23%, followed closely by generalised anxiety disorder (20%), 
social phobia (19%) and agoraphobia with or without panic disorder was noted in 37 
(13%) participants. 
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Table 3.7 
 
Comorbid Anxiety Spectrum Disorders in ASD Group 
Diagnosis ASD Group 
n (%) 
Obsessive compulsive disorder 65 (22.6%) 
Generalised anxiety disorder 58 (20.1%) 
Social phobia 54 (18.8%) 
Agoraphobia  37 (12.8%) 
Social anxiety 5 (1.7%) 
Specific phobia 3 (1%) 
Mixed anxiety and depression 2 (0.7%) 
Somatoform disorder 2 (0.7%) 
Post-Traumatic stress disorder 2 (0.7%)  
Mixed anxiety disorder 1 (0.3%) 
 
 
Attention deficit hyperactivity disorder was the second most frequent comorbid 
diagnosis with 79 (27%) participants receiving a diagnosis of childhood attention deficit 
hyperactivity disorder.  
Mood disorder, combining depressive and bipolar illnesses was ranked third. 
Depressive illness including mild, moderate and severe depression, recurrent 
depressive disorder (both currently depressed and in remission) and dysthymia was 
noted in 65 participants (23%). Of the 65 participants with depressive disorders; 12 
had current mild depression, 17 had current moderate depression, 1 with current 
severe depression with psychotic symptoms, 1 with current severe depression without 
psychotic symptoms, 24 with recurrent depressive disorder (5 in remission), 9 with 
dysthymia and 1 with moderate depression superimposed on dysthymia. Bipolar 
affective disorder was diagnosed in 7 (2%) individuals. Of the 7 individuals with bipolar 
affective disorder examined in this study, 3 were euthymic at the time of assessment, 
1 suffering from mild depression, 2 with moderate depression and 1 was noted to be 
hypomanic. 
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Table 3.8 
 
Comorbid Mood Disorders in ASD Group 
Diagnosis ASD Group 
n (%) 
Recurrent depressive disorder 24 (8.3%) 
Moderate depressive episode 18 (6.3%) 
Mild depressive episode 12 (4.2%) 
Dysthymia 10 (3.5%) 
Bipolar affective disorder 7 (2.4%) 
Severe depressive episode 1 (0.3%) 
Severe depressive episode with psychotic 
symptoms 
1 (0.3%) 
 
 
For the purposes of this study, deliberate self-harm and self-injurious behaviour were 
analysed separately. Deliberate self-harm included attempted self-drowning, 
attempted self-hanging, self-burning, self-cutting, jumping from a height and overdose. 
Self-injurious behaviour referred to hair pulling, head-banging, self-biting, self-
punching, self-scratching, skin picking and damage to property or self. 
Deliberate self-harm was noted in 71 (25%) participants with autism spectrum disorder, 
self-injurious behaviour followed closely at 15%. A number of participants were noted 
to engage in both deliberate self-harm and self-injurious behaviour while a large 
proportion engaged in multiple methods of harm / self-injury.  
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Table 3.9 
 
Comorbid Self-harm and Self-injury in ASD Group 
Method of self-harm / self-injury 
 
ASD Group 
n (%) 
Self-cutting 42 (14.6%) 
Overdose 33 (11.5%) 
Head-banging 20 (6.9%) 
Attempted self-hanging 14 (4.9%) 
Self-scratching 11 (3.8%) 
Self-burning 8 (2.8%) 
Damage to property and self 7 (2.4%) 
Self-biting 6 (2.1%) 
Self-punching 6 (2.1%) 
Skin picking 5 (1.7%) 
Hair pulling 4 (1.4%) 
Jump from a height 4 (1.4%) 
Attempted self-drowning 2 (0.7%) 
 
 
A psychotic illness was diagnosed in 11 (4%) participants with autism spectrum 
disorder. All participants received the diagnosis of schizophrenia. The category divided 
into paranoid schizophrenia (10 participants, 4%) and treatment resistant 
schizophrenia (1 participant, 0.3%). Nine of the 11 participants were unwell at the time 
of assessment with evidence of both positive and negative symptoms of schizophrenia. 
The most common positive symptoms were paranoid and persecutory delusions. 
Three participants were experiencing auditory hallucinations and 1 participant was 
experiencing visual hallucinations. 
Personality disorder was the next most frequent comorbid psychiatric diagnosis among 
the ASD group. A total of 7 (2%) participants were diagnosed with a personality 
disorder. Personality disorders included paranoid personality disorder (3 participants, 
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1%), emotionally unstable personality disorder (2 participants, 0.7%), anankastic 
personality disorder (1 participant 0.3%) and schizotypal personality disorder (1 
participant, 0.3%).  
Substance use disorder occurred at a rate of 2% in participants with autism spectrum 
disorder. Alcohol dependence was the most common at 1% (4 participants), followed 
by 1 participant each for opiate and caffeine addiction. 
Eating disorder was diagnosed in a single participant (0.3%). This participant was 
female with a diagnosis of anorexia nervosa and was noted to be actively unwell at the 
time of assessment with fasting and binge / purge behaviours. 
A trend was noted in the combinations of comorbidities in those with autism spectrum 
disorder. A notable 56% of the ASD group suffered from co-existing mood disorder and 
anxiety spectrum disorder. The next most frequent association was between attention 
deficit hyperactivity disorder and anxiety spectrum disorder at 26%, followed by 
attention deficit hyperactivity disorder and mood disorder at 16%. 
 
3.4.3 Results for Comorbid Psychiatric Illness in Autism Spectrum disorder - 
ASD Subtype 
There was a statistically higher chance of having a diagnosis of any comorbid 
psychiatric illness if an individual was diagnosed with Asperger’s syndrome compared 
to the other three subtypes of autism spectrum disorder recorded in this study. 
Comorbid obsessive compulsive disorder was statistically more likely in those with 
Asperger’s syndrome. Though rare, personality disorder was more likely if the 
participant suffered from pervasive developmental disorder - not otherwise specified 
though this did not reach statistical significance. There was also a non-significant trend 
for self-injurious behaviour in those with childhood autism and atypical autism. 
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Table 3.10 
 
Comorbid Psychiatric Illness in Adults with Autism Spectrum Disorder                      
- ASD Subtype 
Diagnosis 
 
Asperger’s 
Syndrome 
Atypical 
Autism 
Childhood 
Autism 
 
PDD-nos p-value 
BFC: n=40, 
p<0.001 
Comorbid 
psychiatric 
illness 
Yes 84% 
No 16% 
Yes 66.2% 
No 33.8% 
Yes 68.6% 
No 31.4% 
Yes 71.9% 
No 28.1% 
0.004 
 
ADHD Yes 27% 
No 73% 
Yes 32.5% 
No 67.5% 
Yes 20% 
No 80% 
Yes 25% 
No 75% 
0.56 
Depression Yes 25% 
No 75% 
Yes 18.2% 
No 81.8% 
Yes 11.4% 
No 88.6% 
Yes 12.5% 
No 87.5% 
0.16 
Agoraphobia Yes 14.6% 
No 85.4% 
Yes 11.7% 
No 88.3% 
Yes 5.7% 
No 94.3% 
Yes 15.6% 
No 84.4% 
0.51 
Social phobia Yes 23.6% 
No 76.4% 
Yes 10.4% 
No 89.6% 
Yes 17% 
No 83% 
Yes 18.8% 
No 81.2% 
0.12 
GAD Yes 20% 
No 80% 
Yes 18% 
No 82% 
Yes 17% 
No 83% 
Yes 75% 
No 25% 
0.83 
*OCD Yes 30% 
No 70% 
Yes 11.7% 
No 88.3% 
Yes 25.7% 
No 74.3% 
Yes 12.5% 
No 87.5% 
<0.001* 
(Cramer’s V 0.24, 
small to medium 
effect size) 
History of 
deliberate 
self-harm 
Yes 21.5% 
No 78.5% 
Yes 30% 
No 70% 
Yes 17.1% 
No 82.9% 
Yes 34.4% 
No 65.6% 
0.21 
History of self-
injurious 
behaviour 
Yes 13.2% 
No 86.8% 
Yes 18.2% 
No 81.8% 
Yes 28.6% 
No 71.4% 
Yes 6.3% 
No 93.8% 
0.06 
Psychotic 
illness 
Yes 2.8% 
No 97.2% 
Yes 2.6% 
No 97.4% 
Yes 2.9% 
No 97.1% 
Yes 9.4% 
No 90.6% 
0.29 
Personality 
disorder 
Yes 1.4% 
No 98.6% 
Yes 1.3% 
No 98.7% 
Yes 2.9% 
No 97.1% 
Yes 6.3% 
No 93.8% 
0.33 
* Statistically significant results after correction for multiple testing are marked with an asterisk 
152 
 
 
Figure 3.6 Diagnosis of Comorbid Psychiatric Illness - ASD Subtype 
 
 
 
3.4.4 Results for Comorbid Psychiatric Illness in Autism Spectrum disorder - Age 
In line with recommendations made by previous literature, two methods were 
employed to assess rates of comorbid psychiatric illness in the ASD group. Firstly, the 
ASD group was split at its median age (29 years) into younger adults and older adults. 
The groups’ diagnostic rates of total comorbid psychiatric illness remained equal at 
76% each (p = 1.00). If however, psychiatric comorbidity is broken down by illness / 
diagnosis, there is a statistically higher chance of being diagnosed with self-injurious 
behaviour (p = 0.03) and attention deficit hyperactivity disorder (p <0.001) if aged less 
than 29 years and with depression (p = 0.04) and personality disorder (p = 0.04) if aged 
over 29 years. 
Next, 50 years was investigated as the cut-off point from younger adulthood into older 
adulthood. Again the rates of total comorbid psychiatric illness remained largely equal, 
83% and 93%, with no statistical difference between groups (p = 0.64). The only 
statistically significant illness seen when the groups were analysed by individual 
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psychiatric illness, where the over 50 age group was statistically more likely to suffer 
from comorbid generalised anxiety disorder (p = 0.01). 
Comorbid psychiatric illness in adults with autism spectrum disorder according to age 
is outlined in Table 3.11. 
 
Table 3.11 
 
Comorbid Psychiatric Illness in Adults with Autism Spectrum Disorder                       
- Age 
Diagnosis Age <29 years Age >29 years p-value 
 
Comorbid psychiatric illness 
 
Yes 114 
No 36 
Yes 105 
No 33 
1.00 
 
Diagnosis Age <50 years Age >50 years p-value 
 
Comorbid psychiatric illness 
 
Yes 208 
No 67 
Yes 11 
No 2 
0.64 
 
 
3.4.5 Results for Comorbid Psychiatric Illness in Autism Spectrum disorder - 
Gender 
A comorbid psychiatric illness was diagnosed in 78% of males and 81% of females in 
the ASD group. There was no statistical difference in overall receipt of a psychiatric 
illness diagnosis between the groups stratified by gender. However, on initial analysis 
by individual disorder significantly more females than males with autism spectrum 
disorder had a diagnosis of comorbid bipolar affective disorder (p = 0.01). This finding 
did not retain statistical significance on correction for multiple testing as the Bonferroni 
critical value was p<0.004. 
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Table 3.12 
 
Comorbid Psychiatric Illness in Adults with Autism Spectrum Disorder                      
- Gender 
Diagnosis 
 
Males Females p-value 
BFC: n=14, 
p<0.004 
Comorbid psychiatric illness 
 
Yes 77.9% 
No 22.1% 
Yes 80.7% 
No 19.3% 
0.82 
ADHD 
 
Yes 28.4% 
No 71.6% 
Yes 27.2% 
No 72.8% 
1.00 
Depression 
 
Yes 17.7% 
No 82.3% 
Yes 22.8% 
No 77.2% 
0.69 
BPAD 
 
Yes 1% 
No 99% 
Yes 5.3% 
No 94.7% 
0.006 
Agoraphobia 
 
Yes 11.7% 
No 88.3% 
Yes 9.6% 
No 90.4% 
0.92 
Social phobia 
 
Yes 18.4% 
No 81.6% 
Yes 21.1% 
No 78.9% 
0.93 
GAD 
 
Yes 18.7% 
No 81.3% 
Yes 17.5% 
No 82.5% 
0.35 
OCD 
 
Yes 18.7% 
No 81.3% 
Yes 17.5% 
No 82.5% 
0.31 
History of deliberate self-harm 
 
Yes 22.2% 
No 77.8% 
Yes 31.6% 
No 68.4% 
0.14 
History of self-injurious behaviour 
 
Yes 15.6% 
No 84.4% 
Yes 15.8% 
No 84.2% 
1.00 
Psychotic illness 
 
Yes 5.7% 
No 94.3% 
Yes 2.6% 
No 97.4% 
1.00 
Personality disorder 
 
Yes 4.7% 
No 95.3% 
Yes 7.9% 
No 92.1% 
0.07 
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Diagnosis 
 
Males Females p-value 
BFC: n=14, 
p<0.004 
Alcohol dependence 
 
Yes 1.7% 
No 98.3% 
Yes 0.9% 
No 99.1% 
1.00 
Eating disorder 
 
Yes 0% 
No 100% 
Yes 2.6% 
No 97.5% 
0.59 
Historical use of illicit substances 
 
Yes 33.5% 
No 59% 
Yes 29.6% 
No 69.7% 
0.29 
* Statistically significant results before correction for multiple testing are marked with an asterisk 
 
3.5 Results of Analysis of Physical Illness Variables 
3.5.1 Results for Comorbid Physical Illness in Study Sample 
A wide range of lifetime and current physical morbidity was reported by adult 
participants with normal IQ autism spectrum disorder assessed in this study. Table 
3.13 outlines the range of conditions described.  
Table 3.13 
 
Physical Illnesses within each System-Related Category 
Bodily System Physical Illness 
 
Neurological Conditions  Bell’s palsy 
 Cerebral atrophy 
 Cluster / recurrent headaches 
 Epilepsy 
 Febrile convulsion 
 Head injury 
 Hydrocephalus 
 Meningitis 
 Migraine 
 Myasthenia gravis 
 Neuropathic pain 
 Pituitary adenoma 
 Recurrent blackouts 
 Spina bifida 
 Vertigo 
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Respiratory Conditions  Asthma 
 Bronchitis 
 Hayfever 
 Obstructive sleep apnoea 
 Pulmonary embolism 
 Recurrent cough 
 Recurrent lower respiratory tract infection 
 Sarcoidosis 
 Tuberculosis 
 
Orthopaedic Conditions  Accidental bone fracture 
 Gout 
 Hip pain 
 Knee surgery 
 Kyphoscoliosis 
 Kyphosis 
 Osteoarthritis 
 Polydactyly 
 Rheumatoid arthritis 
 Scoliosis 
 Spondylosis 
 Traumatic bone fracture 
 
Gastrointestinal Conditions  Appendicectomy 
 Cholecystectomy 
 Cholecystitis 
 Chron’s disease 
 Coeliac disease 
 Constipation 
 Gastritis 
 Gastroesophageal reflux disease 
 Haemorrhoids 
 Hernia 
 Irritable bowel syndrome 
 Liver abscess 
 Pancreatitis 
 Pilonidal sinus 
 Primary biliary cirrhosis 
 Repair of twisted mesentery 
 Ulcerative colitis 
 
Ear, Nose and Throat 
Conditions 
 
 
 
 Adenoidectomy 
 Chronic rhinitis 
 Cleft palate 
 Hearing impairment  
 Nasal polyps 
 Recurrent nose bleeds 
 Recurrent otitis media 
 Recurrent tonsillitis 
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Ear, Nose and Throat 
Conditions 
 Sinusitis 
 Tinnitus 
 Tonsillectomy 
 
 
Genitourinary Conditions  Amenorrhoea 
 Benign prostatic hypertrophy 
 Circumcision 
 Dysmenorrhoea 
 Ectopic pregnancy 
 Endometriosis 
 Erectile dysfunction 
 Gender reassignment surgery 
 Haematuria 
 Hysterectomy 
 Menorrhagia 
 Miscarriage 
 Nephrectomy 
 Nocturnal enuresis 
 Orchidectomy 
 Orchidopexy 
 Ovarian cysts 
 Postpartum haemorrhage 
 Recurrent renal calculi 
 Recurrent urinary tract infections 
 Sterilisation 
 Termination of pregnancy 
 Underdeveloped kidneys 
 Urinary incontinence 
 Uterine cysts 
 Uterine fibroids 
 Uterine prolapse 
 
 
Cardiac  Conditions  Congenital cardiac defect 
 Endocarditis 
 Heart murmur 
 Hypercholesterolaemia 
 Hypertension 
 Hypotension 
 Intermittent claudication 
 Kawasaki disease 
 Myocardial infarction 
 Myocarditis 
 Pericarditis 
 Supraventricular tachycardia 
 Wolff-Parkinson-White syndrome 
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Bodily System Physical Illness 
 
Endocrine Conditions  Adrenomyeloneuropathy 
 Diabetes mellitus 
 Hyperthyroidism 
 Hypothyroidism 
 Polycystic ovarian syndrome 
 Thymectomy 
 
 
Dermatology Conditions  Acne 
 Cold urticaria 
 Dermatitis 
 Eczema 
 Herpes zoster 
 Psoriasis 
 Raynaud’s disease 
 Systemic lupus erythematosus 
 Ulcers 
 
 
Other Medical Conditions  Accidental poisoning 
 Acute lymphoid leukaemia 
 Anaemia 
 Beta thalassaemia 
 Bone cysts requiring chemotherapy 
 Breast cyst 
 Clumsiness 
 Corneal graft 
 Facial reconstruction 
 Glaucoma 
 Hepatitis C 
 HIV 
 Lipoma 
 Obesity 
 Sciatica 
 Scotopic photosensitivity syndrome 
 Seminoma 
 Septicaemia 
 Sight Loss 
 Strabismus 
 
 
 
Three hundred and thirty four (81%) participants in the total study sample described a 
previous or current diagnosis of medical illness, consisting of 237 (71%) males and 97 
(29%) females, age range 18 - 70 years (mean age 32 years, SD 11.7 years). Sixty 
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seven (16%) participants denied a previous history of or current physical illness. Of 
those who did have a history of physical ill-health or current illness, 33% reported a 
neurological condition, 22% a respiratory illness, 19% with an orthopaedic condition, 
16% with a gastrointestinal diagnosis, 13% an ear nose and throat condition, 12% a 
genitourinary condition, 11% a cardiac condition, 8% indicated a dermatological 
diagnosis and 8% an endocrine condition.  
Two hundred and forty two (84%) participants in the ASD group endorsed a previous 
or current medical condition, compared to 92 (74%) of the nonASD group. This 
difference was not statistically significant. Medical history as reported by the ASD and 
nonASD groups is outlined in Table 3.14. There was no statistical difference between 
the groups when assessed for overall or individual physical illness. 
 
Table 3.14 
 
Comorbid Physical Illness in Study Sample 
Illness 
 
ASD group 
n (%) 
NonASD group 
n (%) 
p-value 
Any comorbid medical 
condition 
242 (84%) 92 (74%) 0.07 
Neurological condition 
 
92 (32%) 45 (36%) 0.29 
Respiratory condition  
 
61 (21%) 28 (22%) 0.65 
Orthopaedic condition  
 
54 (19%) 24 (19%) 0.78 
Gastrointestinal condition 
 
52 (18%) 15 (12%) 0.16 
ENT condition 
 
43 (15%) 10 (8%) 0.07 
Genitourinary condition 
 
40 (14%) 10 (8%) 0.12 
Cardiac condition  
 
30 (10%) 15 (12%) 0.55 
Dermatological condition 
 
22 (8%) 9 (7%) 0.95 
Endocrine condition 
 
27 (9%) 7 (6%) 0.24 
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3.5.2 Results for Comorbid Physical Illness in ASD Group 
Physical illnesses as reported by the ASD group are outlined in Table 3.15. The most 
commonly reported physical ailments were asthma (16%) and head injury (16%), 
followed by accidental / traumatic bone fracture (13%), dyspraxia (8%), headache / 
migraine (7%), recurrent otitis media (7%), hayfever (6%), eczema (5%), hypertension 
(5%), tonsillitis / tonsillectomy (5%), diabetes mellitus (4%), epilepsy (4%), hernia (4%), 
irritable bowel syndrome (4%), appendicectomy (3%), hearing impairment (3%), 
hypothyroidism (3%), obesity (3%), polycystic ovarian syndrome (3%), adenoidectomy 
(2%), dysmenorrhoea / menorrhagia (2%), constipation / haemorrhoids (2%), 
hypercholesterolaemia (2%), inflammatory bowel disease (2%), knee surgery (2%), 
recurrent blackouts (2%), accidental poisoning (1%), arrhythmia (1%), congenital 
cardiac defect (1%), hyperthyroidism (1%), miscarriage (1%), osteoarthritis (1%), 
rheumatoid arthritis (1%), recurrent UTI (1%), sight loss (1%), anaemia (0.7%), atopy 
(0.7%), gout (0.7%), malignant tumour (0.7%), psoriasis (0.7%), Raynaud’s disease 
(0.7%), recurrent renal calculi (0.7%), benign tumours (0.3%), coeliac disease (0.3%), 
dyslexia (0.3%) and systemic lupus erythematosus (0.3%). 
Table 3.15 
 
Comorbid Physical Illness in Adults with Autism Spectrum Disorder 
Illness Prevalence 
 
 
Neurology: 
Head injury 47 (16%) 
Headache / Migraine 21 (7%) 
Epilepsy 12 (3%) 
Recurrent blackouts 6 (2%) 
 
Respiratory: 
Asthma 45 (16%) 
Hayfever 16 (6%) 
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Illness Prevalence 
 
 
Orthopaedic: 
Accidental / Traumatic bone fracture 37 (13%) 
Knee Surgery 7 (2%) 
Osteoarthritis 3 (1%) 
Rheumatoid arthritis 3 (1%) 
Gout 2 (0.7%) 
 
Gastrointestinal: 
Hernia 12 (4%) 
Irritable bowel disease 10 (4%) 
Appendicectomy 8 (3%) 
Constipation / Haemorrhoids 6 (2%) 
Inflammatory bowel disease 5 (2%) 
Coeliac disease 1 (0.3%) 
 
Ear, Nose and Throat: 
Recurrent otitis media 19 (7%) 
Tonsillitis / Tonsillectomy 13 (5%) 
Hearing impairment 9 (3%) 
Adenoidectomy 6 (2%) 
 
Genitourinary: 
Dysmenorrhoea / Menorrhagia 7 (2%) 
Miscarriage 4 (1%) 
Recurrent urinary tract infection 4 (1%) 
Recurrent renal calculi 2 (0.7%) 
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Illness Prevalence 
 
 
Cardiac: 
Hypertension 15 (5%) 
Hypercholesterolaemia 5 (2%) 
Arrhythmia 4 (1%) 
Congenital cardiac defect 4 (1%) 
 
Endocrine: 
Diabetes mellitus 11 (4%) 
Hypothyroidism 8 (3%) 
Polycystic ovarian syndrome 7 (3%) 
Hyperthyroidism 3 (1%) 
 
Dermatology: 
Eczema 13 (5%) 
Psoriasis  2 (0.7%) 
Raynaud’s disease 2 (0.7%) 
Systemic lupus erythematosus 1 (0.3%) 
 
Other Medical Conditions: 
Atopy 62 (22%) 
Dyspraxia 22 (8%) 
Obesity 8 (3%) 
Accidental poisoning 4 (1%) 
Sight loss 4 (1%) 
Anaemia  2 (0.7%) 
Malignant tumours 2 (0.7%) 
Benign tumours 1 (0.3%) 
Dyslexia 1 (0.3%) 
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Other medical ailments recorded as part of this study, given their relevance in available 
ASD literature, included sleep difficulties, appetite disturbance, use of medication and 
allergies. These findings are outlined in section 3.5.6.  
As a number of physical diagnoses have been described as highly prevalent in autism 
spectrum disorder the demographic findings relating to these illnesses were examined 
in more detail. These included epilepsy, gastrointestinal disorders, dyspraxia and 
atopy. Twelve participants reported a previous diagnosis of epilepsy. These included 
9 males (75%) and 3 females (25%) (p = 0.9). There was no statistically significant 
increase in either gender and all individuals were noted to be within the younger age 
bracket of 19 - 31 years (mean 24 years, SD 4.3 years). Age of seizure onset was not 
available. No particular ASD subtype was over-represented in this group. Of those with 
a diagnosis of autism spectrum disorder and epilepsy, 58% received a diagnosis of 
comorbid psychiatric illness; comorbid attention deficit hyperactivity disorder being the 
most common at 33%, followed by obsessive compulsive disorder (25%) and 
depression (17%). One individual was diagnosed with a comorbid psychotic disorder. 
As antipsychotics are known to lower the seizure threshold, the use of prescription 
medications was examined. Of those with autism spectrum disorder and epilepsy, 66% 
were on prescribed medication, 4 receiving an antiepileptic drug, 2 on antidepressants, 
1 on benzodiazepines and 1 on antipsychotic treatment (Quetiapine 100mg nocte). 
Only 2 participants in the epilepsy group were in receipt of physical medication, namely 
treatment for gastrointestinal symptoms and acne. 
Gastrointestinal disorders as reported by ASD participants included coeliac disease, 
constipation, haemorrhoids, hernias, history of appendicectomy, inflammatory bowel 
disease and irritable bowel disease. A total of 52 (18%) participants reported 
gastrointestinal symptoms. These included 42 (81%) males and 10 (19%) females 
aged 22 - 54 years (mean 37 years, SD 14.5 years). Gastrointestinal disorders were 
over-represented in those with Asperger’s syndrome (62%) (p = 0.19) but not to 
statistical significance.  
Dyspraxia was reported by 22 (8%) participants. These included 15 (68%) males and 
7 (32%) females (p = 0.74), aged 18 - 50 years (mean 29 years, SD 11.4 years). 
Dyspraxia was noted for 10 (46%) individuals with Asperger’s syndrome, 8 (36%) of 
those with atypical autism, 3 (14%) with childhood autism and 1 (4%) with PDD-nos.  
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Atopy, referring to eczema, allergic rhinitis and asthma, was reported by 62 (22%) 
participants. Although three individual ailments, this is the highest reported physical 
illness among the ASD group. Forty four (71%) males and 18 (29%) females ranging 
in age from 18 - 50 years (mean 30 years, SD 10.0 years) reported a prior diagnosis 
of eczema, allergic rhinitis or asthma. These conditions were reported most frequently 
by individuals with Asperger’s syndrome (53%), followed by atypical autism (23%), 
childhood autism (16%) and PDD-nos (8%).  
 
3.5.3 Results for Comorbid Physical Illness in Autism Spectrum Disorder - ASD 
Subtype 
At initial analysis, a statistically higher risk for cardiac condition was noted among those 
with a diagnosis of PDD-nos compared to other subtypes of autism spectrum disorder. 
However, this statistical difference did not remain following correction for multiple 
testing as 36 tests reduced the Bonferroni critical value to p<0.001. Results relating to 
each comorbid physical condition recorded in adults with autism spectrum disorder, 
stratified by ASD subtype is outlined in Table 3.16. 
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Table 3.16 
 
Comorbid Physical Illness in Adults with Autism Spectrum Disorder                                                                              
- ASD Subtype 
Diagnosis 
 
Asperger’s 
Syndrome 
Atypical 
Autism 
Childhood 
Autism 
 
PDD-nos p-value 
BFC: n=36, 
p<0.001 
Any comorbid 
medical 
condition 
Yes 88.2% 
No 10.4% 
Yes 76.6% 
No 22.1% 
Yes 91.4% 
No 8.6% 
Yes 75% 
No 18.8% 
0.04 
Neurological 
condition 
Yes 32.6% 
No 66% 
Yes 27.3 % 
No 71.4% 
Yes 48.6% 
No 51.4% 
Yes21.9 % 
No 68.8% 
0.12 
Respiratory 
condition  
Yes 23.6% 
No 75% 
Yes15.6 % 
No 83.1% 
Yes 28.6% 
No 71.4% 
Yes 15.6% 
No 75% 
0.35 
Orthopaedic 
condition  
Yes 20.1% 
No 78.5% 
Yes 14.3% 
No 84.4% 
Yes 17.1% 
No 82.9% 
Yes 25% 
No 65.6% 
0.45 
Gastrointestinal 
condition 
Yes 22.2% 
No 76.4% 
Yes 14.3% 
No 84.4% 
Yes 8.6% 
No 91.4% 
Yes 18.8% 
No 71.9% 
0.19 
ENT             
condition 
Yes 18.8% 
No 79.9% 
Yes 13% 
No 85.7% 
Yes 11.4% 
No 88.6% 
Yes 6.3% 
No 84.4% 
0.29 
Genitourinary 
condition 
Yes 16.7% 
No 81.9% 
Yes 10.4% 
No 89.6% 
Yes 14.3% 
No 85.7% 
Yes 9.4% 
No 81.3% 
0.55 
Cardiac      
condition  
Yes 13.2% 
No 85.4% 
Yes 3.9% 
No 94.8% 
Yes 5.7% 
No 94.3% 
Yes 18.8% 
No 71.9% 
0.03 
Dermatological 
condition 
Yes 9% 
No 89.6% 
Yes 3.9% 
No 94.8% 
Yes 14.3% 
No 85.7% 
Yes 3.1% 
No 87.5% 
0.19 
Endocrine 
condition 
Yes 7.6% 
No 91% 
Yes 11.7% 
No 87% 
Yes 11.4% 
No 88.6% 
Yes 9.4% 
No 84.4% 
0.78 
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3.5.4 Results for Comorbid Physical Illness in Autism Spectrum Disorder - Age 
Previous literature recommends two methods to assess the influence of age on the 
rates of physical illness in adults with autism spectrum disorder. Firstly, the group 
should be split at the median age (29 years) and again at age 30 years. Despite the 
proximity of the two splits, it was decided to proceed with analysis to remain in keeping 
with literature recommendations. There was no statistically significant difference in the 
rates of physical illness in younger versus older adults with autism spectrum disorder 
using either method. 
 
Table 3.17 
 
Comorbid Physical Illness in Adults with Autism Spectrum Disorder                            
- Age 
Diagnosis Age <29 years Age >29 years p-value 
 
Comorbid physical illness 
 
Yes 116 
No 26 
Yes 126 
No 15 
0.10 
 
Diagnosis Age <30 years Age >30 years p-value 
 
Comorbid physical illness 
 
Yes 122 
No 26 
Yes 120 
No 15 
0.17 
 
 
3.5.5 Results for Comorbid Physical Illness in Autism Spectrum Disorder - 
Gender 
Females with autism spectrum disorder were statistically more likely to suffer from 
genitourinary conditions compared to males with the disorder. Cramer’s V was 
reported at 0.3 showing a medium effect size for this variation. Likewise, endocrine 
conditions were statistically more likely in female participants with autism spectrum 
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disorder, this time with a small effect size. Comorbid physical illnesses seen in 
participants with autism spectrum disorder are outlined in Table 3.18. 
Table 3.18 
 
Comorbid Physical Illness in Adults with Autism Spectrum Disorder                            
- Gender 
Diagnosis 
 
Males Females p-value 
BFC: n=9, 
p<0.006 
Any comorbid medical condition Yes 83% 
No 17% 
Yes 86.8% 
No 13.2% 
0.48 
Neurological condition Yes 31.6% 
No 68.4% 
Yes 32.9% 
No 67.1% 
0.88 
Respiratory condition  Yes 21.2% 
No 78.8% 
Yes 21% 
No 79% 
0.94 
Orthopaedic condition  Yes 19.3% 
No 80.7% 
Yes 17.1% 
No 82.9 
0.64 
Gastrointestinal condition Yes 19.8% 
No 80.2% 
Yes 13.2% 
No 86.8% 
0.18 
ENT condition Yes 13.7% 
No 86.3% 
Yes 18.4% 
No 81.6% 
0.34 
*Genitourinary condition Yes 8% 
No 92% 
Yes 30.3% 
No 69.7% 
<0.001* 
(Cramer’s V 0.3,    
medium effect 
size) 
Cardiac condition  Yes 10.4% 
No 89.6% 
Yes 10.5% 
No 89.5% 
0.99 
Dermatological condition Yes 19.8% 
No 80.2% 
Yes 13.2% 
No 86.8% 
0.11 
*Endocrine condition Yes 6.1% 
No 93.9% 
Yes 18.4% 
No 81.6% 
0.002* 
(Cramer’s V 
0.19, small 
effect size) 
* Statistically significant results after correction for multiple testing are marked with an asterisk 
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3.5.6 Results for other Physical Illnesses in ASD Group 
 
Sleep Difficulties 
Sleep difficulties were noted in a large proportion of those with autism spectrum 
disorder as 121 (42%) participants reported difficulties in this area. Initial insomnia was 
the most commonly recorded problem, followed by middle insomnia, reversal of sleep-
wake cycle, early morning waking and hypersomnia. 
 
Table 3.19 
 
Sleep Difficulties in Adults with Autism Spectrum Disorder 
Type of Sleep Difficulty 
 
ASD Group 
n (%) 
Any type of sleep difficulty 121 (42%) 
Initial insomnia 74 (23%) 
Middle insomnia 53 (17%) 
Reversal of sleep-wake cycle 21 (7%) 
Childhood insomnia 17 (5%) 
Early morning waking 11 (4%) 
Hypersomnia 6 (2%) 
 
 
Eating Disturbance 
Change in appetite or dietary intake was reported by one quarter of participants with 
autism spectrum disorder. Restricted dietary repertoire was the most common difficulty 
followed by reduced appetite and picky eating. The types of appetite disturbance seen 
in those with autism spectrum disorder as part of this study are outlined in Table 3.20. 
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Table 3.20 
 
Eating Disturbance in Adults with Autism Spectrum Disorder 
Type of Eating Disturbance 
 
ASD Group 
n (%) 
Any type of eating disturbance 71 (25%) 
Restricted dietary repertoire 20 (7%) 
Reduced appetite 18 (6%) 
Picky eater in childhood 11 (4%) 
Eating a single meal per day 8 (3%) 
Binge-eating 7 (2%) 
Overeating 7 (2%) 
Need reminding to eat 3 (1%) 
Unhealthy dietary choices 2 (0.7%) 
Only eats when alone 1 (0.3%) 
 
Allergies 
Allergies were reported by 123 (43%) participants with autism spectrum disorder. 
Penicillin was the most frequently occurring allergy followed by nuts, animal dander, 
pollen and shellfish. There were no statistically significant differences between the 
ASD and nonASD groups in terms of recorded allergy rates. 
 
Table 3.21 
 
Allergies in Adults with Autism Spectrum Disorder 
Type of Allergy 
 
ASD group 
n (%) 
NonASD group 
n (%) 
p-value 
NKDA 165 (57%) 68 (54%) 0.50 
Penicillin 29 (10%) 8 (6%) 0.33 
Nuts 3 (1%) 2 (2%) 0.56 
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Type of Allergy 
 
ASD group 
n (%) 
NonASD group 
n (%) 
p-value 
Animal dander 2 (0.7%) 0 (0%) 0.88 
Shellfish 2 (0.7%) 0 (0%) 0.37 
^Other 5 (2%) 3 (2%) 0.33 
^Other allergies include strawberries, dairy, beestings, pollen and aspirin 
 
Prescribed Medication Use 
Just over two-thirds of the ASD group reported use of prescription medication, 
compared to just under half of the nonASD group. There was a non-significant trend 
for participants with autism spectrum disorder to receive more prescribed medication 
than the nonASD group (p = 0.10). These results could suggest that those with a 
diagnosis of autism spectrum disorder received more prescribed medications than 
neurotypical psychiatric patients despite both groups having comparable rates of 
comorbid psychiatric and physical illness. Analysis of a larger cohort may clarify this 
finding. 
Though not of statistical significance, rates of sedative use in the ASD group were also 
notably high. Of the twenty two participants with autism spectrum disorder receiving a 
prescription for sedative medication (benzodiazepine and / or hypnotic), 16 (73%) had 
a diagnosis of anxiety spectrum disorder, 6 (27%) had depression and 12 (60%) 
described sleep difficulties. Use of medication to treat gastrointestinal disorders was 
also higher in the ASD group, this time statistically so. Gastrointestinal medication 
included proton pump inhibitors, antispasmodics, antiemetics and laxatives. A non-
significant trend was also noted for participants with childhood autism to receive more 
prescribed psychotropic medication compared to other subtypes of autism spectrum 
disorder. 
Results relating to medication use in those with autism spectrum disorder are outlined 
in Tables 3.21 and 3.22. 
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Table 3.22 
 
Use of Prescribed Medication in Adults with Autism Spectrum Disorder 
Prescribed Medication 
 
ASD group 
n (%) 
NonASD group 
n (%) 
p-value 
 
Any prescribed 
medication  
164 (67%) 59 (47%) 0.10 
 
Psychotropic Medication: 
Antidepressant 86 (30%) 33 (26%) 0.77 
Antipsychotic 25 (9%) 13 (10%) 0.76 
Sedative 22 (8%) 5 (4%) 0.47 
Mood stabiliser / AED 16 (6%) 3 (2%) 0.16 
 
Physical Illness Medication:                                                      BFC: n=3, p<0.02 
Antihypertensives 21 (7%) 8 (6%) 0.78 
Analgesia 20 (7%) 3 (2%) 0.07 
*GI medications 17 (6%) 1 (0.8%) 0.02* 
(Cramer’s V 0.12,  
small effect size) 
* Statistically significant results after correction for multiple testing are marked with an asterisk 
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Table 3.23 
 
Use of Prescribed Medication in Adults with Autism Spectrum Disorder                                                                                          
- ASD Subtype 
Prescribed 
Medication 
 
Asperger’s 
Syndrome 
Atypical 
Autism 
Childhood 
Autism 
 
PDD-nos p-value 
Any prescribed 
medication 
Yes 33.3% 
No 65.3% 
Yes 27.3% 
No 71.4% 
Yes 14.3% 
No 85.7% 
Yes 28.1% 
No 71.9% 
0.19 
Antidepressant Yes 34.7% 
No 65.3% 
Yes 28.6% 
No 71.45 
Yes 14.3% 
No 85.7% 
Yes 28.1% 
No 71.9% 
0.39 
Mood stabiliser / 
AED 
Yes 4.2% 
No 95.8% 
Yes 7.8% 
No 92.2% 
Yes 8.6% 
No 91.4% 
Yes 3.1% 
No 96.9% 
0.53 
Antipsychotic Yes 7.6% 
No 92.4% 
Yes 7.8% 
No 92.2% 
Yes 8.6% 
No 91.4% 
Yes 15.6% 
No 84.4% 
0.50 
Sedative Yes 6.9% 
No 93.1% 
Yes 7.8% 
No 92.2% 
Yes 8.6% 
No 91.4% 
Yes 9.4% 
No 90.6% 
0.86 
 
 
3.6 Summary of Results Chapter 
This chapter describes the results of the demographic analysis of 413 adults. Initial 
analysis was undertaken on the study group as a whole. The group comprised mostly 
of males (72%), with a male-to-female ratio of 2.6:1, ranging in age from 18 - 70 years. 
The majority of participants were single and unemployed, referred by their community 
mental health team and noted to be suffering from a comorbid psychiatric illness.  
Two hundred and eighty eight individuals within the group were diagnosed with autism 
spectrum disorder by the BGC consensus teams (the ASD group). This group 
consisted primarily of males (74%) with a male-to-female ratio of 2.8:1, ranging in age 
from 18 - 67 years. Again, a preponderance of individuals were single and unemployed. 
Asperger’s syndrome was the most frequently diagnosed subtype of autism spectrum 
disorder. Demographic results for the remaining 125 participants, who did not fulfil 
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criteria for autism spectrum disorder (the nonASD group), revealed a largely male 
(70%) group with a male-to-female ratio of 2.3:1, ranging in age from 18 - 70 years.  
A total of 324 participants in the overall study group were diagnosed with a comorbid 
psychiatric illness, 219 (76%) in the ASD group and 105 (84%) of the nonASD group. 
Although a lower proportion of the ASD group were diagnosed with a comorbid 
psychiatric illness, participants suffered relatively greater morbidity, receiving an 
average of 1.5 diagnoses each compared to 1.2 diagnoses among the nonASD group. 
Anxiety was the most common comorbid psychiatric diagnosis in participants with 
autism spectrum disorder with almost half of the group receiving a diagnosis. Attention 
deficit hyperactivity disorder was the second most frequent comorbid diagnosis, 
followed by mood disorders, deliberate self-harm / self-injurious behaviour, psychotic 
illness, personality disorder, substance use disorder and eating disorder. Those with 
Asperger’s syndrome were more likely to suffer from a comorbid psychiatric illness, 
most notably obsessive-compulsive disorder. 
A total of 334 participants in the overall study group described a previous diagnosis of 
physical illness; 242 (84%) in the ASD group and 92 (74%) in the nonASD group. 
Neurological conditions were the most common comorbid physical diagnosis in 
participants with autism spectrum disorder, followed by respiratory, orthopaedic, 
gastrointestinal, ear nose and throat, genitourinary, cardiac, endocrine and 
dermatological conditions. Atopy was the most frequently occurring in those with 
autism spectrum disorder followed by head injury. 
Sleep difficulties, appetite disturbance, allergies and use of prescribed medication are 
also reported in this chapter. Sleep difficulty was reported by 42% of ASD individuals 
in this study most frequently initial insomnia. Appetite disturbance was reported by a 
quarter of the ASD group most commonly restricted dietary repertoire. Penicillin allergy 
was the most commonly reported allergy among those with autism spectrum disorder 
and more of the group were in receipt of a prescription for medication to treat 
gastrointestinal disorders than observed in the nonASD group. 
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Chapter 4: General Discussion Chapter 
 
4.1 Overview 
This chapter includes the thesis summary, summary of findings and discussion of study 
findings. It outlines implications for aetiology of comorbid illness in autism spectrum 
disorder and provides a critique of study design, methodology and sample selection. 
This chapter also addresses some possible implications for clinical practice and future 
research and finishes with the thesis conclusions.  
 
4.2 Thesis Summary 
Autism spectrum disorder is a pervasive illness characterised by deficits in social skills, 
impaired communication style and characteristic repetitive and ritualised behaviours. 
It belongs within the family of conditions known as the neurodevelopmental disorders, 
which also include attention deficit hyperactivity disorder and intellectual disability. 
Autism spectrum disorder has been operationalised by both the International 
Classification of Diseases and the Diagnostic and Statistical Manual of Mental 
Disorders allowing categorisation of symptoms. Diagnosis requires clinical 
assessment, collateral information, screening questionnaires and gold standard 
diagnostic tools. When diagnosed early by skilled clinicians patients are more likely to 
access treatment, reducing the likelihood of a poor long term outcome.  
Challenges remain in the diagnosis and treatment of autism spectrum disorder, namely 
the small number of assessment centres and the shortage of trained assessors. 
Despite increased awareness and interest among general adult psychiatrists, there is 
an acute lack of specialised diagnostic services for adults with a normal range 
intelligence quotient in the Republic of Ireland. Further research in the area of 
comorbidity in normal IQ adults with autism spectrum disorder could assist in providing 
a strong research base from which to acquire increased diagnostic and treatment 
services. In turn, this could allow research in Irish adults with normal IQ autism 
spectrum disorder. 
Rates of autism spectrum disorder, psychiatric comorbidity, physical comorbidity and 
social morbidity have not previously been examined in a large cohort of normal IQ adult 
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patients with autism spectrum disorder. This study availed of information relating to 
413 adults patients assessed at a specialised tertiary referral clinic in the United 
Kingdom, 288 of whom were diagnosed with autism spectrum disorder. The principal 
aims of this study were to determine the frequency of Axis I and Axis II comorbid 
psychiatric disorder in adults with normal IQ autism spectrum disorder, the frequency 
of reported physical conditions in adults with normal IQ autism spectrum disorder, the 
frequency of psychiatric and physical illness by specific ASD subgroup, the frequency 
of psychiatric and physical illness by gender and to draw comparison between the rates 
of psychiatric and physical illness among the ASD population and reported rates 
among the general population.  
This study tested the hypothesis that a sample of adults with normal IQ suffering from 
autism spectrum disorder would report higher rates of comorbid psychiatric and 
physical illness compared to the general population. The findings of this study are 
examined in relation to this hypothesis. 
 
4.3 Summary of Study Findings 
Previous literature to examine rates of psychiatric and physical illness in adults with 
normal range IQ and a diagnosis of autism spectrum disorder amounts to ten articles, 
relating to populations from six countries between 2005 and 2014. The research study 
outlined in this thesis is the first to examine rates beyond mainland Europe and the 
United States of America. 
 
Demographic Data 
The main findings for demographic data relating to normal IQ adults with autism 
spectrum disorder show: 
1. Autism spectrum disorder was diagnosed in 70% of participants in this study. 
 
2. A male-to-female ratio of 2.8:1 was noted for autism spectrum disorder in 
normal IQ adults. 
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3. Milder forms of autism spectrum disorder, namely Asperger’s syndrome, 
atypical autism and PDD-nos were recorded for 88% of participants with autism 
spectrum disorder. 
 
4. A trend towards diagnosis in later life was noted for participants with milder 
forms of autism spectrum disorder. 
 
5. Sixty seven percent of participants with autism spectrum disorder were not in a 
stable relationship. 
 
6. Participants with autism spectrum disorder were more likely to be unemployed. 
Participants with lower functioning forms of autism spectrum disorder were 
especially at risk for unemployment. 
 
7. Participants with autism spectrum disorder were less likely to live independently. 
 
8. Participants with autism spectrum disorder were statistically more likely to have 
been victims of school-yard bullying in national and / or secondary school. 
 
Psychiatric Illness 
The main findings for psychiatric illness among normal IQ adults with autism spectrum 
disorder show: 
1. A total of 76% of participants with autism spectrum disorder suffered from a 
comorbid Axis I psychiatric illness. 
 
2. Within the group of participants with autism spectrum disorder, 2% also suffered 
from a comorbid Axis II condition. 
 
3. Anxiety spectrum disorders were the most common comorbid psychiatric illness 
diagnosed in participants with autism spectrum disorder. 
 
177 
 
4. Attention deficit hyperactivity disorder was the second most frequently diagnosed 
comorbid psychiatric illness in participants with autism spectrum disorder. 
 
5. Mood disorders and deliberate self-harm occurred at equal rates in participants 
with autism spectrum disorder and were the third highest ranking comorbid 
condition. 
 
6. Depression occurred at significantly higher rates than bipolar affective disorder in 
participants with autism spectrum disorder. Unlike comorbidity in adolescent 
cohorts it was not the most common psychiatric condition. 
 
7. Comorbid psychosis rates were lower than expected in participants with autism 
spectrum disorder. 
 
8. Rates of personality disorder were relatively low compared to other psychiatric 
illnesses in participants with autism spectrum disorder. 
 
9. Alcohol addiction is the most frequently occurring substance use disorder in 
participants with autism spectrum disorder. Recorded rates were lower than 
expected. 
 
10. Use of illicit drugs was statistically less likely in participants with autism spectrum 
disorder compared to participants without autism spectrum disorder. 
 
11. Eating disorder was rarely diagnosed in participants with autism spectrum 
disorder. 
 
12. Tic disorder including Tourette’s syndrome was diagnosed at a lower than 
expected rate in participants with autism spectrum disorder. 
 
13. Catatonia was not noted for a single participant with autism spectrum disorder. 
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14. Participants with Asperger’s syndrome were statistically more likely to be 
diagnosed with a comorbid psychiatric illness compared to participants with other 
forms of autism spectrum disorder. 
 
15. Obsessive compulsive disorder occurred at a statistically higher frequency among 
participants with Asperger’s syndrome compared to participants with other forms 
of autism spectrum disorder. 
 
16. Older participants with autism spectrum disorder were statistically more likely to 
be diagnosed with depression and generalised anxiety disorder than younger 
participants. 
 
17. Female participants with autism spectrum disorder were more likely to suffer from 
bipolar affective disorder than male participants with autism spectrum disorder. 
However, this finding lost statistical significance on correction for multiple testing. 
 
Physical Illness 
The main findings for physical illness among normal IQ adults with autism spectrum 
disorder show: 
1. A total of 84% of participants with autism spectrum disorder had a history of 
physical ill health. 
 
2. A total of 16% of participants with autism spectrum disorder described good 
physical health. 
 
3. Neurological conditions were the most prevalent systems illness among 
participants with autism spectrum disorder, at a rate of 32%. Epilepsy rates were 
lower than expected at 3%, the third most frequently occurring neurological 
condition in participants with autism spectrum disorder. 
 
4. Atopy was the most prevalent disease among participants with autism spectrum 
disorder, at a rate of 22%. 
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5. Allergies were documented for 43% of participants with autism spectrum disorder. 
 
6. Sleep difficulties were notably high at 42% among participants with autism 
spectrum disorder. 
 
7. Eating disturbance was noted in 25% of participants with autism spectrum 
disorder. 
 
8. Dyspraxia rates were recorded at 8% in participants with autism spectrum disorder. 
 
9. Dyslexia was rarely recorded for participants with autism spectrum disorder 
(0.3%). 
 
10. Smoking was less likely in participants with autism spectrum disorder than in 
neurotypical participants. 
 
11. Participants with autism spectrum disorder were statistically more likely to take 
medication prescribed for gastrointestinal illness than participants who did not 
suffer from autism spectrum disorder. 
 
12. A notably high prescription rate was seen for sedative medication among 
participants with autism spectrum disorder compared to participants without autism 
spectrum disorder. This difference did not reach statistical significance. 
 
13. No differences were noted in rates of physical illness in participants with autism 
spectrum disorder when examined according to age. 
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4.4 Discussion of Study Findings 
 
4.4.1 Demographic Findings in Normal IQ Adults with Autism Spectrum Disorder 
 
Prevalence Rate of Autism Spectrum Disorder in Normal IQ Adults 
It is generally agreed that the prevalence rate for autism spectrum disorder in children 
of the general population is between 0.6% and 1%. These figures, published in 2006 
and 2008, are significantly higher than the prevalence rate of 0.04% recorded in 1966. 
A number of possible factors have been proposed to explain this gradual increase in 
ASD prevalence over time. Two main theories exist; increased awareness among the 
general public, physicians and psychiatrists which has allowed increased recognition 
of previously undiagnosed and newly arising cases (Miles 2011, Nylander 2013) and 
improved diagnostic criteria reducing diagnostic overshadowing (Kim 2011, Vannucchi 
2014a). Other possible reasons for the gradual increase in prevalence rates were 
identified by the author in this study. These include varying research methodologies 
such as differing sample sizes, differing assessment or diagnostic methods and 
instruments, differing study participants, original research versus use of national data, 
poor participation rates, wide interpretation of diagnostic criteria, the mixing of age and 
IQ within a single cohort, the development of specialist diagnostic services for children 
and in some regions for adults across Europe and the United States of America which 
allowed increased recording of caseness for research purposes and the recognition 
that autism spectrum disorder can co-exist with intellectual disability, normal IQ and 
psychiatric morbidity which has allowed revision of diagnoses in the form of diagnostic 
substitution and recording of both true cases and those of mixed morbidity. Other 
factors identified by the author include population growth which is a naturally occurring 
phenomenon leading to increased prevalence in all illnesses and changes in political 
and healthcare policy which impact prevalence data, as services are planned in 
accordance with illness rates. Factors previously considered causal, but currently 
known to be incidental in the prevalence trends for autism spectrum disorder include 
age of the cohort under investigation, cluster alarms, cultural variability, geographical 
variation, immigration, social class and a rise in the true rate of the disorder. 
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A prevalence rate for autism spectrum disorder in adults with an IQ in the normal range 
has not previously been published. White et al (2011) described a rate of 1.9% in a 
university population in the United States of America. This is the closest figure available 
for a community prevalence rate in the literature to date. It is however notably higher 
than the rate seen in child cohort community studies. This is interesting as autism 
spectrum disorder is a neurodevelopmental condition, present from birth. As one 
cannot develop the condition in adulthood, two options remain to explain the higher 
rates noted by White et al (2011). Firstly, community paediatric studies may have 
underestimated the rate of autism spectrum disorder in their samples. An alternative 
explanation is that individuals with high-functioning autism spectrum disorder show 
greater academic attainment and are more likely to attend university, thus increasing 
the rates identified by White et al. 
Autism spectrum disorder was diagnosed in 70% of participants in this study. As the 
sample does not represent a community population, the rate cannot be generalised or 
interpreted as a prevalence rate for autism spectrum disorder in the general population. 
It could however provide an indication as to the high prevalence rate of autism 
spectrum disorder within the psychiatric population. More specifically the high rate of 
autism spectrum disorder in difficult to diagnose, difficult to treat complex cases. 
 
Gender Ratio in Normal IQ Adults with Autism Spectrum Disorder 
This study identified a male-to-female ratio of 2.8:1. This ratio is equivalent to that 
reported previously in the literature relating to mixed age and mixed IQ populations, 
where 2:1 - 3:1 is considered a reasonable estimate of gender ratio in autism spectrum 
disorder. It is however higher than rates reported by White et al (2011), who reported 
a ratio of 1.5:1 in normal IQ college students and lower than Brugha et al (2011) who 
reported a ratio of 9:1 in mixed IQ adults.  
The male-to-female ratio in autism spectrum disorder has remained relatively stable 
over time. The most likely explanation is that males more frequently suffer from autism 
spectrum disorder. However, another possible reason could be that the current 
concept of autism spectrum disorder focuses primarily on the male presentation. If 
diagnosticians are overly focused on the mode of male presentation, they are likely to 
miss the more subtle phenotype in females. In fact, it has been shown that although 
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expressing the same levels of ASD symptoms, girls are less likely to receive a 
diagnosis than boys (Constantino, 2015). Hans Asperger originally thought the 
condition was unique to males but later modified his view to say it was ‘much more 
common in boys than girls’ (Wing, 1981). Lorna Wing (1981) points out that girls tend 
to be more superficially sociable than boys and Maria Råstam (2008) suggests closer 
consideration of the female phenotype, ‘in the same way as anorexia nervosa criteria 
are designed to pick up females, if the criteria of ASD were to be broadened to include 
behaviours and attitudes more appropriate to females maybe more girls would be 
considered for ASD’.  
 
Relationship Status in Normal IQ Adults with Autism Spectrum Disorder 
This study showed that 67% of participants with autism spectrum disorder were not in 
a stable relationship. This rate is consistent with previous literature showing the 
majority of high-functioning adults with autism spectrum disorder are single. Joshi et al 
(2013) noted 84% of their sample of normal IQ adults with autism spectrum disorder 
to be single. Rydén and Bejerot (2008a), Hofvander et al (2009) and Roy et al (2015) 
also note low relationship rates among participants, ranging from 16% to 28%. 
Information relating to the status of parental relationships is virtually unreported in 
autism spectrum disorder. The only reference identified as part of this literature review 
was by Kanner (1943) who noted three sets of parents (27%) were separated. This 
study recorded parental marital status for 71% of participants with autism spectrum 
disorder. Most frequently, participants’ parents were reported to be married or widowed 
(37%) followed by divorced or separated (34%).  
 
Employment Status in Normal IQ Adults with Autism Spectrum Disorder 
This study showed that adults with normal IQ autism spectrum disorder were more 
likely to be unemployed compared to neurotypical participants. Those with lower 
functioning forms of autism spectrum disorder were especially at risk for 
unemployment. Global functioning is generally more impaired in adults with autism 
spectrum disorder compared to their neurodevelopmentally typical counterparts (Joshi, 
2013). Although two thirds have graduated from secondary school and one quarter 
have completed a college or university qualification, showing equal educational 
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attainment to the general population and the potential to work, few are in regular 
employment (Barnhill 2007, Rydén 2008a, Hofvander 2009). Employment rates range 
from 9% - 34% but inevitably individuals with autism spectrum disorder experience 
lower social and occupational functioning (Barnhill 2007, Rydén 2008a, Hofvander 
2009, Howlin 2012). Mark Romoser (2000) coined the term malemployment to 
describe the working lives of many with Asperger’s syndrome, finding themselves 
working in a job below their skillset to which they are essentially unsuited. 
 
Accommodation Status in Normal IQ Adults with Autism Spectrum Disorder 
Study participants with autism spectrum disorder were noted to be less likely to live 
independently. Only 19% of participants were living alone while the majority (56%) 
continued to live with family members. A surprisingly high percentage (8%) also 
resided in supported accommodation or were effectively homeless. Balfe and Tantam 
(2010) have previously shown that the majority of adults with autism spectrum disorder 
continue to live with their parents. This is supported by Hofvander et al (2009), Bruder 
et al (2012) and Roy et al (2015) who also showed that less than half of their study 
participants lived independently.  
 
Bullying in Normal IQ Adults with Autism Spectrum Disorder 
Bullying, or peer victimisation, refers to direct or indirect, verbal or physical, repeated 
intimidation, aggression and harassment of an individual by another person driven by 
a desire for power or social dominance (Plenty, 2014). Rates in neurotypical children 
typically peak in the preteen years and reduce thereafter (Bejerot, 2013). It is a global 
issue affecting 5% - 45% of school-age children in the general population (Idsoe 2012, 
Plenty 2014, Takizawa 2014). In the general population, boys are almost three times 
more likely to fall victim to school-yard bullying, however girls are shown to experience 
a greater negative psychological impact as a result of bullying (Idsoe, 2012). Females 
display higher rates of internalising behaviours including post-traumatic stress disorder 
and males more externalising behaviours, with those of higher functional ability falling 
victim most frequently (Hoover, 2015). Risk factors for being bullied include being 
male, unassertive, withdrawn or of inhibited temperament, easily upset, of low 
emotional intelligence, socially vulnerable, gullible, highly credulous, perceived as 
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unusual, deficient in social skills, overweight, of an ethnic minority, have below average 
motor skills or to have an illness or disability (Gladstone 2006, Sofronoff 2011, Plenty 
2014, Wolke 2015). A number of these characteristics are seen in individuals with 
autism spectrum disorder, most notably male preponderance, low social intelligence, 
socially vulnerable, gullible and credulous, poor social skills, reduced motor skills and 
being ‘perceived as unusual’. It is estimated that 44% - 77% of children with autism 
spectrum disorder have been bullied over the last month and as many as 94% over 
the past year (Hoover, 2015). 
Studies in neurotypical children who have experienced bullying show increased rates 
of all mental illnesses compared to children who have not been bullied (Lereya, 2015). 
These included increased rates of depression, anxiety and suicidality in children, post-
traumatic stress disorder among female children (Idsoe, 2012) and increased anxiety, 
agoraphobia, generalised anxiety disorder, panic disorder and suicidality among young 
adults aged 19 - 26 years (Copeland 2013, Hoover 2015). Though less frequently 
researched in adults, anxiety spectrum disorders are again clinically considered to be 
significantly associated with a childhood experience of bullying. Takizawa et al (2014) 
examined adult health outcomes of childhood bullying in 7,771 adults in a British birth 
cohort. They showed increased frequency of depression, anxiety spectrum disorders 
and poorer cognitive function among the study sample compared to nonbullied 
counterparts. Similarly, research looking at psychiatric outcomes in children with 
autism spectrum disorder with a history of being bullied showed increased rates of 
anger, loneliness, symptoms of depression, panic disorder and generalised anxiety 
disorder, self-injury and suicidality (Hoover, 2015). Research in young adults with 
autism spectrum disorder shows increased anxiety, suicidal ideation and suicide 
attempts (Hoover, 2015). This is concerning given the findings of Takizawa et al (2014) 
and Lereya et al (2015) showing childhood bullying to result in more severe longterm 
adverse mental health outcomes than physical or emotional maltreatment, sexual 
abuse or neglect and similar mental health sequelae to individuals who had lived in 
institutional care. 
Literature quotes a rate of 44% - 95% for school-yard bullying among normal IQ 
individuals with autism spectrum disorder (Hofvander 2009, Balfe 2010, Hoover 2015). 
A rate of 40% is suggested for sexual or financial exploitation among the same 
population (Balfe, 2010). Findings from this study are consistent with previous literature 
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showing that 61% of participants with autism spectrum disorder were bullied in school 
and that this population are statistically more likely to be victims of bullying compared 
to their neurotypical counterparts. 
 
Ratio of High-Functioning to Low-Functioning Autism Spectrum Disorder in 
Normal IQ Adults 
As people differ in their skill level of social interaction, use of non-verbal skills and 
behavioural habits, the triad of impairments clinically characteristic of autism spectrum 
disorder may be found to varying degrees in many individuals among the general 
population (Wing, 1981). Similarly, the severity of impairment in each domain among 
those with a diagnosis of autism spectrum disorder can vary from mild to severe. 
Individuals on the more severe end of the autism spectrum, especially those with 
language delay, typically receive a diagnosis of childhood autism. Those with less 
severe impairments, tend to receive diagnoses of Asperger’s syndrome, atypical 
autism and pervasive developmental disorder, not otherwise specified (Cederlund 
2008, Lungegård 2012). The term ‘high-functioning’ is widely used to refer to this group 
with milder impairment who generally use language in a superficially normal way and 
can display normal or sometimes above average intelligence (White 2011, Van Elst 
2013). Approximately 10% - 30% of individuals with autism spectrum disorder fall into 
the high-functioning category with a preponderance of males in this category 
(Ghaziuddin 2002a, Goldstein 2002, Williams E 2008). 
While Kanner was unsure as to the level of intellectual functioning of individuals with 
early infantile autism, Asperger reported normal intelligence levels for all subjects with 
autistic psychopathy (Rutter 1978, Wing 1981, Wing 2002a). Currently, it is agreed that 
IQ in autism spectrum disorder is on a spectrum from profound intellectual disability to 
superior intellectual functioning as seen in the general population (White, 2011). As 
approximately 70% of ASD individuals have an intellectual disability (Newschaffer 
2003, Kannabiran 2009), the remaining 30% fall within the normal or superior IQ range. 
Despite registering IQ levels in the normal to superior range, it has been suggested 
that individuals with average or superior IQ and autism spectrum disorder demonstrate 
subnormality in specific areas of intelligence. The most commonly described 
subnormal skill is that of executive function, shown to be less than expected for the 
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individual’s IQ ability. Executive dysfunction with associated cognitive rigidity could 
impair problem solving ability leading to poorer coping and greater comorbidity rates. 
It has been shown that the rate of comorbid intellectual disability in autism spectrum 
disorder is falling. Judith Miles (2011) noted a progressive reduction in the prevalence 
of intellectual disability among those with autism spectrum disorder from 70% to 50% 
and more recently to 30%. Her research reflects the hereto poor detection rates of 
autism spectrum disorder in high-functioning individuals. As detection rates among the 
normal IQ population improve, the relative prevalence of intellectual disability declines. 
A small number of researchers have focused on IQ in autism spectrum disorder and 
show outcomes to be more positive and problems less pervasive in individuals with a 
higher IQ and poorer for those with an IQ below 50 (Howlin, 2000 and 2004). However, 
adults with autism spectrum disorder are shown to receive better support when their 
diagnosis is associated with a lower IQ (Brugha, 2011). Overall, IQ at either extreme, 
at the time of original diagnosis has for some time been considered a reasonable 
predictor of outcome (Rutter 1978, Newschaffer 2003, Billstedt 2005a, White 2011).  
Looking solely at high-functioning individuals with autism spectrum disorder, ratios of 
childhood autism to Asperger’s syndrome appear to consistently suggest childhood 
autism is the more prevalent of the two. A current ratio of 5:1 is accepted (Fombonne, 
2005). This study did not correlate with previous literature as milder forms of autism 
spectrum disorder more frequently presented to the assessment clinic. It is likely that 
diagnoses of milder forms of autism spectrum disorder are more complex to finalise 
leading to higher rates of referral for tertiary assessment. Alternatively, it may suggest 
that individuals with more impaired subtypes of autism spectrum disorder are diverted 
away from the community psychiatric services, perhaps to disability services or other 
community supports. 
 
Diagnosis in Childhood versus Adulthood in Normal IQ Adults with Autism 
Spectrum Disorder 
The diagnosis of autism spectrum disorder is most frequently made in childhood (Cath 
2008, White 2011) as parents, caregivers or teachers note difficulties in the child’s 
social skills and means of communication or behaviours, most commonly before the 
age of five years. Parents become concerned if a child or adolescent is failing to make 
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friends, behaves inappropriately in public or appears indifferent to the opinions of 
others (Lainhart, 1999). The child is initially assessed by a general practitioner followed 
by referral to their local child and adolescent psychiatric service. Child and adolescent 
psychiatrists, paediatricians and child psychologists are skilled in the diagnosis and 
detection of childhood-onset disorders including autism spectrum disorder. Once 
diagnosed, a child can access increased academic and social supports and parents 
are provided with a foundation of knowledge on which to better engage their child. 
Interventions at this age are shown to improve the child’s cognitive, linguistic, social 
and self-help skills (Howlin, 1999). Approximately 80% of cases are detected in this 
way with childhood autism repeatedly shown to be detected at an earlier age than 
Asperger’s syndrome. 
When language, cognitive and social impairments are subtle, diagnosis can be missed 
in childhood (Cath, 2008) and autism spectrum disorder without intellectual disability 
in particular is often diagnosed later in life (Strunz, 2014). In fact, nearly 50% of those 
with Asperger’s syndrome remain undiagnosed until adulthood (Roy, 2015). This leads 
to two main unfortunate outcomes for young adults with undiagnosed autism spectrum 
disorder. Firstly, they typically have completed education before receiving a diagnosis, 
thus possibly leading to poorer academic attainment than might have been possible 
(White, 2011). Secondly, adult psychiatrists are generally less aware of the autism 
spectrum disorder phenotype than their child and adolescent psychiatry colleagues 
and the condition can remain undiagnosed despite general practitioner and 
subsequent consultant psychiatrist assessment (Anholt, 2010).  
This study showed a non-statistically significant trend towards older age at diagnosis 
for participants with PDD-nos. This suggests that individuals with PDD-nos were more 
likely than individuals with other forms of autism spectrum disorder to receive their 
diagnosis as adults. This finding is in keeping with literature indicating those with less 
impairment are diagnosed later in life. 
 
Misdiagnosis in Normal IQ Adults with Autism Spectrum Disorder 
Although referral rates of adults with suspected autism spectrum disorder to tertiary 
assessment centres is rising (Ketelaars, 2008), Nylander et al (2013) suggests the 
autism spectrum disorder diagnosis can be frequently overshadowed by comorbid 
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illness. Often, it is when a patient fails to recover from an original diagnosis, for 
example a depressive episode, that the clinician begins to consider the possibility of 
an underlying neurodevelopmental disorder. Perhaps adult psychiatrists are not 
accustomed to taking a long-term developmental perspective on their patient’s 
presenting complaint (Nylander, 2013). Occasionally, even in the absence of a 
comorbid condition, neurodevelopmental disorders can be missed (Roy, 2013) or are 
not the first consideration among adult psychiatrists. Due to atypical presentations or 
less severe symptoms, many patients with high-functioning autism spectrum disorder 
are misdiagnosed as suffering from depression, bipolar affective disorder, anxiety 
spectrum disorders, schizophrenia, obsessive compulsive disorder, borderline 
personality disorder or other forms of personality disorder (Wing 2002a, Van Elst 2013, 
Vannucchi 2014a). Van Elst et al (2013) hypothesised that very few adult patients in 
Germany are recognised as suffering from autism spectrum disorder and instead many 
patients receive a diagnosis of ‘atypical depression’, ‘atypical psychosis’, ‘atypical 
OCD’ or ‘combined personality disorder’. 
This study showed that 30% of participants were suspected of having autism spectrum 
disorder by the community mental health team but later found to be neurotypical. The 
majority of these participants were found to be suffering from another psychiatric 
illness, most commonly personality disorder followed by psychotic disorder. This 
finding suggests a tendency towards misidentification of personality disorder and 
psychotic symptoms as autism spectrum disorder symptoms by general practitioners 
and general adult psychiatrists.  
 
4.4.2 Psychiatric Illness in Normal IQ Adults with Autism Spectrum Disorder 
Increasingly autism spectrum disorder is associated with a higher prevalence of 
psychiatric illness than seen in the general population (Stewart 2006, Nylander 2008, 
Raja 2008). Roy et al (2015) noted a lifetime prevalence of one of more comorbid 
psychiatric illness in 70% of normal IQ adults with autism spectrum disorder. 
As part of this study, the author reviewed all available literature to compile a table 
comparing prevalence rates for sixteen psychiatric illnesses in the general population 
to rates among adults with normal IQ autism spectrum disorder in previous literature 
and in this study. Comparisons are outlined in Table 4.1. 
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Table 4.1 
 
Prevalence Rates for Psychiatric Illness in Adults 
Diagnosis Rates in the 
General 
Population 
 
Rates for Adults 
with Normal IQ 
Autism Spectrum 
Disorder in 
Previous Literature 
Rates for Adults 
with Normal IQ 
Autism Spectrum 
Disorder in this 
Study 
Anxiety spectrum 
disorders 
 
Obsessive 
compulsive disorder 
 
Generalised anxiety 
disorder 
 
Social phobia 
 
Agoraphobia 
 
Specific phobia 
 
Post-Traumatic 
stress disorder 
1% - 28% 
 
 
1.5% - 3% 
 
 
2% - 5% 
 
8% - 12% 
 
2% 
 
7% - 9% 
 
Unreported 
50% 
 
 
7% - 50% 
 
 
15% - 29% 
 
13% - 50% 
 
15% - 24% 
 
6% - 18% 
 
5% 
49% 
 
 
23% 
 
 
20% 
 
19% 
 
13% 
 
1% 
 
1% 
Attention deficit 
hyperactivity disorder 
 
5% 37% - 43% 27% 
Depression 
 
6% 30% 23% 
Bipolar affective 
disorder 
0.4% - 0.8% 6% - 9% 2% 
Suicidal behaviour Suicidal Ideation 9% 
Suicide Attempt 3% 
Suicidal Ideation 
66% 
Suicide Attempt 
17% - 35% 
Deliberate self-harm 
25% 
Self-injurious 
behaviour 16% 
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Diagnosis Rates in the 
General 
Population 
 
Rates for Adults 
with Normal IQ 
Autism Spectrum 
Disorder in 
Previous Literature 
Rates for Adults 
with Normal IQ 
Autism Spectrum 
Disorder in this 
Study 
Schizophrenia 
 
0.3% - 1% 0% 4% 
Alcohol addiction 
 
1% - 3%  6% 1% 
Eating disorder 
 
0.3% - 4% 5% 0.3% 
Tic disorder / 
Tourette’s syndrome 
0.1% 5% - 20% 1% 
Catatonia 
 
Unreported Unreported 0% 
 
Of the sixteen illnesses assessed in this study, eleven were noted to be more 
prevalent in normal IQ adults with autism spectrum disorder compared to the general 
population. These were anxiety spectrum disorders, obsessive compulsive disorder, 
generalised anxiety disorder, social phobia, agoraphobia, attention deficit 
hyperactivity disorder, depression, bipolar affective disorder, suicidal behaviour, 
schizophrenia and tic disorder. Increased rates varied from a factor of two to a factor 
of ten. Examples include social phobia occurring at a rate of 8% in the general 
population but 19% in the normal IQ ASD population and generalised anxiety disorder 
occurring at a rate of 2% in the general population but 20% in the normal IQ ASD 
population. Rates reported in this study, though higher than those seen in the general 
population, were more conservative than those reported in previous literature.  
Three illnesses previously reported as more prevalent in normal IQ adults with autism 
spectrum disorder compared to the general population were noted to occur at 
comparable rates in this study. These included specific phobia (occurring at 7% - 9% 
in the general population and 1% in participants with autism spectrum disorder), 
alcohol addiction (occurring at 1% - 3% in the general population and 1% in 
participants with autism spectrum disorder) and eating disorder (occurring at 0.3% - 
4% in the general population and 0.3% in participants with autism spectrum disorder). 
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This study found a lower prevalence of post-traumatic stress disorder in adults with 
normal IQ autism spectrum disorder compared to previous literature (previously 
reported at 5% and found at a rate of 1% in this study). To the best of my knowledge, 
this study is the first to report a prevalence rate for catatonia in a normal IQ ASD 
population. This finding, however, should be noted cautiously as the study design did 
not include a specific assessment tool for catatonia.  
 
Anxiety Spectrum Disorders in Normal IQ Adults with Autism Spectrum Disorder 
Rates of anxiety spectrum disorders are reported to be higher in the ASD population 
compared to the general population. Davis et al (2011) found rates of anxiety increased 
from toddlerhood, peaked in childhood and rose again in young adulthood though not 
reaching childhood levels. Lugnegård et al (2011) noted a rate of approximately 50% 
in 54 normal IQ Swedish adults, while Joshi et al (2013) found anxiety spectrum 
disorders to be the third most common comorbid psychiatric illness in a group of 63 
normal IQ American adults. Previous literature has identified social phobia as the most 
common anxiety spectrum disorder, followed by generalised anxiety disorder, specific 
phobia, obsessive compulsive disorder and post-traumatic stress disorder (Joshi, 
2013).  
In line with previous literature, rates of anxiety spectrum disorders were found to be 
extremely high in participants with autism spectrum disorder in this study. In fact, they 
were noted to be the most common comorbid psychiatric illness occurring at a rate of 
49%. Contrary to previous literature, obsessive compulsive disorder was the most 
commonly occurring of the anxiety spectrum disorders, followed by generalised anxiety 
disorder, social phobia and agoraphobia. Prevalence rates for obsessive compulsive 
disorder in individuals with autism spectrum disorder, as reported by five previous 
studies, ranged from 7% - 50% (Russell 2005, Cath 2008, Ketelaars 2008, Hofvander 
2009, Joshi 2013). This study identified a prevalence rate of 30% in keeping with past 
research. Prevalence rates for generalised anxiety disorder in those suffering from 
autism spectrum disorder was previously reported to range from 15% - 29% 
(Hofvander 2009, Lugnegård 2011, Joshi 2013). A rate of 27%, as found in this study, 
is at the higher end of this range. Prevalence rates for comorbid social phobia have 
been reported to range from 13% - 50% (Cath 2008, Ketelaars 2008, Hofvander 2009, 
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Joshi 2013, Stunz 2014). The rate of 21% reported in this study is again in keeping 
with previous literature. Finally, prevalence rates for agoraphobia range from 15% - 
24% (Lugnegård 2011, Joshi 2013), a rate of 13% as noted in this study is lower than 
previous research.  
Autism spectrum disorder, especially high-functioning autism spectrum disorder, 
shares a number of features in common with the anxiety spectrum disorders including 
profound social interaction deficits and communication skills deficits (Cath 2008, Tyson 
2012). It is hypothesised that anxiety spectrum disorders, similar to depression, could 
be a result of the individual’s struggle to comprehend complex social interactions and 
their awareness of being inherently different to others (Balfe, 2010). Prevalence of 
anxiety spectrum disorders may also be increased by an over-representation of 
bullying and victimisation in this population (Balfe, 2010). 
Both disorders could also share common aetiological factors. Similar genetic liability, 
family history of psychiatric illness and behavioural deficits could be lead to the 
emergence and maintenance of both disorders (Tyson, 2012). Although it is not known 
if the disorders share a common neural basis (Russell, 2005), it has been suggested 
that autism spectrum disorder, attention deficit hyperactivity disorder and obsessive 
compulsive disorder could constitute a group of developmental basal ganglia disorders 
(Anholt, 2010). Further research in the area is required to clarify this question. 
 
Attention Deficit Hyperactivity Disorder in Normal IQ Adults with Autism 
Spectrum Disorder 
Roy et al (2013) suggest that there are several overlapping symptom profiles between 
attention deficit hyperactivity disorder and high-functioning autism such as attentional 
impairments, deficits in social interaction, interpersonal struggles, sensory 
hypersensitivity, motor clumsiness and hyper-focussed special interests. Autism 
spectrum disorder and attention deficit hyperactivity disorder also have age and 
developmental stage of onset in common (Taurines, 2010). Theories as to common 
aetiology lie in similar increases in gray matter volume in both conditions and structural 
abnormalities in the prefrontal cortex and inferior parietal lobe (Roy, 2013). The 
conditions are also noted to stem from partly similar genetic origins with overlapping 
loci at chromosome 5p13 and 16p13 (Taurines, 2010). Vannucchi et al (2014b) 
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suggest that autism spectrum disorder and attention deficit hyperactivity disorder could 
share up to 50% - 72% of their genetic aetiology. 
In this study, 27% of participants received a diagnosis of attention deficit hyperactivity 
disorder making it the second most frequently diagnosed comorbid psychiatric illness 
in participants with autism spectrum disorder. This rate is conservative compared to 
previous literature which quoted a rate of 37% (Rydén, 2008a). The most likely reason 
for this discrepancy lies in the differences in recruitment between the two studies. 
Ryden et al (2008a) recruited participants from an inpatient neurodevelopmental 
service specialising in the treatment of autism spectrum disorder and attention deficit 
hyperactivity disorder. It is likely that this increased the rate of attention deficit 
hyperactivity disorder referred to and diagnosed by their study group compared to the 
participants assessed in this study. 
 
Mood Disorders in Normal IQ Adults with Autism Spectrum Disorder 
Research investigating rates of mood disorder in adults with normal IQ autism 
spectrum disorder frequently fail to specify the subtype of mood disorder, namely 
depression, bipolar or mania being assessed. Reports generally focus on overall rates 
for mood disorders and range from 24% - 53% (Ketelaars 2008, Hofvander 2009, Stunz 
2014). Research in adult patients with normal IQ autism spectrum disorder reports 
lifetime prevalence of major depressive disorder as 70% - 77%, recurrent depression 
as 50%, current depressive episode as 30% and dysthymia as 8% (Cath 2008, 
Lugnegård 2011, Joshi 2013). Although rates reported in this study are significantly 
lower than those seen in previous research relating to individuals with autism spectrum 
disorder, they remain greater than rates reported for the general population, namely 
6% (Olsen, 2004). Comparison of rates is outlined in Table 4.2. 
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Table 4.2 
 
Comparison of Rates of Depressive Illnesses                                                            
between Current Study and Previous Literature 
Depressive Illness 
 
Previous Literature Current Study  
Major depressive disorder 
 
30% 11% 
Recurrent depressive disorder 
 
50% 8% 
Dysthymia 
 
8% 4% 
 
While some previous authors have described depression as the most prevalent 
comorbid psychiatric condition in adults with normal IQ autism spectrum disorder 
(Ketelaars 2008, Hofvander 2009, Lugnegård 2011, Strunz 2014), this study found 
depression to be less frequently occurring. Cath et al (2008) also noted depression to 
no more common than obsessive compulsive disorder or social phobia in 12 adults in 
the Netherlands. Likewise, Joshi et al (2013) noted depression to be the second most 
frequently occurring illness following social phobia in 63 adults in the United States of 
America.  
Lifetime bipolar II disorder has a reported prevalence of 25%, current bipolar II disorder 
of 9% and current bipolar I as 6% in the normal IQ adult ASD population (Lugnegård 
2011, Joshi 2013). Rates of bipolar illness reported in this study were lower at 2%. As 
comparable lifetime prevalence rates in the general population are bipolar I disorder 
0.35% - 0.6% and bipolar II disorder 0.8% (Merikangas 2007, Perälä 2007), rates of 
illness in this study sample remain at least two fold higher than the general population.  
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Self-injurious and Suicidal Behaviour in Normal IQ Adults with Autism Spectrum 
Disorder 
As research in deliberate self-harm in adults with normal IQ autism spectrum disorder 
is rare, rates are often extrapolated from mixed IQ and mixed age samples. One study 
on mixed IQ adults with autism spectrum disorder identified 14.4% of patients with a 
history of self-harm (Kobayashi, 1998). A mixed age study of individuals with normal 
IQ autism spectrum disorder noted suicidal ideation in 40% of their study group while 
15% reported a previous suicide attempt (Balfe, 2010). Similarly, a study of adults with 
mixed IQ autism spectrum disorder identified suicidal ideation in 31% of respondents 
but lower rates of previous suicide attempt at 4%, deliberate self-harm in 4% and 
completed suicide in almost 8% (Raja, 2011). Studies in normal IQ autism spectrum 
disorder include Cassidy et al (2014) who reported suicidal ideation in 66% of 374 
adults with Asperger’s syndrome, Ryden et al (2008a) reported a 17% prevalence of 
suicide attempt in 130 normal IQ adults with autism spectrum disorder in Sweden, while 
Paquette-Smith et al (2014) reported a prevalence rate of 35% for attempted suicide 
in 50 adults with Asperger’s syndrome in Ontario. Rates of completed suicide in adults 
with normal IQ autism spectrum disorder have not been reported (Richa, 2014). 
This study identified a prevalence rate of 25% for deliberate self-harm and a rate of 
16% for self-injurious behaviour in participants with autism spectrum disorder. It is 
difficult to compare these rates to previous literature given the wide array of 
nomenclature used in the area of self-induced injury. It would however appear to be 
broadly in line with previous estimates of 17% - 35% and again remains significantly 
higher than the 3% rate reported for the general population. 
 
Personality Disorders in Normal IQ Adults with Autism Spectrum Disorder 
Cluster A personality disorders, namely schizoid, schizotypal and paranoid personality 
disorders and Cluster C, obsessive-compulsive, anxious-avoidant and dependent 
personality disorders are more common in adults with normal IQ autism spectrum 
disorder than the general population (Anckarsäter, 2006). Rydén et al (2008b) studied 
a group of 41 difficult-to-treat adult female patients with normal IQ emotionally unstable 
personality disorder in Stockholm, to determine the rate of comorbid autism spectrum 
disorder in this population. They identified a comorbidity rate of 15% in their EUPD 
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patients which they described as ‘high’ and ‘substantial’. Of interest, all patient with 
emotionally unstable personality disorder fell into the milder ASD subtypes of 
Asperger’s syndrome or PDD-nos.  
Sixty two percent of participants with normal IQ autism spectrum disorder in a 2009 
study by Hofvander et al were found to have a comorbid personality disorder. 
Obsessive-compulsive personality disorder was the most frequently diagnosed at 32%, 
followed by avoidant (25%), schizoid (21%), paranoid (19%), schizotypal (13%), 
borderline (9%), dependent (5%) and antisocial and narcissistic (3%) personality 
disorders. No patient received a diagnosis of histrionic personality disorder. Strunz et 
al (2015) also noted a high prevalence of personality disorder in 59 normal IQ adults 
with autism spectrum disorder in Berlin, Germany. They reported a prevalence rate of 
45%. 
This study found only 2% of participants with autism spectrum disorder to have a 
comorbid personality disorder. This rate is significantly lower than that reported in 
previous literature, ranging from 45% - 62% (Hofvander 2009, Strunz 2015). The 
inconsistency most likely lies in the different assessment methods used between 
studies. Hofvander et al (2009) utilised the SCID-II to assess for personality disorders 
as part of clinical assessment while Strunz et al (2015) used two self-report 
questionnaires to identify personality disorders in their study sample. It is likely that a 
2% prevalence of personality disorder in adults with normal IQ autism spectrum 
disorder, as seen in this study, is an underestimation of the true prevalence rate. 
 
Psychotic Disorders in Normal IQ Adults with Autism Spectrum Disorder 
Schizophrenia has a lifetime prevalence of 0.30% - 0.87% in the general population 
(Perälä 2007, Van Os 2009). Rates among those with autism spectrum disorder are 
less clearly defined. As early as the 1940s, Asperger noted that only one of his 200 
case studies developed schizophrenia (Wing, 1981). Volkmar and Cohen (1991) 
restarted the debate on comorbidity between autism spectrum disorder and 
schizophrenia by examining 163 individuals aged 15 - 41 years with mixed IQ autism 
spectrum disorder in 1991. They identified a single subject with schizophrenia, one 
male with mild intellectual disability from 163 cases assessed. Volkmar and Cohen 
(1991) showed schizophrenia to be rare in individuals with autism spectrum disorder, 
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‘no more commonly observed together than would be expected by chance’. 
Unfortunately, research on the prevalence of comorbid psychotic disorders in adults 
with autism spectrum disorder over the subsequent decades has been scarce 
(Nylander, 2008). Skokauskas et al (2010) conducted a systematic literature search of 
all available studies and did not identify a single such study in the intervening two 
decades. They report a prevalence rate of zero percent to 6% by combining results 
from 11 studies of child and adult subjects with mixed IQ. Following on from 
Skokasukas et al (2010), this study identified four papers addressing the prevalence 
rates of psychotic illness in normal IQ adults with autism spectrum disorder, Hofvander 
et al (2009), Lugnegård et al (2011), Joshi et al (2013) and Selten et al (2015). Both 
Hofvander et al (2009) and Joshi et al (2013) provided prevalence rates for the global 
term ‘psychotic disorders’, ranging from 8% - 12%. Lugnegård et al (2011) identified 
the conditions by subtype; reporting a 2% prevalence rate for brief psychotic disorder, 
2% prevalence of psychotic syndrome-nos, 13% prevalence of ‘recurrent 
hallucinations’ and zero percent for schizophrenia, schizoaffective disorder and 
substance-induced psychotic disorder. Selten et al (2015) took a broader approach, 
incorporating six psychotic illnesses under the term nonaffective psychotic disorder 
(NAPD). By examining the occurance of NAPD in 9,062 young adults of mixed IQ they 
demonstrated a prevalence rates of 0.6% in cases compared to 0.1% of controls. 
Distinguishing between those with and without an intellectual disability, they showed 
NAPD to occur at a rate of 0.4% in normal IQ young adults with autism spectrum 
disorder, representing a four-fold increased risk of NAPD. Unspecificed nonorganic 
psychotic disorder was the most commonly occurring form of NAPD at 45.6%. 
Schizophrenia was diagnosed in 9 cases representing a prevalence rate of 0.99%, 
comparable to the rate among controls. The high detection rate for unspecified 
psychotic disorder may account for the higher odds ratio noted by Selten et al (2015) 
compared to other researchers. 
Researchers interested in schizophrenia have also looked at rates of autism spectrum 
disorder in their study samples. One such study identified far higher comorbidity rates 
between schizophrenia and autism spectrum disorder than noted above. Hallerbäck et 
al (2012) examined 46 young adults aged 23 - 33 years with schizophrenia or 
schizoaffective disorder for the presence of autism spectrum disorder using the SCID, 
DISCO-11 and AQ. A significantly higher prevalence rate for autism spectrum disorder 
was recorded at 52%, mostly among the subgroup with paranoid schizophrenia. The 
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authors acknowledge their rates are ‘clearly at odds with the widespread clinical view 
that there is little or no overlap between autism and schizophrenia’ which they attribute 
to limitations in their study design such as small sample size, preponderance of males 
and use of the DISCO-11 instead of gold standard tools such as the ADI-R and ADOS-
G. 
This study showed a 4% prevalence rate of schizophrenia in normal IQ adults with 
autism spectrum disorder. It also identified schizophrenia as the only psychotic 
disorder diagnosed in participants with autism spectrum disorder. This rate is in 
keeping with previous literature and midway between previously reported rates of zero 
percent to 8%. 
 
Substance Use Disorders in Normal IQ Adults with Autism Spectrum Disorder 
Research is at odds regarding the use of substances by individuals with autism 
spectrum disorder. Authors have suggested that individuals with autism spectrum 
disorder may turn to drugs and alcohol in an attempt to alleviate social awkwardness, 
thereby increasing their risk for substance use disorder (Sizoo, 2009). However, Miles 
and McCarthy (2012) proposed that individuals with autism spectrum disorder would 
have lower rates of substance use disorder owing to their lack of peer relationships 
and lack of social interactions in which alcohol / drugs would be a feature.  
Ketelaars et al (2008) and Hofvader et al (2009) reported substance use disorder of 
16% - 20% in adults with normal IQ autism spectrum disorder in Northern Europe. In 
2009, Sizoo et al examined 75 normal IQ adult patients with autism spectrum disorder 
and comorbid addictive alcohol and drug use identifying a prevalence rate of 18% for 
comorbid substance use disorder in the Netherlands. In 2010, when examining a 
further 70 normal IQ adults with autism spectrum disorder, the group noted a 
prevalence rate of 30% for alcohol, drug and gambling addiction (Sizoo, 2010). Joshi 
et al (2013) reported current alcohol and drug addiction rates of 6% and 3% 
consecutively in a group of 63 normal IQ adults with autism spectrum disorder in the 
United States of America.  
Although rates vary widely and research in the area is severely limited, it does appear 
substance use disorder in normal IQ adults with autism spectrum disorder ranges from 
3% - 30%. This is lower or in line with rates of addiction in both the general population 
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and the psychiatric population (Sizoo 2010, Miles 2012) indicating substance use 
disorder is no more prevalent in the ASD population than in other populations. Early 
identification and diagnosis of those with substance use disorder remains an important 
issue to ensure those with the comorbidity receive early and appropriate treatment 
(Singh 2012, Kronenberg 2014). A targeted approach to individuals with comorbid 
substance use disorder and autism spectrum disorder, differing to the approach 
applied to treatment of addiction in the general or other psychiatric populations, can be 
used to good effect (Kronenberg, 2014). This includes creating and maintaining 
structure in the lives of those with autism spectrum disorder and addiction as well as 
working to strengthen their self-management skills (Kronenberg, 2014).  
This study identified a 2% prevalence for substance use disorder in normal IQ adults 
with autism spectrum disorder. Alcohol addiction was found to be the most frequently 
occurring substance use disorder. This rate is significantly lower than that quoted in 
previous literature. However, individuals with autism spectrum disorder were 
statistically less likely to use illicit drugs than individuals with other psychiatric illnesses 
assessed in this study, which is in line with previous literature. 
 
Eating Disorders in Normal IQ Adults with Autism Spectrum Disorder 
Eating disorders include anorexia nervosa, bulimia nervosa and binge-eating disorder 
(American Psychiatric Association, 2013). Lifetime prevalence estimates among 
women in the general population are: anorexia nervosa 0.9%, bulimia nervosa 1.5% 
and binge-eating disorder 3.5% (Hudson, 2007). Rates among men in the general 
population are slightly lower at: anorexia nervosa 0.3%, bulimia nervosa 0.5% and 
binge-eating disorder 2% (Hudson, 2007).  
While research on eating disorder in normal IQ adults with autism spectrum disorder 
is scarce, it is agreed that autism spectrum disorder is over-represented in the anorexia 
nervosa population (Oldershaw, 2011). A single study was identified from the literature 
quoting a prevalence rate for eating disorder among adults with normal IQ autism 
spectrum disorder, Hofvander et al (2009) who found 5% of their study sample suffered 
from an eating disorder. The rate seen in this study is similarly low at 2%.  
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Tic Disorder, including Tourette’s syndrome in Normal IQ Adults with Autism 
Spectrum Disorder 
While considerable comorbidity between tic disorder and autism spectrum disorder is 
noted in child cohorts (Bejerot, 2007), the prevalence of adult Tourette’s syndrome and 
tic disorder in the ASD population has been reported only three times. Hofvander et al 
(2009) reported a 20% prevalence rate of tic disorder, Lugnegård et al (2011) identified 
a 5% prevalence rate for Tourette’s syndrome and Joshi et al (2013) reported a lower 
rate of 2%. This study showed a prevalence rate of 1%, which is a further reduction in 
rates. It is interesting that the rate of comorbid Tourette’s syndrome is so low 
considering the neurodevelopmental origins of both disorders. This may be due to 
difficulty distinguishing between tics and stereotyped repetitive behaviours (Lainhart, 
1999). Without targeted research it is not possible to determine whether the low rate is 
due to expert clinical skill leading to clearer diagnostic identification of tic disorder in 
those with normal IQ autism spectrum disorder or poor diagnostic ability leading to 
misdiagnosis and under-reporting. 
 
Catatonia in Normal IQ Adults with Autism Spectrum Disorder 
To the best of my knowledge a prevalence rate for catatonia in adults with normal IQ 
autism spectrum disorder has not been published. This study is the first to refer to 
catatonia in this population and reports a prevalence rate of zero percent. This is 
unexpected given a reported prevalence of 6% - 18% in child and intellectual disability 
populations and the high rate of other illnesses, with which catatonia is associated, in 
this population. In this study, it may relate to the lack of a screening questionnaire for 
catatonia as part of the assessment process, it may be due to the low occurrence of 
the more commonly catatonia-associated physical and psychiatric illnesses in the 
study sample or catatonia may in fact be an extremely rare condition among adults 
with normal IQ autism spectrum disorder. 
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Psychiatric Illness in Asperger’s Syndrome Compared to Other Forms of Autism 
Spectrum Disorder 
Research findings in the area of outcome and comorbidity by ASD subtype is sparse. 
Ghaziuddin et al (2002) noted a lack of research on conditions co-occurring with milder 
forms of autism spectrum disorder, such as Asperger’s syndrome and PDD-nos, 
compared to childhood autism. This was reinforced in 2008 by Ketelaars et al who 
noted an ongoing deficit in research. In 2005, Billstedt et al reported a tendency 
towards poorer outcome in individuals with ‘classic’ autism compared to those with 
milder forms of the condition. However, this study is not entirely representative as 95% 
of their study sample had a comorbid intellectual disability.  
This study showed that individuals with Asperger’s syndrome were statistically more 
likely to be diagnosed with a comorbid psychiatric illness compared to individuals with 
other forms of autism spectrum disorder. It also showed that obsessive compulsive 
disorder occurred at a statistically higher frequency among participants with Asperger’s 
syndrome compared to participants with other forms of autism spectrum disorder. 
Although Asperger’s syndrome was previously considered to have a substantially 
better social outcome than childhood autism - such as higher psychosocial adjustment, 
higher rates of independent living, greater educational attainment and more frequently 
in a relationship (Cederlund 2008, Henninger 2012, Lehnhardt 2012), no comparable 
research is available in relation to rates of comorbid psychiatric illness. It is possible 
that individuals with Asperger’s syndrome could show greater social attainment while 
still suffering from higher rates of comorbid psychiatric illness.  
 
Gender Differences in Rates of Psychiatric Illness in Normal IQ Adults with 
Autism Spectrum Disorder 
Although studies from the 1990s showed that females with autism spectrum disorder 
tended to do worse than males (Billstedt, 2005b), research in the 2000s showed males 
fare worse than females (Cederlund, 2008). To complicate the picture further, more 
recent research would imply that the differences between outcomes in males and 
females are very few (Hofvander, 2009) or non-existent (Lugnegård, 2011). Vannucchi 
et al (2014a) have suggested that women display greater improvements in 
compensatory socio-communication ability into adulthood suggesting outcomes can 
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vary if older females are assessed. Kočovská et al (2012) agree that age of 
assessment impacts on findings in female cohorts, but argue in the opposite direction, 
saying more female cases of autism spectrum disorder are missed if assessed at a 
younger age. Although statistical significance was lost on correction for multiple 
testing, this study initially showed that adult females with autism spectrum disorder are 
more likely to suffer from bipolar affective disorder than males. As bipolar affective 
disorder was relatively rarely diagnosed among the study sample, examination of a 
larger cohort could possibly clarify this finding.  
Discrepancies remain as to the impact of gender on epidemiology, symptom 
expression and outcomes in autism spectrum disorder. This area would benefit from 
further research given the significant rates of morbidity and social suffering associated 
with undiagnosed bipolar affective disorder and mania. 
 
4.4.3 Physical Illness in Normal IQ Adults with Autism Spectrum Disorder 
Early researchers believed individuals with autism spectrum disorder lacked the ability 
to perceive pain, to communicate their distress and in fact lacked ‘the social inclination’ 
to do so (Lainhart, 1999). More recently authors have hypothesised that individuals 
with autism spectrum disorder have difficulty reporting physical complaints and instead 
express pain and physical distress as agitation and / or behavioural disturbance 
(Russell, 2005). There is an urgent need to accurately assess the patterns and rates 
of physical comorbidity in adults with autism spectrum disorder. At planning and policy 
level, it is also important to understand the physical health needs of adults with autism 
spectrum disorder, if clinicians are to ensure the delivery of effective treatment services 
(Mouridsen, 2012). 
Medical conditions are seen in approximately 10% - 20% of the intellectual disability 
population suffering from autism spectrum disorder (Oliveira, 2007). A number of 
conditions in particular are thought to occur more commonly, including epilepsy, 
tuberous sclerosis and retinopathy (Gillberg, 2000). However, previous literature on 
comorbidity in normal IQ adults with autism spectrum disorder is sparse. Only 
anecdotal accounts exist in relation to adults with normal range IQ, many of which 
hypothesise that rates of physical ill-health are increased compared to the general 
population (Howlin, 2012). This study could not identify a comparable paper of physical 
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illness rates in normal IQ adults with autism spectrum disorder. The closest matching 
research was a study by Kelbrick et al (2015), which looked at physical illness in 16 
adult males with mixed IQ levels. Kelbrick and colleagues identified a prevalence rate 
of 50% for at least one comorbid physical illness across a range of body systems. The 
most commonly reported ailment was cardiometabolic illness including 
hyperlipidaemia, excess weight, low activity levels and hypertension. 
This study identified a prevalence rate of 84% for at least one physical health condition 
among normal IQ adults with autism spectrum disorder, noting atopy, asthma and 
head-injury to be the most commonly reported physical ailments. Findings would 
suggest physical ill-health to be more common among adults with normal IQ autism 
spectrum disorder compared to a mixed IQ sample. This is unexpected as the proven 
increased rates of physical illness among adults with intellectual disability compared to 
the general population (Emerson, 2016) would suggest that physical illness in normal 
IQ autism spectrum disorder surpasses both. 
 
Neurological Conditions in Normal IQ Adults with Autism Spectrum Disorder  
The prevalence of epilepsy within the neurotypical population is reported as 2% - 3% 
for children and 0.63% for adults (Canitano 2007, Bolton 2011). To my knowledge, only 
a single study has reported the prevalence rate of epilepsy among normal IQ adults 
with autism spectrum disorder. Mouridsen et al (2011) reported epilepsy rates among 
118 adults who had received a diagnosis of autism spectrum disorder as children. Their 
study group was of mixed IQ but as they report results for each of three distinct IQ 
categories, the prevalence rate for epilepsy in adults with autism spectrum disorder 
and an IQ greater than 69 was noted to be 8.8% (Mouridsen, 2011). 
Epilepsy rates in this study were lower than expected at 3%, the third most frequently 
occurring neurological condition in participants with autism spectrum disorder. As there 
is only one previous study for comparison, it is difficult to know why the rates in this 
current study are lower than previously seen. One possible reason could be Mouridsen 
et al’s restriction of their sample to individuals with childhood autism only. Comparably, 
childhood autism only comprised 25% of this study’s cohort of individuals with epilepsy. 
As childhood autism is considered to be lower functioning than the three other subtypes 
of autism spectrum disorder and epilepsy occurs at higher rates in low-functioning 
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individuals, such as those with an intellectual disability compared to the general 
population, it is possible that the prevalence of epilepsy is higher in individuals with 
childhood autism compared to those with Asperger’s syndrome, PDD-nos and atypical 
autism. This may indicate an over-representation of the prevalence of comorbid 
epilepsy in Mouridsen et al’s sample. Further research is required to expand the 
literature on this subject. 
 
Atopy in Normal IQ Adults with Autism Spectrum Disorder 
Atopy was the most prevalent disease among participants with autism spectrum 
disorder recorded at a rate of 22%. This group consisted primarily of individuals 
suffering from asthma (16%). Rates for allergic rhinitis and eczema were 6% and 5% 
respectively. 
It is difficult to compare rates of asthma in those with normal IQ autism spectrum 
disorder to the general population given the significant geographical variation in 
asthma prevalence and the scarcity of literature relating to asthma in individuals with 
autism spectrum disorder. The illness is thought to occur at an average rate of 4.3% 
worldwide (To, 2012). However it appears at the significantly higher rate of 18% in the 
United Kingdom, where this study sample resided (To, 2012).  
Two studies reporting rates of asthma in autism spectrum disorder were identified as 
part of the literature review for this study. Lyall et al (2015) recorded a prevalence rate 
of 16% in a child cohort in the USA. Kobayashi et al (1998) reported a significantly 
lower rate of 7% in adults with intellectual disability in Japan.  Comparatively, the 
general population prevalence rates for asthma in the United States and Japan are 
lower at 7.8% and 6.5% respectively (Nishima 2009, Moorman 2011). A prevalence 
rate for asthma in normal IQ adults with autism spectrum disorder could not be 
identified as part of the literature search for this study. Overall however, it would appear 
that the rate of 16% identified in this study is comparable to the rate seen in the general 
population in the same region. 
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Allergies in Normal IQ Adults with Autism Spectrum Disorder 
This study reported a prevalence rate of 43% for allergies in adults with autism 
spectrum disorder. Lyall et al (2015) reported a slightly higher rate of allergy in those 
with autism spectrum disorder compared to neurotypical controls in a sample of 951 
children in the United States, occurring in 42% and 40% respectively. Dairy was the 
most frequently occurring food allergy and penicillin was the most frequently occurring 
medication allergy. This study showed comparable rates of overall allergy to those 
seen in Lyall et al’s normal IQ paediatric cohort. 
Food allergies are estimated to affect 5% of the general adult population (Sicherer, 
2014) and were suspected to be higher in individuals with autism spectrum disorder 
(Råstam, 2008). This study identified food allergies among 2% of the ASD sample. 
Despite Råstam et al’s prediction, rates of food allergy appear to be lower than that 
seen in the general population. Rates of medication allergy in the general population 
are approximately 7% (Demoly, 2014). This study reported a medication allergy rate 
of 10%, slightly higher than that seen in the general population. A comparable 
prevalence rate for allergies, to food or medication, in adults with normal range IQ and 
autism spectrum disorder could not be identified as part of the literature review for this 
study.  
 
Sleep Difficulties in Normal IQ Adults with Autism Spectrum Disorder 
Sleep appears to be a relatively well-researched topic in autism spectrum disorder. In 
fact, it has been referred to as the second most researched area of ASD comorbidity, 
only surpassed by epilepsy (Mannion, 2014b). This literature review supports this 
finding sourcing a large number of studies relating to normal IQ individuals of all ages 
with autism spectrum disorder. A possible reason for the greater interest in sleep 
disorders may be the established link between sleep disturbance, age and intellectual 
functioning in autism spectrum disorder. 
Sleep studies in normal IQ infants with autism spectrum disorder have shown that 90% 
of sleep difficulties start at an early age including difficulty falling asleep, more frequent 
night waking and early morning waking (Øyane, 2005). Studies of school-age children 
with autism spectrum disorder have noted difficulties with bedtime resistance, 
increased sleep latency, poor sleep maintenance, early morning waking, reduced 
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sleep time and quality, increased night waking and irregular sleep patterns in 50% - 
80% of subjects (Øyane 2005, Limoges 2005, Canitano 2007, Reynolds 2011). 
Insomnia rates of 36% have been reported in the child population, most commonly 
middle insomnia, followed by initial insomnia (Mattila, 2010). Adolescent and young 
adult studies also identify a high prevalence of sleep disorders (80%) including low 
sleep efficiency, short total sleep time, long sleep latency, more frequent shifts into 
REM sleep from waking and increased REM sleep disruption (Ghaziuddin 2002a, 
Øyane 2005).  
Studies in adults with normal IQ autism spectrum disorder have identified a less stable 
circadian rhythm relating to sleep, weaker links to environmental synchronisers, 
difficulty initiating and maintaining sleep, increased early morning waking, increased 
REM sleep disruption and fragmentation, reduced sleep quality, quantity and 
efficiency, reduced periods in NREM and slow wave sleep, reduced rapid eye 
movements during REM sleep, reduced sleep spindles with increased θ power and 
reduced Δ power on EEG and higher rates of periodic limb movements of sleep 
(Godbout 1999, Tani 2003, Tani 2004, Limoges 2005, Hare 2006a). However, as yet 
the prevalence rate for sleep disturbance and sleep disorders among adults with 
normal IQ autism spectrum disorder have not been reported (Deliens, 2015). 
In this study, 42% of participants with autism spectrum disorder reported sleep 
difficulties. Initial insomnia was the most frequently occurring sleep difficulty followed 
by middle insomnia, reversal of sleep-wake cycle, childhood insomnia and early 
morning waking. Hypersomnia was rarely reported. To my knowledge, this is the first 
recorded prevalence rate of sleep difficulties in adults with normal IQ autism spectrum 
disorder. It is comparable to rates seen in school-age children but lower than rates 
reported in adolescents. This suggests that while sleep difficulties vary with age in 
individuals with autism spectrum disorder, rates remain extremely high at each 
developmental stage.  
The aetiology of sleep disturbance in individuals with autism spectrum disorder 
remains to be clarified. A number of theories have been proposed over the decades, 
although none have proven sufficient to explain each impairment of sleep function. 
Some theories are outlined below, the variety of which suggests the aetiology of sleep 
difficulties in autism spectrum disorder is most likely multifactorial. 
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 Psychiatric illnesses such as depression and demographic factors such as 
gender could influence sleep quality and quantity, however this has not been 
shown by objective assessment (Tani 2004, Hare 2006a). 
 
 A previous suggestion by Tani et al (2004) that increased baseline anxiety 
worsening sleep quality and quantity was explored by Limoges et al in 2005. 
Limoges and colleagues measured both anxiety and cortisol levels in normal IQ 
adults with autism spectrum disorder with and without sleep disturbance. They 
showed both anxiety scores, rated on the State-Trait Anxiety Inventory and 
saliva cortisol levels to be equal in both groups concluding ‘this prevents further 
association’ between anxiety spectrum disorders, autism spectrum disorder and 
sleep disturbance (Limoges, 2005). 
 Physical comorbidities commonly seen in those with autism spectrum disorder 
such as epilepsy, obstructive sleep apnoea, constipation, eczema and asthma 
could account for a proportion of sleep difficulties (Richdale 2009, Reynolds 
2011). 
 
 Strict nocturnal routines, as part of the insistence on sameness, seen in autism 
spectrum disorder have been suggested as a cause for poor sleep patterns in 
ASD individuals. Theorists suggest a rigid and unusual night-time routine can 
lead to difficulty settling to sleep (Richdale, 1999) and could explain difficulties 
with sleep latency. 
 
 Social and communication deficits have been suggested as resulting in the ASD 
individual missing environmental cues that act for others as indicators of 
bedtime (Richdale, 2009). 
 
 Hypersensitivity to external noise has been proposed as a cause for initial 
insomnia in those with autism spectrum disorder (Tani, 2003). 
 
 Neurochemical and neuropharmacological studies have noted deficits in 
plasma 5-HT in individuals with normal IQ autism spectrum disorder. This could 
be associated with sleep disturbance as melatonin, a major element in the 
modulation of the circadian rhythm relating to the human sleep-wake cycle, is 
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synthesised from serotonin (Hare 2006a, Reynolds 2011). Abnormal levels of 
melatonin and elevated levels of catecholamines have also been implicated in 
paediatric studies (Venkat, 2012). 
 
 In my opinion, increased use of hypnotics and benzodiazepines in the adult ASD 
population could also account for the differences in sleep patterns. However, 
studies to date have not examined this possible link.  
 
It is important to determine the presence of sleep difficulties in individuals with autism 
spectrum disorder as such difficulties are highly debilitating yet highly amenable to 
treatment. Treatment options for sleep difficulties in individuals with autism spectrum 
disorder include behavioural therapy, chronotherapy, light therapy, massage therapy 
and use of immediate-release melatonin to reduce sleep latency or controlled-release 
melatonin to increase total sleep time (Richdale 1999, Øyane, 2005, Canitano 2007, 
Galli-Carminati 2009, Guénolé 2011, Deliens 2015). 
 
Eating Disturbance in Normal IQ Adults with Autism Spectrum Disorder 
Although historically considered almost diagnostic for autism spectrum disorder, eating 
disturbance is now known to be associated with only 12% - 40% of child and / or 
intellectually disabled individuals with autism spectrum disorder (Gillberg 2000, 
Whiteley 2000, Råstam 2008, Kuschner 2015). As part of the literature review for this 
study, the author was unable to find a published prevalence rate for eating disturbance 
in normal IQ adults with autism spectrum disorder. Kuschner et al (2015) also noted 
an absence of published literature relating to abnormal eating habits in adults with 
autism spectrum disorder without an intellectual disability.  
Six of Kanner’s original case studies displayed feeding difficulties in infancy while two 
of Asperger’s cases had a below average body weight (Kanner 1943, Råstam, 2008). 
Kanner (1943) proposed that the rejection of food by infants with autism spectrum 
disorder was their way of expressing an anxiety to ‘keep the outside world away’ and 
an effort to not be interfered with. Through the 1980s and 1990s, a link was made 
between excess CNS opioid, derived from gluten and casein foods, and challenging 
behaviour in children with autism spectrum disorder (Whiteley, 1999). A Cochrane 
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review in 2008 showed evidence for this theory to be poor (Millward, 2008) and it has 
since largely fallen from favour (Lange, 2015). More recently, Kuschner et al (2015) 
reported a preference for familiar foods, dislike of textured foods such as apple sauce, 
cottage pie and chunky peanut butter and strong flavours such as spices among 65 
adolescents and young adults with normal IQ autism spectrum disorder. This suggests 
a link between eating disturbance and sensory processing difficulties in the normal IQ 
ASD population. 
Eating disturbance was noted in 25% of participants with autism spectrum disorder in 
this study. Restricted dietary repertoire was the most commonly reported eating 
disturbance. Further difficulties included reduced appetite, picky eating, eating only a 
single meal per day, only eating when alone, unhealthy dietary choices, binge-eating, 
overeating and unhealthy dietary choices. Though rates are comparable to those seen 
in child and intellectual disability ASD populations, true comparison is not possible due 
to the likely differences in clinical significance, social impact of such difficulties and 
available healthcare / treatment services to children and individuals with intellectual 
disability such as dietetics, occupational therapy and speech and language therapy, 
not currently available for normal IQ adults with autism spectrum disorder. It is 
unfortunate that the findings of this study cannot be compared to rates in the general 
population or the normal IQ ASD population, given the significant number of 
participants outlining such difficulties. 
 
Motor Skills in Normal IQ Adults with Autism Spectrum Disorder 
Asperger described awkwardness as typical in autistic psychopathy (Wing 2002a, 
Barnhill 2007, Raja 2009) while Kanner (1943) noted that several children under his 
care were somewhat clumsy in gait with gross motor deficits but all were skilled in fine 
motor movements. Although not included in the DSM-5 diagnostic criteria, clumsiness 
is commented upon in the ICD-10’s description of Asperger’s syndrome (World Health 
Organisation, 1992). Wing (1981) observed poorly co-ordinated movements, odd 
posture and abnormal gait while more recently Vannucchi et al (2014b) described 
clumsiness and illegible handwriting as atypical features of Asperger’s syndrome and 
Van Wijngaarden-Cremers et al (2014) noted clumsiness in the case of a 14 year old 
girl with Asperger’s syndrome and comorbid drug addiction.  
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In general, it is acknowledged that motor skill deficits are frequently observed in 
patients with autism spectrum disorder with a prevalence of 21% - 100% (Gowen, 
2012). This study reports dyspraxia rates of 8% in adults with normal IQ autism 
spectrum disorder. This rate is lower than that previously reported. This may be due to 
the lack of a screening questionnaire for motor skill deficits as part of the clinical 
assessment or the lack of occupational therapy input as part of the multidisciplinary 
assessment.  
 
Smoking in Normal IQ Adults with Autism Spectrum Disorder 
Available research on smoking rates in those with autism spectrum disorder is sparse 
(Mattila, 2010). As part of this literature review, only two papers were found in relation 
to this research question, Bejerot and Nylander (2003) and Joshi et al (2013). Bejerot 
and Nylander (2003) reported a current smoking rate of 15.8% in 95 community 
dwelling normal IQ adults with autism spectrum disorder in Stockholm, Sweden. 
‘Current’ smoking was defined as the consumption of at least one nicotine containing 
product (cigarette or snuff) per day for the preceding six months. Joshi et al (2013) 
reported a current smoking rate of zero percent in 63 adults with normal IQ autism 
spectrum disorder attending an adult neurodevelopmental clinic in Massachusetts, 
USA. Smoking prevalence among the general public is 10.7% in Sweden and 13.7% 
in North America (OECD, 2013). Both papers suggest a lower rate of smoking in 
patients with autism spectrum disorder compared to the psychiatric population but 
comparable rates to the general public.  
This study identified a similarly low rate of smoking in adults with normal IQ autism 
spectrum disorder compared to the general population. In 2014, 19% of adults in the 
United Kingdom were smokers (Ash, 2016). As only 12.5% of ASD participants in this 
study were recorded as current smokers, the rate is comparably lower. In fact, smoking 
was statistically less likely in those with autism spectrum disorder compared to 
neurotypical study participants. Suggestions as to the reason for lower smoking rates 
in those with autism spectrum disorder compared to those with other psychiatric 
illnesses include reduced social outlets, rigid routines and lower reward dependence 
(Bejerot, 2003). 
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Gastrointestinal Disease in Normal IQ Adults with Autism Spectrum Disorder 
Available research in relation to gastrointestinal disease in autism spectrum disorder 
is varied and controversial. Less again is available in relation to the prescription of 
gastrointestinal medications in individuals with autism spectrum disorder. However, 
both the literature review and identified rates of gastrointestinal disease among ASD 
participants in this study would suggest that previously reported higher rates of 
gastrointestinal disease in individuals with autism spectrum disorder were greatly 
exaggerated. In this light, the finding that participants with autism spectrum disorder 
were statistically more likely to take medication for gastrointestinal illness, was 
unexpected. Literature could not be found which may explain this discrepancy. 
However, this finding may suggest a lingering perception among physicians that 
individuals with autism spectrum disorder are at higher risk of gastrointestinal disease, 
leading to potential diagnostic overshadowing when assessing patients with 
ambiguous physical symptoms. Further research among primary care physicians 
would be helpful in determining which treatment options they consider in adults with 
normal IQ autism spectrum disorder and vague physical symptoms. 
 
Dyslexia 
Previous literature identifies a prevalence rate of 14% for dyslexia in normal IQ adults 
with autism spectrum disorder (Hofvander, 2009). Dyslexia was infrequently recorded 
in the BGC medical reports reviewed for this study. It would appear that a greater 
number of participants received a diagnosis of dyslexia from their community mental 
health team (dyslexia 8.5%) than at the Behavioural Genetics Clinic (dyslexia 0.3%). It 
is most likely that dyslexia was under-reported in this study as the diagnosis requires 
specialist testing by a psychologist, testing which was not undertaken as part of the 
assessment.  
 
4.5 Possible Aetiology of Comorbid Psychiatric Illness in Autism Spectrum 
Disorder 
There have been many studies that explore the factors placing individuals with autism 
spectrum disorder at increased risk of psychiatric illness but the results of each study 
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and opinion of each researcher varies significantly (Howlin, 2012). While Van Elst 
(2013) promotes a causal relationship between autism spectrum disorder and 
psychiatric illness, specifying that autism spectrum disorder symptoms result in chronic 
conflicts and failure in relationships which in turn lead to depression, anxiety spectrum 
disorders and sometimes psychosis-like stress reactions, other researchers have not 
been so direct. A broad range of risk and causal factors have been suggested including 
age, degree of social deprivation, interplay of environmental factors, poor self-
confidence, severity of ASD symptomatology particularly communication deficits, 
experience of major life transitions and life events such as loss, inadequate support, 
loneliness and social isolation often associated with rejection by peers (Kannabiran 
2009, Howlin 2012).  
 
Stress Response 
Stress is a physical reaction of the body to happy or unhappy life events, which place 
the individual under pressure to maintain the homoeostasis of equilibrium (Hirvikoski, 
2014). It is a subjective experience when an individual feels the perceived social 
demands outweigh their available resources and skill-set (Hare, 2014). Exactly what 
type of experience or demand is considered stressful differs from individual to 
individual as does the individual’s subjective opinion of their ability to withstand such 
pressures (Hirvikoski, 2014). Should the individual repeatedly endure such stressors, 
psychological sequelae can result including psychiatric illness (Groden, 2001). 
Individuals with autism spectrum disorder report significantly higher stress levels and 
a poorer ability to cope compared to neurotypical individuals (Hirvikoski, 2014). This 
could account for a higher rate of psychiatric illness in this population. 
Hirvikoski et al (2014) examined self-perceived stress levels in 25 adults with autism 
spectrum disorder in Stockholm, Sweden. In this study, intellectually able adults with 
autism spectrum disorder reported high levels of subjective stress and a perception of 
low coping ability regarding stressors in everyday life. High levels of self-perceived 
stress were statistically associated with higher perceived distress and lower perceived 
coping ability, akin to the levels previously shown for individuals with attention deficit 
hyperactivity disorder. Hirvikoski and colleagues suggest a link between executive 
dysfunction, sensory processing difficulties and impaired adaptive behaviour in autism 
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spectrum disorder and the inability to select an appropriate coping skill. Despite 
average intellectual capacity, individuals with autism spectrum disorder struggle in 
many everyday situations (Hirvikoski, 2014). Without the required coping skills to 
adequately manage such stresses they are at increased risk for anxiety spectrum 
disorders and depressive illness (Gillott 2007, Hare 2014).  
Many of life’s greatest challenges are endured during adolescence. It is the time of 
greatest change, of self-awareness and self-development, a time of individuation from 
the primary care giver and of starting one’s journey into adulthood. This transition to 
adulthood is particularly challenging for individuals with autism spectrum disorder. The 
increased requirement for proficient interpersonal skills to develop social relationships 
and a supportive social network is notably absent for young adults with autism 
spectrum disorder (Barnhill 2007, Hare 2014).  
As early as 1998, Ghaziuddin et al hypothesised that if depression is proven to be 
more common in individuals with autism spectrum disorder ‘it may be linked to difficulty 
in coping and the resulting social stigma experienced by patients during adolescence’. 
In 1999, Lainhart suggested that ‘difficulties in coping with situations result in 
dysfunctional behaviours and distressful emotions such as anxiety and depression’. 
More recently, significant similarity has been shown between an ASD individual’s 
response to stress, namely through high levels of self-focus and rumination, and the 
cognitive models of generalised anxiety disorder (Hare, 2014). 
Increased insight into the causes of stress, distress and perceived inability to cope with 
social demands in individuals with autism spectrum disorder would be a valuable step 
in understanding the pathway to psychiatric illness in this population. Early diagnosis 
and appropriate support and treatment opportunities would be invaluable in this setting.  
 
Interpersonal Difficulties and Social Isolation 
Features of autism spectrum disorder can negatively affect social functioning. 
Predisposing factors include a compromised capacity for mentalising the feelings and 
self-states of others, poor social perception and social incompetence (Rydén 2008b, 
Van Elst 2013). Since the early 1980s, it has been suggested that the ASD individual’s 
subjective awareness of reduced social functioning can lead to negative self-image, 
feelings of distress, high anxiety states particularly social anxiety, interpersonal 
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difficulties, over-sensitivity to criticism, vulnerability to bullying and victimisation, self-
isolation and loneliness (Wing 1981, Barnhill 2007, Rydén 2008b, White 2011). More 
recently, Van Elst et al (2013) argue that many cases of comorbid psychiatric illness 
including depression, anxiety spectrum disorders and some psychosis-like stress 
reactions, are a direct result of influential ASD symptoms which result in interpersonal 
misunderstandings and failure in personal and work relationships. 
 
Autism Symptomatology 
An association has been shown between severity of ASD symptomatology and rates 
of psychiatric illness. Symptoms such as insistence on sameness, an extensive 
repertoire of fixed behaviours and routines, hyper- and hypo- reactivity to sensory input 
and a fear of change have a relationship with clinically detectable psychiatric illness 
(Gillott, 2007). The inability to accurately predict another’s intent, actions or emotions 
can lead to fear, severe panic and anxiety (Lainhart, 1999). Reduced fine motor co-
ordination can lead to avoidance or compulsive behaviours (Lainhart, 1999). 
Sometimes, cognitive compensatory strategies such as keeping eye contact and 
ensuring accurate turn taking in conversation could lead to exhaustion in adulthood 
(Van Elst, 2013). Depression and anxiety spectrum disorders in particular are felt to 
result from increased severity of ASD symptomatology (Van Elst 2013, Hare 2014). 
 
4.6 Critique of Study Design, Methodology and Sample Selection 
 
Strengths of the Study 
 This study is the first to examine rates of psychiatric and physical comorbidity 
in adults with normal IQ autism spectrum disorder outside of mainland Europe 
and the United States of America. Previous literature from the United Kingdom 
has referred to mixed IQ adult samples or child cohorts. No previous literature 
referring to adults with normal IQ autism spectrum disorder could be sourced 
on an Irish population. 
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 This study examines the largest cohort of normal IQ adults to date. Previous 
studies have ranged in number from 12 to 130 adults, this study includes over 
double that number at 288. This study includes adults across a broader age 
range than previous studies. Previous studies looked at adults up to age 60 
years, this study includes adults up to age 70 years. This study includes a 
sizeable proportion of female participants and participants aged over 50 years, 
two demographics which have been significantly under-represented in previous 
studies. Researchers propose that time and financial constraints have 
previously prevented such a cohort being examined. 
 
 
 This study was based in a national tertiary referral centre specialising in the 
assessment of adults with normal range IQ for autism spectrum disorder. 
Consultant, NCHD and psychology staff are highly skilled in the diagnosis of 
autism spectrum disorder and other psychiatric illnesses. Assessments were 
lengthy and thorough as clinicians used clinical interview, collateral information, 
referral letters, school reports, previous clinical reports, expert clinical opinion 
and multidisciplinary consensus meetings to reach clear diagnoses supported 
by gold standard diagnostic tools. All findings were presented in clear 
standardised reports. These methods exceed previous research for rigour and 
completeness. 
 
 All diagnoses of psychiatric comorbidity and autism spectrum disorder were in 
line with the ICD-10, removing an obstacle encountered by previous 
researchers when diagnostic criteria changed mid-study. All consultants 
provided patients with comorbid diagnoses where appropriate, despite 
hierarchal systems endorsed by ICD-10. 
 
Limitations of the Study 
 The single largest limitation to this study is the lack of a definitive IQ 
measurement for each participant. There is a possibility that participants with 
an IQ outside of the normal range were included as IQ was not directly 
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measured during each assessment. However, dedicated autism spectrum 
disorder clinics assess very low proportions of patients with genetic syndromes 
or autism spectrum disorder related to a known medical condition and these 
children and adults are typically seen in medical genetics clinics (Miles, 2011). 
Furthermore, significant care was taken to identify and exclude any participant 
with a documented or suspected low range IQ or intellectual disability at the 
data gathering stage of this study. 
 
 The use of a clinical sample of individuals referred by community psychiatric 
services is a limitation of this study and a community based, targeted 
recruitment would have been preferable. However, this approach is widely cited 
as time-consuming, resource-consuming and expensive due to the nature of the 
diagnostic assessment required. This reduced the feasibility of recruiting a 
population-based cohort. The present design may thus be the only feasible 
option. Alternatively, use of a psychiatrically-referred population could be 
considered a strength in a clinical sense, as the sample under investigation 
could more closely represent those patients seen by psychiatry colleagues on 
a daily basis allowing greater generalisability.  
 
 Although all attempts were made to extensively include all potential comorbid 
psychiatric and physical illnesses in a normal IQ autism spectrum disorder adult 
population, no comprehensive list of such disorders has been previously 
compiled. This study focuses on well-known Axis I and II psychiatric conditions 
and major physical illnesses. 
 
 Certain parameters were recorded through patient report only. This could lead 
to bias relating to poor recall - examples include history of bullying, childhood 
eating or sleeping difficulties and medical history. Formal assessment such as 
a questionnaire relating to childhood bullying, parental collateral on childhood 
disorders or medical records from the participant’s general practitioner could 
have strengthened the reliability of these data. 
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 Although it would have been preferable to record both prevalence and incidence 
of all psychiatric and physical illnesses, the use of a cross-sectional sample 
does not definitively allow measurement of illness by age of onset, only by 
binary presence or absence at a particular age.  
 
 The Behavioural Genetics Clinic does not routinely accept referrals for patients 
who currently use illicit substances. Consequently, this could reduce this study’s 
ability to pick up a truly reflective prevalence of drug use in participants with 
autism spectrum disorder. 
 
 Sourcing literature on autism spectrum disorder was difficult. Many articles 
focused on a particular subtype of autism spectrum disorder such as childhood 
autism or Asperger’s syndrome, while others favoured a particular subset of 
participants such as children, adolescents, adults or the intellectually disabled 
population. Unfortunately, the majority of authors mixed their study populations, 
often combining children with adults or intellectually disabled participants with 
those of normal intellectual functioning. Some authors also failed to differentiate 
between mixed population studies when citing previous research; 
misrepresenting rates of illness among adults by quoting mixed age studies, 
rates in normal IQ populations by quoting mixed IQ research and aetiology in 
humans by quoting primate studies. Care had to be taken to prevent similar 
errors in this study. While an abundance of literature focusing on children and 
intellectually disabled populations was available, literature pertaining to normal 
IQ adults with autism spectrum disorder was scarce. 
 
 Despite the limitations of this study, it highlights high rates of psychiatric and 
physical comorbidity in an under-researched population and is the largest study 
sample ever to report on this research topic. 
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4.7 Implications for Clinical Practice 
Diagnosis of autism spectrum disorder in normal IQ adults is difficult but crucial 
(Spencer, 2011). Individuals with normal IQ autism spectrum disorder suffer higher 
rates of physical and psychiatric morbidity, display a poorer ability to engage with 
treatment and have a lower chance of recovery. Suspecting and accurately diagnosing 
autism spectrum disorder is important in both understanding the patient’s 
psychopathology and in directing treatment. 
Considering the genetic heritability, neurocognitive deficits, complex psychiatric 
comorbidity, significant physical health needs and the nature of the treatments 
proposed, it is reasonable that psychiatry, based within a multidisciplinary team, is the 
best placed discipline to take responsibility for the assessment, diagnosis and 
treatment of patients with autism spectrum disorder. 
As children previously diagnosed with autism spectrum disorder by child and 
adolescent psychiatrists are growing into adults, they require ongoing medical and 
psychiatric input for complex healthcare needs. As adults, they expect the same 
degree of expertise and knowledge available to them when they were children 
(Nylander, 2008). At present, the health services are not adequately resourced or 
trained to fulfil this requirement. The diagnosis and treatment of physical and 
psychiatric morbidity and comorbidity in normal IQ adults with autism spectrum 
disorder is a significant unmet need. 
Adults with normal IQ autism spectrum disorder have particular and highly specific 
needs. Community mental health teams, general practitioners, hospital medical staff 
and liaison psychiatrists may not be well equipped to diagnose or treat this population. 
Clinicians, at all stages of training and in all disciplines, should be educated to consider 
autism spectrum disorder more frequently in their patients and to adjust not only their 
treatment models but their clinical approach to a large cohort of patients with significant 
social and communication difficulties. 
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The clinical recommendations from this study are: 
 Improved knowledge of childhood disorders (autism spectrum disorder, 
attention deficit hyperactivity disorder and Tourette’s syndrome) by adult 
physicians and psychiatrists as well as increased knowledge of adult disorders 
(personality disorders) by child psychiatrists and paediatricians is needed to 
better serve patients. 
 
 Increased awareness of complex symptom presentations and diagnostic 
overshadowing is required to prevent inappropriate and / or ineffective 
treatments as inappropriate and / or ineffective treatments lead to poorer 
engagement with treatment, leading to poorer health and social outcomes. 
 
 Strong consideration should be given to creating specialist multidisciplinary 
diagnostic teams for assessment and treatment of autism spectrum disorder in 
adults with normal range IQ in the Republic of Ireland. 
 
 Multidisciplinary assessment teams should consist of psychiatry, psychology, 
occupational therapy and speech and language therapy specialists to ensure 
not only accurate diagnosis of a neurodevelopmental disorder if present, but 
accurate detection of each comorbid condition associated with the disorder. 
 
 Increased awareness of autism spectrum disorder, increased availability of 
assessment, creation of targeted treatments programmes and ongoing 
research in the area of adult autism spectrum disorder is vital. 
 
 
4.8 Implications for Future Research  
The area of autism spectrum disorder and comorbidity is grossly under-researched, 
underdiagnosed and undertreated. The problem to date underlying all research has 
been the human and financial resources and the considerable cost involved (Wing, 
2002a). A need for increased research into the neural basis of anxiety spectrum 
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disorders in autism spectrum disorder, the prevalence rate of epilepsy in normal IQ 
adult autism spectrum disorder, the impact of gender on comorbidity and the causes 
of stress and varying coping styles that result in higher rates of comorbidity, were 
identified as under-researched areas of the literature. This study is an initial step 
towards meeting that need, hopefully improving understanding of psychiatric and 
physical illness in adults with autism spectrum disorder.  
Further research should consider the impact timing of a comorbid condition has on 
autism spectrum disorder. Research on the temporal relationship of comorbidity in 
autism spectrum disorder would provide clinicians with a better understanding of the 
effects of comorbidity at different life stages for a patient with autism spectrum disorder, 
allowing more efficient research into treatment options.  
Further research is required into the link between experience of childhood bullying and 
increased rates of anxiety spectrum disorders in adults with autism spectrum disorders. 
Post-traumatic stress disorder in particular is a rarely examined form of anxiety 
spectrum disorder in those with autism spectrum disorder (Morrow Kerns, 2015). 
Studies in neurotypical populations show rates of post-traumatic stress disorder among 
bullied children to range from 28% - 41% and among adolescents to range form 44% 
- 76% (Idsoe, 2012). Hoover (2015) suggests a combination of self- and parental-report 
is sufficient to accurately detect bullying rates in future research. Few valid rating 
scales measuring incidence of bullying could be identified as part of the literature 
review for this study, however future research may consider use of instruments such 
as the Social Vulnerability Scale (Sofronoff, 2011) or the Bullying Screener (Wolke 
2015) to lend strength to the research design. 
Bullying is shown to result in lower educational attainment, increased unemployment, 
reduced tendency to marry or form longterm relationships, reduced social support and 
poorer quality of life in neurotypical adults who were bullied as children (Takizawa, 
2014). Expansion of this area of research to include the social and economic impact 
of bullying for normal IQ adults with autism spectrum disorder would be beneficial. 
Such research would assist previous researchers in calling for educator-based 
interventions for children with autism spectrum disorder who are bullied in mainstream 
school to reduce rates or perhaps prevent the negative social, economic and mental 
health consequences of undetected school-yard bullying on this vulnerable population.  
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Diagnosis of comorbid psychiatric illness in individuals with autism spectrum disorder 
is complex with high rates of misdiagnosis and diagnostic overshadowing noted in 
previous literature (Hannon, 2013). An emerging area of research, the Experience 
Sampling Method, could assist clinicians in better understanding the often unique 
presentation of psychiatric illness in normal IQ adults with autism spectrum disorder. 
Devised in 1975, the Experience Sampling Method is a valid means of capturing the 
subjective experiences of individuals in their natural environment (Csikszentmihalyi, 
2014). The method uses a bleeper or programmed watch to randomly alert the 
research participant to record desired information using questionnaires or free text. 
The Experience Sampling Method has a number of advantages over other research 
designs. It reduces recall bias by using immediate self-report of thoughts, feelings or 
experiences as they occur, is less intrusive and labour intensive than objective 
assessment, is more ethical (Weisner, 2001) and more reflective of an individual’s 
subjective experience than semi-structured or structured interview. It has proven high 
correlation (0.93) with diary entry as a research method (Weisner, 2001). 
The Experience Sampling Method could address questions such as the timing, context, 
nature, severity and impact of psychiatric symptoms in the daily lives of normal IQ 
adults with autism spectrum disorder. It has been used in neurotypical adult patients 
to distinguish ‘social anhedonia’ from social anxiety in schizophrenia and provided 
clearer descriptions of the subjective experience of agoraphobia (Myin-Germeys, 
2009). In 1994, Hurlburt et al used the Experience Sampling Method to examine the 
inner experiences of three high-functioning adults with Asperger’s syndrome. The 
group demonstrated a greater capacity to describe inner emotional experiences, 
especially in visual form than previously appreciated. More recently, Hintzen et al 
(2010) disproved the generally-held belief that a lack of peer relationships on the part 
of ASD individuals was due to social anhedonia. They showed that normal IQ adults 
with high-functioning autism spectrum disorder did not prefer to be alone, did not spend 
more time alone and derived equal pleasure from the company of others as 
neurotypical controls (Hintzen, 2010). Future researchers should utilise the Experience 
Sampling Method to enrich clinical information available to diagnosticians thereby 
improving not only diagnostic methods and diagnostic accuracy but the range and 
effectiveness of treatment options available to normal IQ adults with autism spectrum 
disorder. 
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Research into the ability of normal IQ adults with autism spectrum disorder to access 
healthcare services and identification of the most appropriate treatment pathways for 
this vulnerable group is urgently required. Research performed jointly by child and 
adolescent psychiatrists and adult psychiatrists could be an initial step in this direction. 
A better understanding of the number of children, adolescents and adults with normal 
intellectual ability and autism spectrum disorder within the Irish population is not 
currently available. Data relating to diagnostic rates within the CAMHs service, 
discharge rates and numbers graduating to general adult mental health services is 
acutely lacking.  
Research questions could include: 
 The number of suspected cases of normal IQ autism spectrum disorder referred 
to the CAMHs service on a yearly basis 
 The prevalence of diagnosed normal IQ autism spectrum disorder within the 
CAMHs service 
 An indication of the services provided by CAMHs to children and adolescents 
with normal IQ autism spectrum disorder 
 Discharge rates for children and adolescents with normal IQ autism spectrum 
disorder from the CAMHs service on a yearly basis 
 The frequency of discharge when a patient is considered fit and well compared 
to the numbers discharged due to unavailability of follow-on care 
 
 The number of suspected cases of normal IQ autism spectrum disorder referred 
to the general adult psychiatry services on a yearly basis 
 The prevalence of diagnosed normal IQ autism spectrum disorder within the 
general adult psychiatry services 
 
 An indication of the expertise available within general adult psychiatry services 
to assess and diagnose autism spectrum disorder in adults with normal 
intellectual ability 
 An indication of the resources available to general adult psychiatry services to 
co-ordinate treatment for normal IQ adults with autism spectrum disorder 
 An indication of resource utilisation by individuals with normal IQ autism 
spectrum disorder compared to other patients attending general adult psychiatry 
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services, for example those with transient illness, chronic and enduring mental 
illness, those with personality disorder and individuals with complex care needs 
 
 The number of suspected cases of normal IQ autism spectrum disorder on 
General Practitioner caseloads 
 An indication of the reasoning for such unreferred cases on General Practitioner 
caseloads 
 
 Very little is known of what happens to individuals with autism spectrum disorder 
as they age as almost all adult studies focus on participants aged 20 - 40 years. 
Increased research in older adults; assessing the impact of aging on mental and 
physical health and the diagnostic, treatment and social care health needs of 
this patient group is required. 
 
Valuable information could be gained through the above research questions to 
determine the potential value of creating and implementing a National Care 
Programme in Adult Autism Spectrum Disorder. 
Studies examining ASD individuals of mixed intellectual ability from age 10 to 52 years 
have shown that caring for an individual with autism spectrum disorder is associated 
with greater caregiver burden than caring for a person with an intellectual disability, 
Fragile X syndrome, Down syndrome or attention deficit hyperactivity disorder and 
comparable to levels of strain seen in those caring for individuals with a brain injury 
(Kring 2010, Cadman 2012). Cadman et al (2012) hypothesised that low diagnostic 
rates among adults with high-functioning autism spectrum disorder result in a 
significant lack of health and social care service involvement with the burden of care 
falling to family members. Research focusing on individuals with normal IQ autism 
spectrum disorder is required to determine who provides support and care to these 
individuals, which risk factors lend to increased burden and which moderate risk, the 
impact of receiving a diagnosis of autism spectrum disorder and the impact of comorbid 
psychiatric and physical illness on carer burden. 
Researchers could extend the assessment of burden beyond maternal strain and the 
family unit as higher proportions of high-functioning individuals with autism spectrum 
disorder may be in school, employment and relationships compared to child and ID 
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samples. Studies could utilise distress measurement instruments such as the Brief 
Family Distress Scale (Weiss, 2010) to quantify carer burden allowing comparison with 
prevalence rates of different forms of physical and psychiatric illness. Studies should 
examine the most effective means of supporting family, partners and carers of 
individuals with normal IQ autism spectrum disorder and the cost to society of 
undiagnosed cases.  
It is striking that only ten studies examining psychiatric comorbidity in normal IQ adults 
with autism spectrum disorder were identified as part of the literature review for this 
study. These studies spanned a significant period of research activity, ten years. 
Future research should continue to investigate the overlap between autism spectrum 
disorder, psychiatric illness and physical illness. Addition to this body of knowledge is 
crucial.  
 
 
4.9 Conclusions 
Autism spectrum disorder is a pervasive illness characterised by deficits in social skills, 
impaired communication style and characteristic repetitive and ritualised behaviours. 
It is a lifelong condition associated with significant social suffering, physical morbidity, 
psychiatric morbidity and overall increased mortality. As previously undiagnosed and 
misdiagnosed cases of autism spectrum disorder are identified, the numbers will grow 
worldwide. As the population ages, those diagnosed with autism spectrum disorder will 
reach young, middle and older adulthood. As a consequence, an improved 
understanding of their healthcare needs will be urgently required. 
Adults, just as frequently as children, suffer from autism spectrum disorder and a 
substantial number remain undiagnosed into adulthood. A first diagnosis rate of 82%, 
as seen in this study, highlights the under-recognition of autism spectrum disorder in 
the normal IQ population and by extension in general practice surgeries and 
community mental health clinics. To improve outcomes for adults with autism spectrum 
disorder it is imperative to increase awareness of the condition and ensure diagnoses 
are provided early. However, diagnosis alone without adequate identification of 
comorbid psychiatric and physical illness would be an injustice.  
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This study has shown that 76% of normal IQ adults with autism spectrum disorder 
suffer from a psychiatric illness and 84% suffer from physical ill-health. The presence 
of co-occurring psychiatric and physical illness indicates a potential for increased use 
of psychiatric and medical services by adults with autism spectrum disorder. Although 
there is no known medical treatment, well-structured behavioural interventions have 
been beneficial and high levels of compensatory learning can occur. In this light, all 
clinicians require access to training on appropriate engagement, effective assessment 
and accurate diagnosis of this patient group. Only consistent diagnosis of the primary 
disorder and associated comorbidity will allow appropriate intervention strategies 
resulting in effective treatments for individuals affected by autism spectrum disorder. It 
is important to understand the comorbid needs of our ASD patients if we are to 
adequately support and treat them. 
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